1
|
Saxena A, Ginzler EM, Gibson K, Satirapoj B, Santillán AEZ, Levchenko O, Navarra S, Atsumi T, Yasuda S, Chavez-Perez NN, Arriens C, Parikh SV, Caster DJ, Birardi V, Randhawa S, Lisk L, Huizinga RB, Teng YKO. Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial. Arthritis Rheumatol 2024; 76:59-67. [PMID: 37466424 DOI: 10.1002/art.42657] [Citation(s) in RCA: 12] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Revised: 06/01/2023] [Accepted: 06/13/2023] [Indexed: 07/20/2023]
Abstract
OBJECTIVE AURORA 2 evaluated the long-term safety, tolerability, and efficacy of voclosporin compared to placebo in patients with lupus nephritis (LN) receiving an additional two years of treatment following completion of the one-year AURORA 1 study. METHODS Enrolled patients continued their double-blinded treatment of voclosporin or placebo randomly assigned in AURORA 1, in combination with mycophenolate mofetil and low-dose glucocorticoids. The primary objective was safety assessed with adverse events (AEs) and biochemical and hematological assessments. Efficacy was measured by renal response. RESULTS A total of 216 patients enrolled in AURORA 2. Treatment was well tolerated with 86.1% completing the study and no unexpected safety signals. AEs occurred in 86% and 80% of patients in the voclosporin and control groups, respectively, with an AE profile similar to that seen in AURORA 1, albeit with reduced frequency. Investigator reported AEs of both glomerular filtration rate (GFR) decrease and hypertension occurred more frequently in the voclosporin than the control group (10.3% vs 5.0%, and 8.6% vs 7.0%, respectively). Mean corrected estimated GFR (eGFR) was within the normal range and stable in both treatment groups. eGFR slope over the two-year period was -0.2 mL/min/1.73 m2 (95% confidence interval [CI] -3.0 to 2.7) in the voclosporin group and -5.4 mL/min/1.73 m2 (95% CI -8.4 to -2.3) in the control group. Improved proteinuria persisted across three years of treatment, leading to more frequent complete renal responses in patients treated with voclosporin (50.9% vs 39.0%; odds ratio 1.74; 95% CI 1.00-3.03). CONCLUSION Data demonstrate the safety and efficacy of long-term voclosporin treatment over three years of follow-up in patients with LN.
Collapse
Affiliation(s)
- Amit Saxena
- Division of Rheumatology, New York University School of Medicine, New York, New York
| | - Ellen M Ginzler
- Department of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York
| | - Keisha Gibson
- Department of Medicine, UNC Kidney Center, Chapel Hill, North Carolina
| | - Bancha Satirapoj
- Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand
| | | | | | - Sandra Navarra
- Rheumatology Section, University of Santo Tomas, Manila and St Luke's Medical Center, Quezon City, Philippines
| | - Tatsuya Atsumi
- Department of Rheumatology, Endocrinology and Nephrology, Hokkaido University, Sapporo, Japan
| | - Shinsuke Yasuda
- Department of Rheumatology, Graduate School of Medical and Dental Medicine, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - Nilmo Noel Chavez-Perez
- Unidad de Reumatología, Hospital General de Enfermedades, Instituto Guatemalteco de Seguridad Social, Guatemala City, Guatemala
| | - Cristina Arriens
- Department of Arthritis & Clinical Immunology, Rheumatology, Oklahoma Medical Research Foundation and Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City
| | - Samir V Parikh
- Department of Nephrology, The Ohio State University Wexner Medical Center, Columbus
| | - Dawn J Caster
- Department of Medicine, Division of Nephrology and Hypertension, University of Louisville School of Medicine, Louisville, Kentucky
| | - Vanessa Birardi
- Medical Affairs, Aurinia Pharmaceuticals, Edmonton, Alberta, Canada
| | | | - Laura Lisk
- Clinical Development, Aurinia Pharmaceuticals, Edmonton, Alberta, Canada
| | - Robert B Huizinga
- Reformation Consulting Services, North Saanich, British Columbia, Canada; Research and Development, Aurinia Pharmaceuticals, Edmonton, Alberta, Canada
| | - Y K Onno Teng
- Center for Expertise on Lupus-, Vasculitis- and Complement-mediated Systemic Autoimmune Diseases, Department of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands
| |
Collapse
|
2
|
Cowlishaw S, Gibson K, Alexander S, Howard A, Agathos J, Strauven S, Chisholm K, Fredrickson J, Pham L, Lau W, O’Donnell ML. Improving mental health following multiple disasters in Australia: a randomized controlled trial of the Skills for Life Adjustment and Resilience (SOLAR) programme. Eur J Psychotraumatol 2023; 14:2284032. [PMID: 38073550 PMCID: PMC10993813 DOI: 10.1080/20008066.2023.2284032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/24/2023] [Accepted: 10/20/2023] [Indexed: 12/18/2023] Open
Abstract
Background: The mental health impacts of climate change-related disasters are significant. However, access to mental health services is often limited by the availability of trained clinicians. Although building local community capability for the mental health response is often prioritised in policy settings, the lack of evidence-based programs is problematic. The aim of this study was to test the efficacy of the Skills for Life Adjustment and Resilience programme (SOLAR) delivered by trained local community members following compound disasters (drought, wildfires, pandemic-related lockdowns) in Australia.Method: Thirty-six community members were trained to deliver the SOLAR programme, a skills-based, trauma informed, psychosocial programme. Sixty-six people with anxiety, depression and/or posttraumatic stress symptoms, and impairment were randomised into the SOLAR programme or a Self-Help condition. They were assessed pre, post and two months following the interventions. The SOLAR programme was delivered across five 1-hourly sessions (either face to face or virtually). Those in the Self-Help condition received weekly emails with self-help information including links to online educational videos.Results: Multigroup analyses indicated that participants in the SOLAR condition experienced significantly lower levels of anxiety and depression, and PTSD symptom severity between pre - and post-intervention (T1 to T2), relative to the Self-Help condition, while controlling for scores at intake. These differences were not statistically different at follow-up. The SOLAR programme was associated with large effect size improvements in posttraumatic stress symptoms over time.Conclusion: The SOLAR programme was effective in improving anxiety, depression and posttraumatic stress symptoms over time. However, by follow-up the size of the effect was similar to an active self-help condition. Given the ongoing stressors in the community associated with compounding disasters it may be that booster sessions would have been useful to sustain programme impact.Trial registration: Australian New Zealand Clinical Trials Registry identifier: ACTRN12621000283875..
Collapse
Affiliation(s)
- S. Cowlishaw
- Phoenix Australia - Centre for Posttraumatic Mental Health, Carlton, Australia
- Department of Psychiatry, The University of Melbourne, Parkville, Australia
| | - K. Gibson
- Phoenix Australia - Centre for Posttraumatic Mental Health, Carlton, Australia
- Department of Psychiatry, The University of Melbourne, Parkville, Australia
| | - S. Alexander
- Phoenix Australia - Centre for Posttraumatic Mental Health, Carlton, Australia
- Department of Psychiatry, The University of Melbourne, Parkville, Australia
| | - A. Howard
- Phoenix Australia - Centre for Posttraumatic Mental Health, Carlton, Australia
- Department of Psychiatry, The University of Melbourne, Parkville, Australia
| | - J. Agathos
- Phoenix Australia - Centre for Posttraumatic Mental Health, Carlton, Australia
- Department of Psychiatry, The University of Melbourne, Parkville, Australia
| | - S. Strauven
- Phoenix Australia - Centre for Posttraumatic Mental Health, Carlton, Australia
- Department of Psychiatry, The University of Melbourne, Parkville, Australia
| | - K. Chisholm
- Phoenix Australia - Centre for Posttraumatic Mental Health, Carlton, Australia
- Department of Psychiatry, The University of Melbourne, Parkville, Australia
| | - J. Fredrickson
- Phoenix Australia - Centre for Posttraumatic Mental Health, Carlton, Australia
- Department of Psychiatry, The University of Melbourne, Parkville, Australia
| | - L. Pham
- Phoenix Australia - Centre for Posttraumatic Mental Health, Carlton, Australia
- Department of Psychiatry, The University of Melbourne, Parkville, Australia
| | - W. Lau
- Phoenix Australia - Centre for Posttraumatic Mental Health, Carlton, Australia
- Department of Psychiatry, The University of Melbourne, Parkville, Australia
| | - M. L. O’Donnell
- Phoenix Australia - Centre for Posttraumatic Mental Health, Carlton, Australia
- Department of Psychiatry, The University of Melbourne, Parkville, Australia
| |
Collapse
|
3
|
Khilnani NM, Wasan SM, Pappas PJ, Deol Z, Schoonover JP, Daugherty SF, Attaran RR, Cartee TV, Straight TM, Fish J, Granzow JW, Winokur RS, Desai KR, Salazar G, Stoughton J, Gibson K, Jones AD, Lohr JM, Vayuvegula S, Meissner MH. Core content for venous and Lymphatic Medicine: 2022 revision. Phlebology 2023:2683555231212302. [PMID: 37934910 DOI: 10.1177/02683555231212302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2023]
Abstract
The core content for a medical specialty outlines the scope of the discipline as well as the categories of knowledge considered essential to practice in the field. It provides a template for the development of curricula for medical school, graduate, and postgraduate education, as well as for creating certification standards. Venous and Lymphatic Medicine (VLM) is a specialty that has benefitted from contributions from specialists from several medical disciplines. Optimally, the societies, boards, and residency review committees representing these disciplines would uniformly recognize the scope of VLM to develop education and assessment standards to allow training and identification of qualified practitioners. In order to inform the standard setting bodies and other stakeholders of the current scope of VLM, a task force of VLM experts from cardiology, dermatology, emergency medicine, general surgery, interventional radiology, vascular medicine, and vascular surgery was formed to revise a 2014 consensus document defining the core content of the specialty of VLM.
Collapse
Affiliation(s)
- N M Khilnani
- Division of Interventional Radiology, Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY, USA
| | - S M Wasan
- REX Vascular Speicalists, UNC Health, Raleigh, NC, USA
| | - P J Pappas
- Center for Vein Restoration, Morristown, NJ, USA
| | - Z Deol
- Center for Vein Restoration, Toledo, Ohio and Detroit, MI, USA
| | | | | | - R R Attaran
- Department of Cardiology, Yale School of Medicine, Norwich, CT, USA
| | - T V Cartee
- Division of Dermatology, Penn State College of Medicine, Hershey, PA, USA
| | | | - J Fish
- Department of Medicine, Jobst Vascular Instituteof Promedica, Toledo, OH, USA
| | - J W Granzow
- Granzow Lymphedema and Lipedema Center, Jacksonville, FL, USA
| | - R S Winokur
- Division of Interventional Radiology, Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY, USA
| | - K R Desai
- Division of Interventional Radiology, Northwestern UniversityFeinberg School of Medicine, Chicago, IL, USA
| | - G Salazar
- Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - J Stoughton
- Department of Vascular Surgery, Massachusetts General Hospital, Stoneham, MA, USA
| | - K Gibson
- Lake Washington Vascular Surgeons, Bellevue, WA, USA
| | - A D Jones
- Inova Vein Specialty Center, Bend, OR, USA
| | - J M Lohr
- Division of Vascular and Endovascular Surgery, William Jennnings Bryan Dorn VA, Columbia, SC, USA
| | | | - M H Meissner
- Department of Surgery, University of WashingtonSchool of Medicine, Seattle, WA, USA
| |
Collapse
|
4
|
Abstract
Idiopathic nephrotic syndrome is the most common glomerular disease in children. Corticosteroids are the cornerstone of its treatment, and steroid response is the main prognostic factor. Most children respond to a cycle of oral steroids, and are defined as having steroid-sensitive nephrotic syndrome. Among the children who do not respond, defined as having steroid-resistant nephrotic syndrome, most respond to second-line immunosuppression, mainly with calcineurin inhibitors, and children in whom a response is not observed are described as multidrug resistant. The pathophysiology of nephrotic syndrome remains elusive. In cases of immune-mediated origin, dysregulation of immune cells and production of circulating factors that damage the glomerular filtration barrier have been described. Conversely, up to a third of cases of steroid-resistant nephrotic syndrome have a monogenic origin. Multidrug resistant nephrotic syndrome often leads to kidney failure and can cause relapse after kidney transplant. Although steroid-sensitive nephrotic syndrome does not affect renal function, most children with steroid-sensitive nephrotic syndrome have a relapsing course that requires repeated steroid cycles with significant side-effects. To minimise morbidity, some patients require steroid-sparing immunosuppressive agents, including levamisole, mycophenolate mofetil, calcineurin inhibitors, anti-CD20 monoclonal antibodies, and cyclophosphamide. Close monitoring and preventive measures are warranted at onset and during relapse to prevent acute complications (eg, hypovolaemia, acute kidney injury, infections, and thrombosis), whereas long-term management requires minimising treatment-related side-effects. A subset of patients have active disease into adulthood.
Collapse
Affiliation(s)
- Marina Vivarelli
- Division of Nephrology, Laboratory of Nephrology, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
| | - Keisha Gibson
- Division of Nephrology and Hypertension, University of North Carolina Kidney Center, University of North Carolina at Chapel Hill, NC, USA
| | - Aditi Sinha
- Division of Nephrology, Indian Council of Medical Research Center for Advanced Research in Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
| | - Olivia Boyer
- Néphrologie Pédiatrique, Centre de Référence Maladies Rénales Héréditaires de l'Enfant et de l'Adulte, Hôpital Necker - Enfants Malades, Assistance Publique Hôpitaux de Paris, Inserm U1163, Institut Imagine, Université Paris Cité, Paris, France
| |
Collapse
|
5
|
Stein JN, Gaddy JJ, Sorah JD, Wooten M, Gibson K, Collichio FA. Seeking Racial Equity in Hematology and Oncology: a Fellow-Led Educational Series to Promote Reflection and Action. J Cancer Educ 2023; 38:1241-1244. [PMID: 36598746 PMCID: PMC10463164 DOI: 10.1007/s13187-022-02255-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 12/14/2022] [Indexed: 06/17/2023]
Abstract
The USA is experiencing a reckoning with racial injustice and graduate medical education programs are seeking ways to address this important topic in training. Fellows in hematology/oncology at the University of North Carolina recognized this important gap and adapted a curriculum for medical residents on racial equity to a subspecialty audience. Aims were (1) to improve knowledge and awareness about implicit bias and systemic racism and (2) introduce methods to address racial inequities. We used lived experiences and collated materials from scientific literature and lay media to illustrate key points. The course explored the effects of implicit bias on individual, clinical, and health system levels, anchored in Kahneman's two-system theory. Videos, journal articles, and group discussion were employed to appeal to many learning styles. A post-curriculum survey assessed perceptions of racial inequality in medicine and the series' effects using a Likert scale. Twenty-nine participants completed the survey (12 fellows), 71% reported improved awareness of racial inequities, and 61% reported improved comfort level in addressing racial inequities. All participants recognized at least "some" racial inequity in medicine, and over 75% of participants indicated interest in further sessions. Formulation of an educational curriculum by fellows and delivered in a division-wide setting was feasible and well received by participants, filling a key educational gap. We encourage other institutions to take similar steps to highlight issues of systemic racism and move our field in the right direction.
Collapse
Affiliation(s)
- Jacob N Stein
- UNC Lineberger Comprehensive Cancer Center, 170 Manning Drive, CB 7305, Chapel Hill, NC, USA.
- University of North Carolina at Chapel Hill School of Medicine, 101 Manning Dr, Chapel Hill, NC, USA.
| | - Jacquelyne J Gaddy
- UNC Lineberger Comprehensive Cancer Center, 170 Manning Drive, CB 7305, Chapel Hill, NC, USA
- University of North Carolina at Chapel Hill School of Medicine, 101 Manning Dr, Chapel Hill, NC, USA
| | - Jonathan D Sorah
- UNC Lineberger Comprehensive Cancer Center, 170 Manning Drive, CB 7305, Chapel Hill, NC, USA
- University of North Carolina at Chapel Hill School of Medicine, 101 Manning Dr, Chapel Hill, NC, USA
| | - Melissa Wooten
- University of North Carolina at Chapel Hill School of Medicine, 101 Manning Dr, Chapel Hill, NC, USA
| | - Keisha Gibson
- University of North Carolina at Chapel Hill School of Medicine, 101 Manning Dr, Chapel Hill, NC, USA
| | - Frances A Collichio
- UNC Lineberger Comprehensive Cancer Center, 170 Manning Drive, CB 7305, Chapel Hill, NC, USA
- University of North Carolina at Chapel Hill School of Medicine, 101 Manning Dr, Chapel Hill, NC, USA
| |
Collapse
|
6
|
Krissberg JR, O'Shaughnessy MM, Smith AR, Helmuth ME, Almaani S, Aviles DH, Brathwaite KE, Cai Y, Cattran D, Gbadegesin R, Glenn DA, Greenbaum LA, Iragorri S, Jain K, Khalid M, Kidd J, Kopp J, Lafayette R, Lane JC, Lugani F, Nestor JG, Parekh RS, Reidy K, Selewski DT, Sethna CB, Sperati CJ, Tuttle K, Twombley K, Vasylyeva TL, Weaver DJ, Wenderfer SE, Gibson K. Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease. Am J Kidney Dis 2023; 81:318-328.e1. [PMID: 36191724 PMCID: PMC9974571 DOI: 10.1053/j.ajkd.2022.08.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2022] [Accepted: 08/03/2022] [Indexed: 01/25/2023]
Abstract
RATIONALE & OBJECTIVE The effects of race, ethnicity, socioeconomic status (SES), and disease severity on acute care utilization in patients with glomerular disease are unknown. STUDY DESIGN Prospective cohort study. SETTING & PARTICIPANTS 1,456 adults and 768 children with biopsy-proven glomerular disease enrolled in the Cure Glomerulonephropathy (CureGN) cohort. EXPOSURE Race and ethnicity as a participant-reported social factor. OUTCOME Acute care utilization defined as hospitalizations or emergency department visits. ANALYTICAL APPROACH Multivariable recurrent event proportional rate models were used to estimate associations between race and ethnicity and acute care utilization. RESULTS Black or Hispanic participants had lower SES and more severe glomerular disease than White or Asian participants. Acute care utilization rates were 45.6, 29.5, 25.8, and 19.2 per 100 person-years in Black, Hispanic, White, and Asian adults, respectively, and 55.8, 42.5, 40.8, and 13.0, respectively, for children. Compared with the White race (reference group), Black race was significantly associated with acute care utilization in adults (rate ratio [RR], 1.76 [95% CI, 1.37-2.27]), although this finding was attenuated after multivariable adjustment (RR, 1.31 [95% CI, 1.03-1.68]). Black race was not significantly associated with acute care utilization in children; Asian race was significantly associated with lower acute care utilization in children (RR, 0.32 [95% CI 0.14-0.70]); no significant associations between Hispanic ethnicity and acute care utilization were identified. LIMITATIONS We used proxies for SES and lacked direct information on income, household unemployment, or disability. CONCLUSIONS Significant differences in acute care utilization rates were observed across racial and ethnic groups in persons with prevalent glomerular disease, although many of these difference were explained by differences in SES and disease severity. Measures to combat socioeconomic disadvantage in Black patients and to more effectively prevent and treat glomerular disease are needed to reduce disparities in acute care utilization, improve patient wellbeing, and reduce health care costs.
Collapse
Affiliation(s)
- Jill R Krissberg
- Division of Pediatric Nephrology, Anne & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
| | - Michelle M O'Shaughnessy
- Department of Renal Medicine, Cork University Hospital, Ireland; and School of Medicine, University College Cork, Ireland
| | - Abigail R Smith
- Arbor Research Collaborative for Health, Ann Arbor, Michigan
| | | | - Salem Almaani
- Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio
| | - Diego H Aviles
- Louisiana State University Health Sciences Center, New Orleans, Louisiana
| | - Kaye E Brathwaite
- Division of Pediatric/Nephrology, Children's Hospital at Montefiore/Einstein, Bronx, New York
| | - Yi Cai
- Pediatric Nephrology, Dialysis and Transplantation, Helen DeVos Children's Hospital, Grand Rapids, Michigan
| | - Daniel Cattran
- Division of Nephrology, University Health Network, University Health Network and University of Toronto, Toronto, ON, Canada
| | - Rasheed Gbadegesin
- Department of Pediatrics, Division of Nephrology, Duke University Medical Center, Durham, North Carolina
| | - Dorey A Glenn
- Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
| | - Larry A Greenbaum
- Division of Pediatric Nephrology, Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia
| | | | - Koyal Jain
- Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
| | - Myda Khalid
- Department of Pediatrics, Division of Nephrology, Indiana University School of Medicine, Indianapolis, Indiana
| | - Jason Kidd
- Virginia Commonwealth University, Richmond, Virginia
| | - Jeffrey Kopp
- Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
| | - Richard Lafayette
- Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Stanford, California
| | - Jerome C Lane
- Division of Pediatric Nephrology, Anne & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
| | - Francesca Lugani
- L'Unità Operativa Complessa Nefrology, Dialysis and Transplant, Laboratorio di Nefrologia Molecolare, Istituto Giannina Gaslini Istituto di Ricovero e Cura a Carattere Scientifico, Genoa, Italy
| | - Jordan G Nestor
- Department of Medicine, Division of Nephrology, Columbia University, New York, New York
| | - Rulan S Parekh
- Division of Nephrology, Department of Pediatrics and Medicine, Hospital for Sick Children, University Health Network and University of Toronto, Toronto, ON, Canada
| | - Kimberly Reidy
- Division of Pediatric/Nephrology, Children's Hospital at Montefiore/Einstein, Bronx, New York
| | - David T Selewski
- Department of Pediatrics, Division of Nephrology, Medical University of South Carolina, Charleston, South Carolina
| | - Christine B Sethna
- Division of Pediatric Nephrology, Cohen Children's Medical Center, New Hyde Park, New York
| | - C John Sperati
- Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Katherine Tuttle
- Providence Health Care, Department of Medicine, Division of Nephrology, University of Washington, Spokane and Seattle, Washington
| | - Katherine Twombley
- Department of Pediatrics, Division of Nephrology, Medical University of South Carolina, Charleston, South Carolina
| | - Tetyana L Vasylyeva
- Department of Pediatrics, Texas Tech University Health Sciences Center, Amarillo, Texas
| | - Donald J Weaver
- Division of Pediatric Nephrology and Hypertension, Atrium Health Levine Children's, Charlotte, North Carolina
| | - Scott E Wenderfer
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas
| | - Keisha Gibson
- Department of Medicine and Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
| |
Collapse
|
7
|
Wang L, Smith-Salzberg B, Meyers KE, Glenn DA, Tuttle KR, Derebail VK, Brady TM, Gibson K, Smith AR, O'Shaughnessy MM, Srivastava T, Hall G, Zee J, Bitzer M, Sethna CB. Tobacco exposure in adults and children with proteinuric glomerulopathies: a NEPTUNE cohort study. BMC Nephrol 2023; 24:30. [PMID: 36759756 PMCID: PMC9912673 DOI: 10.1186/s12882-023-03073-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Accepted: 01/30/2023] [Indexed: 02/11/2023] Open
Abstract
BACKGROUND Tobacco exposure has been recognized as a risk factor for cardiovascular disease (CVD) and progression of kidney disease. Patients with proteinuric glomerulopathies are at increased risk for cardiovascular morbidity and mortality. Multiple studies have linked tobacco exposure to CVD and chronic kidney disease, but the relationships between smoking and proteinuric glomerulopathies in adults and children have not been previously explored. METHODS Data from the Nephrotic Syndrome Study Network (NEPTUNE), a multi-center prospective observational study of participants with proteinuric glomerulopathies, was analyzed. 371 adults and 192 children enrolled in NEPTUNE were included in the analysis. Self-reported tobacco exposure was classified as non-smoker, active smoker, former smoker, or exclusive passive smoker. Baseline serum cotinine levels were measured in a sub-cohort of 178 participants. RESULTS The prevalence of active smokers, former smokers and exclusive passive smoking among adults at baseline was 14.6%, 29.1% and 4.9%, respectively. Passive smoke exposure was 16.7% among children. Active smoking (reference non-smoking) was significantly associated with greater total cholesterol among adults (β 17.91 95% CI 0.06, 35.76, p = 0.049) while passive smoking (reference non-smoking) was significantly associated with greater proteinuria over time among children (β 1.23 95% CI 0.13, 2.33, p = 0.03). Higher cotinine levels were associated with higher baseline eGFR (r = 0.17, p = 0.03). CONCLUSION Tobacco exposure is associated with greater risk for CVD and worse kidney disease outcomes in adults and children with proteinuric glomerulopathies. Preventive strategies to reduce tobacco exposure may help protect against future cardiovascular and kidney morbidity and mortality in patients with proteinuric glomerulopathies.
Collapse
Affiliation(s)
- Linda Wang
- Cohen Children's Medical Center of NY, New Hyde Park, NY, USA
| | | | | | - Dorey A Glenn
- Division of Nephrology and Hypertension, UNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Katherine R Tuttle
- Providence Medical Research Center, Providence Health Care, Spokane, WA, USA
- Nephrology Division and Kidney Research Institute, University of Washington, Seattle, WA, USA
| | - Vimal K Derebail
- Division of Nephrology and Hypertension, UNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Tammy M Brady
- Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Keisha Gibson
- Division of Nephrology and Hypertension, UNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | | | | | | | - Gentzon Hall
- Division of Nephrology, Duke University School of Medicine, 269-01 76th Avenue, 11040, Durham, NC, USA
| | - Jarcy Zee
- Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
| | | | - Christine B Sethna
- Cohen Children's Medical Center of NY, New Hyde Park, NY, USA.
- Division of Nephrology, Duke University School of Medicine, 269-01 76th Avenue, 11040, Durham, NC, USA.
| |
Collapse
|
8
|
Glenn DA, Zee J, Mansfield S, O’Shaughnessy MM, Bomback AS, Gibson K, Greenbaum LA, Mariani L, Falk R, Hogan S, Mottl A, Denburg MR. Immunosuppression Exposure and Risk of Infection-Related Acute Care Events in Patients With Glomerular Disease: An Observational Cohort Study. Kidney Med 2022; 4:100553. [PMID: 36339665 PMCID: PMC9630793 DOI: 10.1016/j.xkme.2022.100553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
Rationale & Objective Infections cause morbidity and mortality in patients with glomerular disease. The relative contributions from immunosuppression exposure and glomerular disease activity to infection risk are not well characterized. To address this unmet need, we characterized the relationship between time-varying combinations of immunosuppressant exposure and infection-related acute care events while controlling for disease activity, among individuals with glomerular disease. Study Design Prospective, multicenter, observational cohort study. Setting & Participants Adults and children with biopsy-proven minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, or immunoglobulin A nephropathy/vasculitis were enrolled at 71 clinical sites in North America and Europe. A total of 2,388 Cure Glomerulonephropathy Network participants (36% aged <18 years) had at least 1 follow-up visit and were included in the analysis. Exposures Immunosuppression exposure modeled on a weekly basis. Outcome Infections leading to an emergency department visit or hospitalization. Analytical Approach Marginal structural models were used to estimate the effect of time-varying immunosuppression exposure on hazard of first infection-related acute care event while accounting for baseline sociodemographic and clinical factors, and time-varying disease activity. Results A total of 2,388 participants were followed for a median of 3.2 years (interquartile range, 1.6-4.6), and 15% experienced at least 1 infection-related emergency department visit or hospitalization. Compared to no immunosuppression exposure, steroid exposure, steroid with any other immunosuppressant, and nonsteroid immunosuppressant exposure were associated with a 2.65-fold (95% CI, 1.83-3.86), 2.68-fold (95% CI, 1.95-3.68), and 1.7-fold (95% CI, 1.29-2.24) higher risk of first infection, respectively. Limitations Absence of medication dosing data, lack of a control group, and potential bias in ascertainment of outcome events secondary to the coronavirus 2 pandemic. Conclusions Corticosteroids with or without concomitant additional immunosuppression significantly increased risk of infection leading to acute care utilization in adults and children with glomerular disease.
Collapse
|
9
|
Arriens C, Teng YKO, Ginzler EM, Parikh SV, Askanase AD, Saxena A, Gibson K, Caster DJ, Atsumi T, Lisk L, Randhawa S, Gluck R, Solomons N, Huizinga RB. Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus Nephritis. Arthritis Care Res (Hoboken) 2022. [PMID: 36039949 DOI: 10.1002/acr.25007] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2022] [Revised: 07/26/2022] [Accepted: 08/25/2022] [Indexed: 11/09/2022]
Abstract
OBJECTIVE This integrated analysis evaluates the efficacy and safety of voclosporin, a novel calcineurin inhibitor, at 23.7 mg twice daily in combination with mycophenolate mofetil (MMF) and oral glucocorticoids in lupus nephritis (LN) using pooled data from two large phase II and phase III clinical trials. The purpose was to expand the pool of patients for safety analyses and to increase power for efficacy analyses in patient subpopulations. METHODS Aurinia Urinary Protein Reduction in Active Lupus with Voclosporin (AURA-LV) (phase II) and Aurinia Renal Response in Active Lupus With Voclosporin (AURORA 1) (phase III) were randomized, placebo-controlled, double-blind trials with similar designs and end points comparing voclosporin to control in combination with MMF and oral glucocorticoids for the treatment of LN. The primary efficacy outcome of the integrated analysis was complete renal response (CRR) at approximately one year (Week 48 data from AURA-LV and Week 52 from AURORA 1). Safety was assessed throughout the trials. RESULTS Overall, 534 patients (268 voclosporin; 266 control) were included in the integrated analysis. Significantly more patients achieved a CRR at one year in the voclosporin group than in the control group (43.7% vs. 23.3%; OR 2.76; 95% CI 1.88, 4.05 P < 0.0001). The incidence of adverse events (AEs) was similar (91.4% voclosporin; 87.2% control). Most AEs were mild to moderate in severity; the most commonly reported AEs were classified as infections and infestations (62.2% voclosporin; 54.9% control) and gastrointestinal disorders (45.3% voclosporin; 35.3% placebo). No new or unexpected safety signals were detected. CONCLUSIONS This integrated analysis demonstrates the efficacy and safety of voclosporin in the treatment of LN across the diverse racial and ethnic groups studied.
Collapse
Affiliation(s)
- Cristina Arriens
- Oklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center, Oklahoma City
| | - Y K Onno Teng
- Leiden University Medical Centre, Leiden, The Netherlands
| | - Ellen M Ginzler
- SUNY Downstate Health Sciences University, Brooklyn, New York
| | - Samir V Parikh
- The Ohio State University Wexner Medical Center, Columbus
| | | | - Amit Saxena
- New York University School of Medicine, New York
| | - Keisha Gibson
- University of North Carolina Kidney Center, Chapel Hill
| | - Dawn J Caster
- University of Louisville School of Medicine, Louisville, Kentucky
| | | | - Laura Lisk
- Aurinia Pharmaceuticals Inc., Victoria, British Columbia, Canada
| | - Simrat Randhawa
- Aurinia Pharmaceuticals Inc., Victoria, British Columbia, Canada
| | - Rashieda Gluck
- Aurinia Pharmaceuticals Inc., Victoria, British Columbia, Canada
| | - Neil Solomons
- Aurinia Pharmaceuticals Inc., Victoria, British Columbia, Canada
| | | |
Collapse
|
10
|
Gipson DS, Troost JP, Spino C, Attalla S, Tarnoff J, Massengill S, Lafayette R, Vega-Warner V, Adler S, Gipson P, Elliott M, Kaskel F, Fermin D, Moxey-Mims M, Fine RN, Brown EJ, Reidy K, Tuttle K, Gibson K, Lemley KV, Greenbaum LA, Atkinson MA, Hingorani S, Srivastava T, Sethna CB, Meyers K, Tran C, Dell KM, Wang CS, Yee JL, Sampson MG, Gbadegesin R, Lin JJ, Brady T, Rheault M, Trachtman H. Comparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis. JAMA Netw Open 2022; 5:e2228701. [PMID: 36006643 PMCID: PMC9412226 DOI: 10.1001/jamanetworkopen.2022.28701] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
IMPORTANCE Focal segmental glomerulosclerosis (FSGS) is a common cause of end-stage kidney disease (ESKD) across the lifespan. While 10% to 15% of children and 3% of adults who develop ESKD have FSGS, it remains uncertain whether the natural history differs in pediatric vs adult patients, and this uncertainty contributes to the exclusion of children and adolescents in clinical trials. OBJECTIVE To examine whether there are differences in the kidney health outcomes among children, adolescents, and adults with FSGS. DESIGN, SETTING, AND PARTICIPANTS This cohort study used pooled and parallel analyses, completed July 5, 2022, from 3 complimentary data sources: (1) Nephrotic Syndrome Rare Disease Clinical Research Network (NEPTUNE); (2) FSGS clinical trial (FSGS-CT); and (3) Kidney Research Network (KRN). NEPTUNE is a multicenter US/Canada cohort study; FSGS-CT is a multicenter US/Canada clinical trial; and KRN is a multicenter US electronic health record-based registry from academic and community nephrology practices. NEPTUNE included 166 patients with incident FSGS enrolled at first kidney biopsy; FSGS-CT included 132 patients with steroid-resistant FSGS randomized to cyclosporine vs dexamethasone with mycophenolate; and KRN included 184 patients with prevalent FSGS. Data were collected from November 2004 to October 2019 and analyzed from October 2020 to July 2022. EXPOSURES Age: children (age <13 years) vs adolescents (13-17 years) vs adults (≥18 years). Covariates of interest included sex, disease duration, APOL1 genotype, urine protein-to-creatinine ratio, estimated glomerular filtration rate (eGFR), edema, serum albumin, and immunosuppressive therapy. MAIN OUTCOMES AND MEASURES ESKD, composite outcome of ESKD or 40% decline in eGFR, and complete and/or partial remission of proteinuria. RESULTS The study included 127 (26%) children, 102 (21%) adolescents, and 253 (52%) adults, including 215 (45%) female participants and 138 (29%) who identified as Black, 98 (20%) who identified as Hispanic, and 275 (57%) who identified as White. Overall, the median time to ESKD was 11.9 years (IQR, 5.2-19.1 years). There was no difference in ESKD risk among children vs adults (hazard ratio [HR], 0.67; 95% CI, 0.43-1.03) or adolescents vs adults (HR, 0.85; 95% CI, 0.52-1.36). The median time to the composite end point was 5.7 years (IQR 1.6-15.2 years), with hazard ratio estimates for children vs adults of 1.12 (95% CI, 0.83-1.52) and adolescents vs adults of 1.06 (95% CI, 0.75-1.50). CONCLUSIONS AND RELEVANCE In this study, the association of FSGS with kidney survival and functional outcomes was comparable at all ages.
Collapse
Affiliation(s)
- Debbie S. Gipson
- Division of Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor
| | - Jonathan P. Troost
- Michigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor
| | - Cathie Spino
- School of Public Health, Department of Biostatistics, University of Michigan, Ann Arbor
| | - Samara Attalla
- Division of Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor
| | - Joshua Tarnoff
- NephCure Kidney International, King of Prussia, Pennsylvania
| | - Susan Massengill
- Division of Pediatric Nephrology, Department of Pediatrics, Levine Children’s Hospital, Atrium Health, Charlotte, North Carolina
| | - Richard Lafayette
- Department of Internal Medicine, Division of Nephrology, Stanford University, Palo Alto, California
| | - Virginia Vega-Warner
- Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor
| | - Sharon Adler
- Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor–University of California, Torrance
| | - Patrick Gipson
- Division of Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor
| | | | - Frederick Kaskel
- Division of Nephrology, Children’s Hospital at Montefiore; Albert Einstein College of Medicine, Bronx, New York
| | - Damian Fermin
- Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor
| | - Marva Moxey-Mims
- Division of Nephrology, Children’s National Hospital, Department of Pediatrics, The George Washington University School of Medicine, Washington, DC
| | - Richard N. Fine
- Renaissance School of Medicine at Stony Brook University, Stony Brook University Medical Center, Stony Brook, New York
| | - Elizabeth J. Brown
- Division of Nephrology, Department of Pediatrics, UT Southwestern Medical Center, Dallas, Texas
| | - Kimberly Reidy
- Division of Nephrology, Department of Pediatrics, Albert Einstein College of Medicine, Montefiore Medical Center, New York, New York
| | - Katherine Tuttle
- Providence Medical Research Center, Providence Health Care, Spokane, Washington
- Kidney Research Institute, Nephrology Division, and Institute for Translational Health Sciences, University of Washington, Seattle
| | - Keisha Gibson
- University of North Carolina Kidney Center at Chapel Hill
| | - Kevin V. Lemley
- Department of Pediatrics, USC Keck School of Medicine, Children’s Hospital Los Angeles, Los Angeles, California
| | - Larry A. Greenbaum
- Division of Pediatric Nephrology, Department of Pediatrics, Emory University School of Medicine and Children’s Healthcare of Atlanta, Atlanta, Georgia
| | - Meredith A. Atkinson
- Division of Pediatric Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Sangeeta Hingorani
- Department of Pediatrics, University of Washington and Division of Nephrology, Seattle Children’s, Seattle
| | - Tarak Srivastava
- Section of Nephrology, Children’s Mercy Hospital and University of Missouri at Kansas City
| | - Christine B. Sethna
- Pediatric Nephrology, Cohen Children’s Medical Center of New York, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York
| | - Kevin Meyers
- Division of Nephrology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
| | - Cheryl Tran
- Children’s Center, Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
| | - Katherine M. Dell
- Center for Pediatric Nephrology, Cleveland Clinic Children’s, Cleveland, Ohio
| | - Chia-shi Wang
- Division of Pediatric Nephrology, Department of Pediatrics, Emory University School of Medicine and Children’s Healthcare of Atlanta, Atlanta, Georgia
| | - Jennifer Lai Yee
- Division of Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor
| | - Matthew G. Sampson
- Division of Nephrology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts
- Kidney Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts
| | | | - J. J. Lin
- Pediatric Nephrology, Wake Forest Baptist Health, Winston Salem, North Carolina
| | - Tammy Brady
- Division of Pediatric Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Michelle Rheault
- Department of Pediatrics, Division of Nephrology, University of Minnesota, Minneapolis
| | - Howard Trachtman
- Division of Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor
| |
Collapse
|
11
|
Wang CS, Troost JP, Wang Y, Greenbaum LA, Gibson K, Trachtman H, Srivastava T, Reidy K, Kaskel F, Sethna CB, Meyers K, Dell KM, Tran CL, Hingorani S, Lemley KV, Lin JJ, Gipson DS. Determinants of medication adherence in childhood nephrotic syndrome and associations of adherence with clinical outcomes. Pediatr Nephrol 2022; 37:1585-1595. [PMID: 34796395 PMCID: PMC10182827 DOI: 10.1007/s00467-021-05176-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/12/2021] [Revised: 05/17/2021] [Accepted: 06/09/2021] [Indexed: 11/29/2022]
Abstract
BACKGROUND Pediatric patients with nephrotic syndrome take medications long-term with significant toxicity and complex regimens, yet data on medication adherence are limited. METHODS In a multicenter observational study of patients with nephrotic syndrome, NEPTUNE (NCT01209000), we surveyed caregivers of patients <19 years old and adolescent patients on medication adherence during longitudinal follow-up beginning in June 2015. Data extraction was in October 2020. We described the proportion of nonadherent patients at first survey. Participant social and economic factors, condition-related factors, therapy-related factors, and patient-related factors were examined for relationships with nonadherence by generalized linear mixed models using the longitudinal data. In exploratory fashion, we assessed the relationship between adherence and subsequent steroid response classification by binary logistic regression and adherence with healthcare utilization by Poisson regression. RESULTS A total of 225 participants completed a median of 3 surveys during follow-up (IQR, 2-5), with a total of 743 surveys. Overall, 80 (36%) reported nonadherence with medications. In adjusted analysis, older age (per 1 year; OR 1.08; 95% CI, 1.03 1.12), lower maternal educational level (≥ high school vs. < high school; OR 0.47; 95% CI 0.25 to 0.89), and increased parent and self-identification of medications barriers (per 1 point; OR 1.57; 95% CI, 1.15-2.15) were significantly associated with nonadherence. No relationship between nonadherence and subsequent frequency of healthcare utilization was observed. A trend toward increased subsequent steroid resistance classification was seen with nonadherence, though not statistically significant. CONCLUSIONS Medication nonadherence is common in pediatric nephrotic syndrome. Investigations into the use of surveys in the clinic setting to identify at-risk patients and ways to support families over time are needed. A higher resolution version of the Graphical abstract is available as Supplementary information.
Collapse
Affiliation(s)
- Chia-Shi Wang
- Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.
| | | | - Yujie Wang
- University of Michigan, Ann Arbor, MI, USA
| | - Larry A Greenbaum
- Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA
| | | | | | - Tarak Srivastava
- Children's Mercy Hospital and University of Missouri at Kansas City, Kansas City, MO, USA
| | | | | | | | - Kevin Meyers
- Children's Hospital of Philadelphia, Philadelphia, PA, USA
| | - Katherine M Dell
- Cleveland Clinic Children's, Case Western Reserve University, Cleveland, OH, USA
| | | | | | | | - Jen-Jar Lin
- Wake Forest University, Winston-Salem, NC, USA
| | | |
Collapse
|
12
|
Stein JN, Gaddy JJ, Sorah JD, Wooten M, Gibson K, Collichio FA. Seeking racial equity in hematology and oncology: A fellow-led educational series to promote reflection and action. J Clin Oncol 2022. [DOI: 10.1200/jco.2022.40.16_suppl.11004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
11004 Background: With the murder of George Floyd and health disparities laid bare by the COVID pandemic, the US is reckoning with racial injustice. Across medicine and oncology, institutions are grappling with how to address systemic racism and improve care for patients of color. At the University of North Carolina (UNC), trainees developed an educational curriculum to raise awareness of implicit bias and introduce methods to address racial inequities. We present our findings on feasibility and acceptability of a fellow-led course on racism in medicine at a major academic medical center. Methods: UNC oncology fellows adapted a curriculum on implicit bias and racism in medicine in spring 2021. Our aims were 1) to improve knowledge and awareness about implicit bias and systemic racism and 2) introduce methods to address racial inequities. We used lived experiences and collated materials from scientific literature and lay media to illustrate key points. Sessions were: 1) Introduction and Implicit Bias, 2) Implicit Bias in Action: A Case Study, 3) Race-Based Metrics: Journal Club, 4) Career Perspective on Equity in Oncology. Videos, journal articles, and group discussion were employed to appeal to many learning styles. Results: Four sessions were held virtually for the Divisions of Oncology and Hematology. Attendance ranged from 28 to 35 per session. A post curriculum survey assessed perception of racial inequality in medicine and the series’ effects using a Likert scale. Twenty-nine participants completed the survey, 12 of whom were fellows. Of all participants, 71% reported that the course improved knowledge or awareness of racial inequities "some" or "a great deal" and 61% reported that it improved their comfort level addressing racial inequities "some" or "a great deal." All participants endorsed at least “some” racial inequity in medicine. Notably, over 75% of participants indicated interest in further sessions. Conclusions: Formulation of an educational curriculum by fellows and delivered in a division wide setting was feasible and well received by participants with robust discussion and interest in further work. Fundamental to this series’ effectiveness was creating a space for discussion and reflection among colleagues. The goals of improving knowledge and introducing methods to address racial inequities were met. Importantly, our course was integrated alongside institutional efforts on DEI. We were limited by a lack of pre-course survey results due to a technical error. Given the current groundswell of interest and focus in improving racial equity in our society, we encourage other institutions to take similar steps to highlight issues of systemic racism and continue to move our field in the right direction.
Collapse
Affiliation(s)
| | | | | | - Melissa Wooten
- University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC
| | - Keisha Gibson
- University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC
| | - Frances A. Collichio
- Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC
| |
Collapse
|
13
|
Alten R, Burmester GR, Matucci Cerinic M, Ostor A, Zaremba-Pechmann L, Herrera M, Gibson K, Treuer T, Gerwien J, Fautrel B. POS0666 A MULTINATIONAL, PROSPECTIVE, OBSERVATIONAL STUDY IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING BARICITINIB, TARGETED SYNTHETIC OR BIOLOGIC DISEASE-MODIFYING THERAPIES: 12 MONTH TIME TO DISCONTINUATION, EFFECTIVENESS AND PATIENT REPORTED OUTCOME DATA FROM THE EUROPEAN COHORT. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundBaricitinib (BARI), an oral selective JAK 1/2 inhibitor, is approved for treating adults with moderate to severe active rheumatoid arthritis (RA). RA-BE-REAL is a 3-year, multinational, prospective, observational study of adult patients with RA evaluating time to discontinuation of initial RA treatment for all causes (excluding sustained clinical response) over 24 months (M).ObjectivesThis analysis reports time to discontinuation in the European (France, Germany, Italy, Spain, UK) subgroup, treated with either BARI, biologic (b) disease-modifying anti-rheumatic drugs (DMARDs) or any other targeted synthetic (ts)DMARDs, as well as, the effectiveness of RA treatment, at 12M.MethodsIn the two cohorts, patients were initiated with BARI 2-mg or 4-mg (cohort A), or any bDMARD or tsDMARD (b/tsDMARDs; cohort B). Treatment initiation and changes are at the discretion of the patient or physician. Response rates for remission, low disease activity (LDA), moderate disease activity (MDA) or high disease activity (HDA) were determined using the Clinical Disease Activity Index (CDAI) at 12M. Quality of life using the EQ-5D-5L and patient reported outcome (PRO) measures for pain (pain visual analogue scale; VAS) and physical functioning (Health Assessment Questionnaire Disability Index; HAQ-DI) were also assessed at 12M. This pre-specified interim analysis reports descriptive 12M data using summary statistics, without any inferential testing.ResultsThis analysis involved 1073 adult RA patients with a mean age (standard deviation; SD) of 59.1 (13.2) (cohort A) and 57.0 (13.9) yrs (cohort B), respectively, and a mean disease duration (SD) of 10.0 (9.1) (cohort A) and 8.9 (9.6) yrs (cohort B), respectively. At baseline, 50.9% of patients in cohort A and 31.2% in cohort B initiated treatment as a monotherapy. At 12M, 26.7% of patients in cohort A and 44.1% of patients in cohort B had discontinued treatment. The most common reason for discontinuation in both cohorts was primary non-response. At 12M, 24.1% of patients in cohort A and 16.6% in cohort B achieved CDAI remission (Figure 1). The mean CDAI reduction was -14.5 and -12.0, respectively in cohorts A and B. Mean reductions from baseline in physician global assessment (PhGA) and in patient global assessment (PGA) were -3.4 and -2.5, respectively in cohort A and -3.0 and -2.1, respectively in cohort B. Improvements from baseline in EQ-5D-5L, HAQ-DI, and pain (VAS) were reported in both cohorts at 12M. The mean pain (VAS) reduction from baseline was -24.6 and -19.3 in cohort A and cohort B, respectively.Figure 1.Percentage of pts in cohorts A and B achieving remission and LDA at 12MConclusionThe majority of BARI-treated patients were in remission or had low disease activity and continued treatment at 12M.Table 1.Disease activity and patient reported outcomes at baseline and 12MCohort A BaricitinibCohort B b/tsDMARDsBaseline12MCFBBaseline12MCFBCDAI24.0 (11.7)9.1 (8.2)-14.5 (12.4)23.8 (12.4)10.7 (9.8)-12.0 (12.6)SJC5.2 (4.8)1.3 (2.4)-3.9 (4.8)4.7 (4.9)1.3 (2.8)-3.0 (4.6)TJC7.3 (6.1)2.2 (3.6)-4.7 (6.0)7.8 (6.5)3.0 (4.8)-4.0 (6.1)PhGA5.6 (2.0)2.3 (2.1)-3.4 (2.5)5.5 (2.1)2.5 (2.1)-3.0 (2.6)PGA5.9 (2.3)3.4 (2.5)-2.5 (2.9)5.8 (2.4)3.8 (2.6)-2.1 (3.0)HAQ-DI1.4 (0.7)1.0 (0.8)-0.4 (0.6)1.3 (0.7)1.0 (0.8)-0.3 (0.6)Pain (VAS)59 (23.1)33.2 (26.2)-24.6 (28.7)56.5 (24.3)36.6 (26.5)-19.3 (30.4)EQ-5D-5L0.5 (0.3)0.7 (0.2)0.1 (0.3)0.5 (0.3)0.7 (0.2)0.1 (0.3)Values represent observed mean (SD)b/tsDMARDs; biologic/targeted synthetic disease-modifying anti-rheumatic drugs, CFB; change from baseline, CDAI; clinical disease activity index, SJC; swollen joint count, TJC; tender joint count, P(h)GA; patient (physician) global assessment of disease activity, HAQ-DI; health assessment questionnaire disability index, VAS; visual analogue scale (mm), EQ-5D-5L; European quality of life 5 dimensions 5 levelsDisclosure of InterestsRieke Alten Speakers bureau: Eli Lilly and Company, Pfizer, Galapagos, Consultant of: Eli Lilly and Company, Pfizer, Galapagos, Grant/research support from: Eli Lilly and Company, Pfizer, Galapagos, Gerd Rüdiger Burmester Speakers bureau: Amgen, AbbVie, BMS, Galapagos, Eli Lilly and Company, MSD, Pfizer, Roche, Sanofi, Consultant of: Amgen, AbbVie, BMS, Galapagos, Eli Lilly and Company, MSD, Pfizer, Roche, Sanofi, Marco Matucci Cerinic Speakers bureau: Biogen, Eli Lilly and Company, Grant/research support from: Actelion, Biogen, Novartis, MSD, Andrew Ostor Consultant of: AbbVie, BMS, Roche, Janssen, Eli Lilly and Company, Novartis, Pfizer, UCB, Gilead, Paradigm, Liliana Zaremba-Pechmann: None declared, Marta Herrera Shareholder of: Eli Lilly and Company, Employee of: Eli Lilly and Company, Kathy Gibson Speakers bureau: UCB, Consultant of: Janssen, Novartis, Grant/research support from: Novartis, Employee of: Eli Lilly and Company, Tamas Treuer Shareholder of: Eli Lilly and Company, Employee of: Eli Lilly and Company, Jens Gerwien Shareholder of: Eli Lilly and Company, Employee of: Eli Lilly and Company, Bruno Fautrel Consultant of: AbbVie, Biogen, BMS, Celgene, Janssen, Eli Lilly and Company, Medac, MSD, Nordic Pharma, Novartis, Pfizer, Roche, Sanofi-Aventis, SOBI, UCB, Grant/research support from: AbbVie, MSD, Pfizer, Eli Lilly and Company
Collapse
|
14
|
Li T, Gibson K, Pincus T, Schmukler J, Morlà R, Luta G. AB1477 MEDIAN 0-10 PATIENT GLOBAL ASSESSMENT WAS 2.5-5 POINTS HIGHER IN INFLAMMATORY ARTHRITIS PATIENTS POSITIVE VS NEGATIVE FOR FAST4 (FIBROMYALGIA ASSESSMENT SCREENING TOOL) AND/OR MSD2 (MDHAQ DEPRESSION SCREEN): 2 EASILY-SCORED MULTIDIMENSIONAL HEALTH ASSESSMENT QUESTIONNAIRE (MDHAQ) INDICES. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.3029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BackgroundPatient global assessment (PATGL) is included in DAS28, CDAI, ASDAS, DAPSA, and other indices to assess rheumatoid arthritis (RA) or spondyloarthropathy (SpA). PATGL reflects inflammatory activity in many patients, but may be elevated by comorbid fibromyalgia (FM) and/or depression (Dep), which are often unrecognized in others, complicating interpretation and use in treat-to-target. A 2-page multidimensional health assessment questionnaire (MDHAQ) includes PATGL and two easily scored cumulative indices, FAST4 (0-4 FM assessment screening tool) and MDS2 (0-2 MDHAQ Dep screen), which agree more than 80% with reference 2011 revised FM criteria, HADS-D and PHQ-9,1-3 and may clarify interpretation of high PATGL and index scores, particularly in busy clinical settings.ObjectivesAnalysis of PATGL in patients with RA or SpA according to MDHAQ FAST4 and/or MDS2 positivity (+) or negativity (-).MethodsMDHAQ was completed at a routine care visit at 3 sites in Australia, Spain, and USA. Medians and interquartile ranges (IQRs) for PATGL were computed for RA and SpA, according to FAST4 + or – and/or MDS2 + or -. Differences between medians of PATGL with 95% confidence intervals (CIs) for FAST4 and/or MDS2 were estimated from median regression models that included FAST4 and MDS2 for each setting, and setting for pooled analyses.ResultsAmong 393 RA and 175 SpA patients, 23.0%-32.7% were FAST4+ and 29.4%-36.7% MDS2+, with 41.1% positive for either FAST4 or MDS2 (data not shown). PATGL medians were 4.8-5.0 in all RA and 3.0-6.0 in SpA, 2.0-3.0 in FAST4-/MDS2-, 5.5-6.0 in FAST4-/MDS2+, 7.0-7.5 in FAST4+/MDS2-, and 7.0-8.0 in FAST4+/MDS2+ patients, similar in RA and SpA at 3 settings in 3 continents (Table 1). Adjusted median differences were 3.0–3.5 for FAST4 + vs - (twice the level for FAST4 -, MDS2 -) and 2.0–2.5 for MDS2 + vs - groups (Table 1).Table 1.Median scores and interquartile ranges for PATGL according to positive or negative FAST4 and/or MDS2Primary ICD10 diagnosisTotalFAST4 NEG MDS2 NEGFAST4 NEG MDS2 POSFAST4 POS MDS2 NEGFAST4 POS MDS2 POSAdjusted median difference (95% CI) (FAST4 POS – FAST4 NEG)Adjusted median difference (95% CI) (MDS2 POS – MDS2 NEG)Three sites pooledn=518n=305 (58.9%)n=71 (13.7%)n=50 (9.7%)n=92 (17.8%)RA3553.0 (1.0, 5.0)5.5 (3.6, 6.5)7.5 (6.5, 8.5)8.0 (7.0, 9.0)3.5 (2.8, 4.2)2.0 (1.4, 2.6)SpA1632.5 (1.0, 5.0)6.0 (4.0, 6.5)7.3 (6.8, 8.5)8.0 (6.5, 10.0)3.0 (2.1, 3.9)2.5 (1.5, 3.5)Australian=257n=155 (60.3%)n=35 (13.6%)n=22 (8.6%)n=45 (17.5%)RA1823.0 (1.0, 5.0)5.5 (4.5, 6.5)7.5 (7.0, 8.0)8.0 (7.0, 9.0)4.0 (3.0, 5.0)1.5 (0.5, 2.5)SpA752.5 (1.0, 5.0)4.5 (2.0, 6.8)9.0 (7.0, 9.5)8.0 (7.0, 8.5)4.0 (2.2, 5.8)1.0 (-0.8, 2.8)Spainn=169n=90 (53.3%)n=27 (16.0%)n=18 (10.7%)n=34 (20.1%)RA1013.0 (1.0, 4.5)5.5 (3.6, 6.8)6.0 (5.5, 7.0)8.5 (8.0, 8.5)3.0 (2.1, 3.9)2.5 (1.7, 3.3)SpA683.0 (0.8, 5.0)6.5 (6.0, 7.0)7.3 (6.5, 8.0)7.5 (6.5, 10.0)3.0 (1.1, 4.9)2.5 (0.9, 4.1)USAn=92n=60 (65.2%)n=9 (9.8%)n=10 (10.9%)n=13 (14.1%)RA723.0 (1.0, 6.0)6.0 (3.5, 7.0)8.5 (8.0, 9.5)7.0 (7.0, 9.0)5.0 (2.7, 7.3)1.0 (-1.3, 3.3)SpA202.0 (1.0, 4.5)2.0 (1.0, 3.0)7.0 (7.0, 7.0)*8.5 (5.5, 10.0)5.0 (0.5,10.5)0 (-3.3, 3.3)*NEG = negative, POS = positive, NA=Not available (No patients or the adjusted median differences cannot be estimated due to the small number of patients), *=Only one patient in category.ConclusionMedian 0-10 PATGL was 2-3-fold higher in 41.1% of RA or SpA patients with positive MDHAQ FM and/or DEP screening indices vs 59% with 2 negative indices. Differences were greater according to FM than Dep. MDHAQ may clarify interpretation of PATGL and indices, including in treat–to–target, using a single, brief, feasible questionnaire in research and busy clinical settings.References[1]Schmukler et al. ACR Open Rheumatol. 2019;1:516-25.[2]Gibson et al, J Rheumatol. 2020;47:761-9.[3]Morla et al, Arthritis Care & Research. 2021;73:120-9.Disclosure of InterestsTengfei Li: None declared, Kathryn Gibson Grant/research support from: Dr. Gibson has received honoraria from UCB, Novartis, and Janssen and grants support from Novartis., Employee of: Dr. Gibson is a part-time employee of Eli Lilly but no financial or other support was received from Eli Lilly in the creation of this abstract., Theodore Pincus: None declared, Juan Schmukler: None declared, Rosa Morlà: None declared, George Luta: None declared
Collapse
|
15
|
Golder V, Kandane-Rathnayake R, Louthrenoo W, Chen YH, Cho J, Lateef A, Hamijoyo L, Luo SF, Jan Wu YJ, Navarra S, Zamora L, LI Z, An Y, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake B, Chan M, Kikuchi J, Takeuchi T, Bae SC, O’neill S, Goldblatt F, Oon S, Gibson K, Ng K, Law A, Tugnet N, Kumar S, Tee C, Tee M, Tanaka Y, Lau CS, Nikpour M, Hoi A, Morand EF. OP0142 COMPARISON OF ATTAINMENT AND PROTECTIVE EFFECTS OF THE LUPUS LOW DISEASE ACTIVITY STATE IN PATIENTS WITH NEWLY DIAGNOSED VERSUS ESTABLISHED SLE - A MULTICENTRE PROSPECTIVE STUDY. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.3909] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BackgroundLupus low disease activity state (LLDAS) attainment has been reported to be associated with reduced damage accrual, flare, and mortality, as well as improved quality of life, in cohorts of SLE patients with established disease. Whether these associations are present in recent-onset disease is less well known.ObjectivesTo evaluate the associations of LLDAS attainment with outcomes in patients with recent onset SLE.MethodsData from a 13-country longitudinal SLE cohort (ACR/SLICC criteria) were collected prospectively between 2013 and 2020 using standard templates. Organ damage and flare were captured using SLICC Damage Index and SELENA-SLEDAI Flare Index, respectively. LLDAS was defined as Golder et al., 2019 [1]. An inception cohort was defined based on duration since SLE diagnosis<1 year at enrolment. Patient characteristics between inception and non-inception cohorts were compared using Wilcoxon rank-sum (continuous variables) or Pearson’s Chi-squared tests (categorical variables). Survival analyses were performed to examine the association between LLDAS attainment and damage accrual and flare.ResultsThe study cohort included 4,106 patients of whom 680 (16%) were recruited within 1 year of SLE diagnosis (inception cohort). Compared to the non-inception cohort, inception cohort patients were significantly younger, had higher disease activity (SLEDAI-2K and physician global assessment), used more glucocorticoids and immunosuppressants but had less organ damage at enrolment and only 88 (13.6%) patients accrued damage during a median 2.2 years follow-up (Table 1).Table 1.Non-inception cohortInception cohortp-valuen=3426n=680Age at enrolment (years), median [IQR]40 [31, 51]33 [25, 44]<0.001Age at diagnosis (years), median [IQR]28 [21, 38]33 [25, 43]<0.001SLE duration at enrolment (years), median [IQR]10 [5, 16]1 [0, 1]<0.001Study duration (years), median [IQR]2.5 [1.0, 5.4]2.2 [0.9, 3.7]<0.001Females, n (%)3155 (92.1%)623 (91.6%)0.68Asian ethnicity, n (%)3037 (89.1%)595 (88.1%)0.49Prednisolone (PNL) use - ever, n (%)2865 (83.6%)620 (91.2%)<0.001Time adjusted mean (TAM)-PNL, median [IQR]5.0 [2.2, 8.6]6.2 [3.2, 10.3]<0.001Cumulative PNL (g), median [IQR]3.4 [0.5, 9.7]3.8 [1.1, 8.5]0.26Anti-Malarial use - ever, n (%)2669 (77.9%)569 (83.7%)<0.001Immunosupressant use -ever, n (%)2367 (69.1%)521 (76.6%)<0.001AMS (TAM-SLEDAI-2K), median [IQR]2.8 [1.2, 4.6]3.1 [1.6, 5.0]0.002TAM-PGA, median [IQR]0.4 [0.2, 0.7]0.4 [0.3, 0.8]<0.001Mild/moderate/severe flare ever, n (%)1789 (52.2%)391 (57.5%)0.012Organ damage accrual, n (%)629 (20.8%)88 (13.6%)<0.001LLDAS at baseline, n (%)1730 (50.5%)195 (28.7%)<0.001LLDAS-ever (at least once), n (%)2637 (78.2%)492 (73.9%)0.014≥50% time in LLDAS (LLDAS-5), n (%)1612 (50.6%)256 (41.1%)<0.001Significantly fewer inception cohort patients were in LLDAS at enrolment than the non-inception cohort (29% vs. 51%, p<0.001). However, 74% of inception and 78% of non-inception cohort patients achieved LLDAS at least once during follow-up. Limiting analysis only to patients not in LLDAS at enrolment, time to first LLDAS attainment was assessed: inception cohort patients were 60% more likely to attain their first LLDAS (HR = 1.60 (95%CI: 1.40, 1.82), p<0.001) than non-inception cohort patients. LLDAS attainment was significantly protective against flare in the inception (HR, 95% CI) and non-inception (HR, 95% CI) cohorts. Trends towards protection against damage accrual in association with LLDAS in the inception cohort were not significant.ConclusionLLDAS attainment is protective from flare in recent onset SLE. Significant protection from damage accrual was not observed, due to low rates of damage accrual in the first years after SLE diagnosis.References[1]Golder, V., et al., Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study. The Lancet Rheumatology, 2019. 1(2): p. e95-e102.AcknowledgementsWe thank all patients participating in the Asia Pacific Lupus Collaboration (APLC) cohort, and all data collectors for their ongoing support for APLC research activities.The APLC has received unrestricted project grants from AstraZeneca, BMS, Eli Lily, Janssen, Merck Serono, and UCB to support data collection contributing to this work.Disclosure of InterestsVera Golder: None declared, Rangi Kandane-Rathnayake: None declared, Worawit Louthrenoo: None declared, Yi-Hsing Chen Speakers bureau: Pfizer, Novartis, Abbvie, Johnson & Johnson, BMS, Roche, Lilly, GSK, Astra& Zeneca, Sanofi, MSD, Guigai, Astellas, Inova Diagnostics, UCB, Agnitio Science Technology, United Biopharma, Thermo Fisher, Consultant of: Pfizer, Novartis, Abbvie, Johnson & Johnson, BMS, Roche, Lilly, GSK, Astra and Zeneca, Sanofi, Guigai, Astellas, Inova Diagnostics, UCB, Agnitio Science Technology, United Biopharma, Thermo Fisher, Gilead, Grant/research support from: Yes. Clinical trials and/or research grants from Pfizer, Norvatis, BMS, Abbevie, Johnson & Johnson, Roche,Sanofi, Guigai, Roche, Boehringer Ingelheim, UCB, MSD, Astra-Zeneca,Astellas, Gilead, Jiacai Cho: None declared, Aisha Lateef: None declared, Laniyati Hamijoyo Speakers bureau: Pfizer, Novartis, Abbot, Shue Fen Luo: None declared, Yeong-Jian Jan Wu Speakers bureau: Pfizer, Lilly, Novartis, Abbvie, Sandra Navarra Speakers bureau: Pfizer, Johnson & Johnson, Novartis, Astellas, Grant/research support from: Astellas, Johnson & Johnson, Leonid Zamora: None declared, Zhanguo Li Speakers bureau: Eli, Lilly, Novartis, GSK, AbbVie, Paid instructor for: Pfizer, Roche, Johnson, Consultant of: Lilly, Pfizer, Grant/research support from: Pfizer, Yuan An: None declared, Sargunan Sockalingam Speakers bureau: Yes. Pfizer, Roche, Novartis, Grant/research support from: Roche and Novartis, Yasuhiro Katsumata Speakers bureau: Chugai Pharmaceutical Co., Ltd., Glaxo-Smithkline K.K., and Sanofi K.K., Masayoshi Harigai Speakers bureau: MH has received speaker’s fee from AbbVie Japan GK, Ayumi Pharmaceutical Co., Boehringer Ingelheim Japan, Inc.,Bristol Myers Squibb Co., Ltd., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., GlaxoSmithKline K.K., Kissei Pharmaceutical Co., Ltd., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd, Consultant of: MH is a consultant for AbbVie, Boehringer-ingelheim, Bristol Myers Squibb Co., Kissei Pharmaceutical Co.,Ltd. and Teijin Pharma., Grant/research support from: MH has received research grants from AbbVie Japan GK, Asahi Kasei Corp., Astellas Pharma Inc., Ayumi Pharmaceutical Co., Bristol Myers Squibb Co., Ltd., Chugai Pharmaceutical Co., Daiichi-Sankyo, Inc.,Eisai Co., Ltd., Kissei Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Nippon Kayaku Co., Ltd., Sekiui Medical, Shionogi & Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd., Yanjie Hao: None declared, Zhuoli Zhang Speakers bureau: Norvatis, GSK, Pfizer, BMDB Basnayake: None declared, Madelynn Chan Speakers bureau: AbbVie, Novartis, Consultant of: Advisory Board member for Pfizer, Eli-Lilly, Jun Kikuchi: None declared, Tsutomu Takeuchi Speakers bureau: AbbVie AYUMI Pharmaceutical Corp. Bristol-Myers Squibb Chugai Pharmaceutical Co, Ltd. Daiichi Sankyo Co., Ltd. Eisai Co., Ltd. Eli Lilly Japan, Gilead Sciences, Inc. Mitsubishi-Tanabe Pharma Corp. Pfizer Japan Inc. Sanofi K.K., Consultant of: Astellas Pharma, Inc. Chugai Pharmaceutical Co, Ltd. Eli Lilly Japan, Mitsubishi-Tanabe Pharma Corp., Grant/research support from: AbbVie Asahikasei Pharma Corp. Chugai Pharmaceutical Co, Ltd. Mitsubishi-Tanabe Pharma Corp. Sanofi K.K, Sang-Cheol Bae: None declared, Sean O’Neill Paid instructor for: Advisory board member for GSK, Fiona Goldblatt: None declared, Shereen Oon: None declared, Kathryn Gibson Speakers bureau: UCB, Consultant of: Novartis – co-chair for NSW and steering committee member for ARISE meeting Feb 2021Janssen Pharmaceuticals – advisory board, Grant/research support from: Novartis, Employee of: Eli Lilly, Kristine Ng Speakers bureau: speaker fees and advisory board (Abbvie, Novartis, Janssen), Annie Law: None declared, Nicola Tugnet: None declared, Sunil Kumar: None declared, Cherica Tee: None declared, Michael Tee: None declared, Yoshiya Tanaka Speakers bureau: Daiichi-Sankyo, Eli Lilly, Novartis, YL Biologics, Bristol-Myers, Eisai, Chugai, Abbvie, Astellas, Pfizer, Sanofi, Asahi-kasei, GSK, Mitsubishi-Tanabe, Gilead, Janssen, Grant/research support from: Daiichi-Sankyo, Eli Lilly, Novartis, YL Biologics, Bristol-Myers, Eisai, Chugai, Abbvie, Astellas, Pfizer, Sanofi, Asahi-kasei, GSK, Mitsubishi-Tanabe, Gilead, Janssen, C.S. Lau Shareholder of: Pfizer, Sanofi and Janssen, Mandana Nikpour Speakers bureau: Actelion, GSK, Janssen, Pfizer, UCB, Paid instructor for: UCB, Consultant of: Actelion, Boehringer Ingelheim, Certa Therapeutics, Eli Lilly, GSK, Janssen, Pfizer, UCB, Grant/research support from: Actelion, Astra Zeneca, BMS, GSK, Janssen, UCB, Alberta Hoi Consultant of: AH is on the advisory board for Abbvie and GSK, Grant/research support from: AH has received research support from AstraZeneca, GSK, BMS, Janssen, and Merck Serono, Eric F. Morand Speakers bureau: AstraZeneca, Paid instructor for: Eli Lilly, Consultant of: AstraZeneca, Amgen, Biogen, BristolMyersSquibb, Eli Lilly, EMD Serono, Genentech, Janssen, Grant/research support from: AstraZeneca, BristolMyersSquibb, Eli Lilly, EMD Serono, Janssen
Collapse
|
16
|
Aaltonen T, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Appel JA, Arisawa T, Artikov A, Asaadi J, Ashmanskas W, Auerbach B, Aurisano A, Azfar F, Badgett W, Bae T, Barbaro-Galtieri A, Barnes VE, Barnett BA, Barria P, Bartos P, Bauce M, Bedeschi F, Behari S, Bellettini G, Bellinger J, Benjamin D, Beretvas A, Bhatti A, Bland KR, Blumenfeld B, Bocci A, Bodek A, Bortoletto D, Boudreau J, Boveia A, Brigliadori L, Bromberg C, Brucken E, Budagov J, Budd HS, Burkett K, Busetto G, Bussey P, Butti P, Buzatu A, Calamba A, Camarda S, Campanelli M, Carls B, Carlsmith D, Carosi R, Carrillo S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavaliere V, Cerri A, Cerrito L, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Cho K, Chokheli D, Clark A, Clarke C, Convery ME, Conway J, Corbo M, Cordelli M, Cox CA, Cox DJ, Cremonesi M, Cruz D, Cuevas J, Culbertson R, d'Ascenzo N, Datta M, de Barbaro P, Demortier L, Deninno M, D'Errico M, Devoto F, Di Canto A, Di Ruzza B, Dittmann JR, Donati S, D'Onofrio M, Dorigo M, Driutti A, Ebina K, Edgar R, Elagin A, Erbacher R, Errede S, Esham B, Farrington S, Fernández Ramos JP, Field R, Flanagan G, Forrest R, Franklin M, Freeman JC, Frisch H, Funakoshi Y, Galloni C, Garfinkel AF, Garosi P, Gerberich H, Gerchtein E, Giagu S, Giakoumopoulou V, Gibson K, Ginsburg CM, Giokaris N, Giromini P, Glagolev V, Glenzinski D, Gold M, Goldin D, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González López O, Gorelov I, Goshaw AT, Goulianos K, Gramellini E, Grosso-Pilcher C, Guimaraes da Costa J, Hahn SR, Han JY, Happacher F, Hara K, Hare M, Harr RF, Harrington-Taber T, Hatakeyama K, Hays C, Heinrich J, Herndon M, Hocker A, Hong Z, Hopkins W, Hou S, Hughes RE, Husemann U, Hussein M, Huston J, Introzzi G, Iori M, Ivanov A, James E, Jang D, Jayatilaka B, Jeon EJ, Jindariani S, Jones M, Joo KK, Jun SY, Junk TR, Kambeitz M, Kamon T, Karchin PE, Kasmi A, Kato Y, Ketchum W, Keung J, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SH, Kim SB, Kim YJ, Kim YK, Kimura N, Kirby M, Kondo K, Kong DJ, Konigsberg J, Kotwal AV, Kreps M, Kroll J, Kruse M, Kuhr T, Kurata M, Laasanen AT, Lammel S, Lancaster M, Lannon K, Latino G, Lee HS, Lee JS, Leo S, Leone S, Lewis JD, Limosani A, Lipeles E, Lister A, Liu Q, Liu T, Lockwitz S, Loginov A, Lucchesi D, Lucà A, Lueck J, Lujan P, Lukens P, Lungu G, Lys J, Lysak R, Madrak R, Maestro P, Malik S, Manca G, Manousakis-Katsikakis A, Marchese L, Margaroli F, Marino P, Matera K, Mattson ME, Mazzacane A, Mazzanti P, McNulty R, Mehta A, Mehtala P, Menzione A, Mesropian C, Miao T, Michielin E, Mietlicki D, Mitra A, Miyake H, Moed S, Moggi N, Moon CS, Moore R, Morello MJ, Mukherjee A, Muller T, Murat P, Mussini M, Nachtman J, Nagai Y, Naganoma J, Nakano I, Napier A, Nett J, Nigmanov T, Nodulman L, Noh SY, Norniella O, Oakes L, Oh SH, Oh YD, Okusawa T, Orava R, Ortolan L, Pagliarone C, Palencia E, Palni P, Papadimitriou V, Parker W, Pauletta G, Paulini M, Paus C, Phillips TJ, Piacentino G, Pianori E, Pilot J, Pitts K, Plager C, Pondrom L, Poprocki S, Potamianos K, Pranko A, Prokoshin F, Ptohos F, Punzi G, Redondo Fernández I, Renton P, Rescigno M, Rimondi F, Ristori L, Robson A, Rodriguez T, Rolli S, Ronzani M, Roser R, Rosner JL, Ruffini F, Ruiz A, Russ J, Rusu V, Sakumoto WK, Sakurai Y, Santi L, Sato K, Saveliev V, Savoy-Navarro A, Schlabach P, Schmidt EE, Schwarz T, Scodellaro L, Scuri F, Seidel S, Seiya Y, Semenov A, Sforza F, Shalhout SZ, Shears T, Shepard PF, Shimojima M, Shochet M, Shreyber-Tecker I, Simonenko A, Sliwa K, Smith JR, Snider FD, Song H, Sorin V, St Denis R, Stancari M, Stentz D, Strologas J, Sudo Y, Sukhanov A, Suslov I, Takemasa K, Takeuchi Y, Tang J, Tecchio M, Teng PK, Thom J, Thomson E, Thukral V, Toback D, Tokar S, Tollefson K, Tomura T, Torre S, Torretta D, Totaro P, Trovato M, Ukegawa F, Uozumi S, Vázquez F, Velev G, Vellidis K, Vernieri C, Vidal M, Vilar R, Vizán J, Vogel M, Volpi G, Wagner P, Wallny R, Wang SM, Waters D, Wester WC, Whiteson D, Wicklund AB, Wilbur S, Williams HH, Wilson JS, Wilson P, Winer BL, Wittich P, Wolbers S, Wolfmeister H, Wright T, Wu X, Wu Z, Yamamoto K, Yamato D, Yang T, Yang UK, Yang YC, Yao WM, Yeh GP, Yi K, Yoh J, Yorita K, Yoshida T, Yu GB, Yu I, Zanetti AM, Zeng Y, Zhou C, Zucchelli S. High-precision measurement of the W boson mass with the CDF II detector. Science 2022; 376:170-176. [PMID: 35389814 DOI: 10.1126/science.abk1781] [Citation(s) in RCA: 77] [Impact Index Per Article: 38.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
The mass of the W boson, a mediator of the weak force between elementary particles, is tightly constrained by the symmetries of the standard model of particle physics. The Higgs boson was the last missing component of the model. After observation of the Higgs boson, a measurement of the W boson mass provides a stringent test of the model. We measure the W boson mass, MW, using data corresponding to 8.8 inverse femtobarns of integrated luminosity collected in proton-antiproton collisions at a 1.96 tera-electron volt center-of-mass energy with the CDF II detector at the Fermilab Tevatron collider. A sample of approximately 4 million W boson candidates is used to obtain [Formula: see text], the precision of which exceeds that of all previous measurements combined (stat, statistical uncertainty; syst, systematic uncertainty; MeV, mega-electron volts; c, speed of light in a vacuum). This measurement is in significant tension with the standard model expectation.
Collapse
Affiliation(s)
| | - T Aaltonen
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland.,Helsinki Institute of Physics, FIN-00014, Helsinki, Finland
| | - S Amerio
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy.,University of Padova, I-35131 Padova, Italy
| | - D Amidei
- University of Michigan, Ann Arbor, MI 48109, USA
| | - A Anastassov
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - A Annovi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Antos
- Comenius University, 842 48 Bratislava, Slovakia.,Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - G Apollinari
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J A Appel
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | | | - A Artikov
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - J Asaadi
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - W Ashmanskas
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - B Auerbach
- Argonne National Laboratory, Argonne, IL 60439, USA
| | - A Aurisano
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - F Azfar
- University of Oxford, Oxford OX1 3RH, UK
| | - W Badgett
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - T Bae
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - A Barbaro-Galtieri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - V E Barnes
- Purdue University, West Lafayette, IN 47907, USA
| | - B A Barnett
- The Johns Hopkins University, Baltimore, MD 21218, USA
| | - P Barria
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Siena, I-53100 Siena, Italy
| | - P Bartos
- Comenius University, 842 48 Bratislava, Slovakia.,Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - M Bauce
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy.,University of Padova, I-35131 Padova, Italy
| | - F Bedeschi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Behari
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - G Bellettini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - J Bellinger
- University of Wisconsin-Madison, Madison, WI 53706, USA
| | | | - A Beretvas
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - A Bhatti
- The Rockefeller University, New York, NY 10065, USA
| | - K R Bland
- Baylor University, Waco, TX 76798, USA
| | - B Blumenfeld
- The Johns Hopkins University, Baltimore, MD 21218, USA
| | - A Bocci
- Duke University, Durham, NC 27708, USA
| | - A Bodek
- University of Rochester, Rochester, NY 14627, USA
| | - D Bortoletto
- Purdue University, West Lafayette, IN 47907, USA
| | - J Boudreau
- University of Pittsburgh, Pittsburgh, PA 15260, USA
| | - A Boveia
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - L Brigliadori
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy.,University of Bologna, I-40127 Bologna, Italy
| | - C Bromberg
- Michigan State University, East Lansing, MI 48824, USA
| | - E Brucken
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland.,Helsinki Institute of Physics, FIN-00014, Helsinki, Finland
| | - J Budagov
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - H S Budd
- University of Rochester, Rochester, NY 14627, USA
| | - K Burkett
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - G Busetto
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy.,University of Padova, I-35131 Padova, Italy
| | - P Bussey
- Glasgow University, Glasgow G12 8QQ, UK
| | - P Butti
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - A Buzatu
- Glasgow University, Glasgow G12 8QQ, UK
| | - A Calamba
- Carnegie Mellon University, Pittsburgh, PA 15213, USA
| | - S Camarda
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193 Bellaterra (Barcelona), Spain
| | | | - B Carls
- University of Illinois, Urbana, IL 61801, USA
| | - D Carlsmith
- University of Wisconsin-Madison, Madison, WI 53706, USA
| | - R Carosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Carrillo
- University of Florida, Gainesville, FL 32611, USA
| | - B Casal
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Casarsa
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy
| | - A Castro
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy.,University of Bologna, I-40127 Bologna, Italy
| | - P Catastini
- Harvard University, Cambridge, MA 02138, USA
| | - D Cauz
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy.,Gruppo Collegato di Udine, I-33100 Udine, Italy.,University of Udine, I-33100 Udine, Italy
| | - V Cavaliere
- University of Illinois, Urbana, IL 61801, USA
| | - A Cerri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - L Cerrito
- University College London, London WC1E 6BT, UK
| | - Y C Chen
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - M Chertok
- University of California, Davis, Davis, CA 95616, USA
| | - G Chiarelli
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - G Chlachidze
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - K Cho
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - D Chokheli
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - A Clark
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - C Clarke
- Wayne State University, Detroit, MI 48201, USA
| | - M E Convery
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J Conway
- University of California, Davis, Davis, CA 95616, USA
| | - M Corbo
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Cordelli
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - C A Cox
- University of California, Davis, Davis, CA 95616, USA
| | - D J Cox
- University of California, Davis, Davis, CA 95616, USA
| | - M Cremonesi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - D Cruz
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - J Cuevas
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - R Culbertson
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - N d'Ascenzo
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Datta
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - P de Barbaro
- University of Rochester, Rochester, NY 14627, USA
| | - L Demortier
- The Rockefeller University, New York, NY 10065, USA
| | - M Deninno
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - M D'Errico
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy.,University of Padova, I-35131 Padova, Italy
| | - F Devoto
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland.,Helsinki Institute of Physics, FIN-00014, Helsinki, Finland
| | - A Di Canto
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - B Di Ruzza
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | | | - S Donati
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - M D'Onofrio
- University of Liverpool, Liverpool L69 7ZE, UK
| | - M Dorigo
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy.,University of Trieste, I-34127 Trieste, Italy
| | - A Driutti
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy.,Gruppo Collegato di Udine, I-33100 Udine, Italy.,University of Udine, I-33100 Udine, Italy
| | - K Ebina
- Waseda University, Tokyo 169, Japan
| | - R Edgar
- University of Michigan, Ann Arbor, MI 48109, USA
| | - A Elagin
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - R Erbacher
- University of California, Davis, Davis, CA 95616, USA
| | - S Errede
- University of Illinois, Urbana, IL 61801, USA
| | - B Esham
- University of Illinois, Urbana, IL 61801, USA
| | | | - J P Fernández Ramos
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - R Field
- University of Florida, Gainesville, FL 32611, USA
| | - G Flanagan
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - R Forrest
- University of California, Davis, Davis, CA 95616, USA
| | - M Franklin
- Harvard University, Cambridge, MA 02138, USA
| | - J C Freeman
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - H Frisch
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | | | - C Galloni
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | | | - P Garosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Siena, I-53100 Siena, Italy
| | - H Gerberich
- University of Illinois, Urbana, IL 61801, USA
| | - E Gerchtein
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - S Giagu
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - V Giakoumopoulou
- National and Kapodistrian University of Athens, 157 71 Athens, Greece
| | - K Gibson
- University of Pittsburgh, Pittsburgh, PA 15260, USA
| | - C M Ginsburg
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - N Giokaris
- National and Kapodistrian University of Athens, 157 71 Athens, Greece
| | - P Giromini
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - V Glagolev
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - D Glenzinski
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Gold
- University of New Mexico, Albuquerque, NM 87131, USA
| | - D Goldin
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - A Golossanov
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - G Gomez
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | | | - M Goncharov
- Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - O González López
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - I Gorelov
- University of New Mexico, Albuquerque, NM 87131, USA
| | | | - K Goulianos
- The Rockefeller University, New York, NY 10065, USA
| | - E Gramellini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - C Grosso-Pilcher
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | | | - S R Hahn
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J Y Han
- University of Rochester, Rochester, NY 14627, USA
| | - F Happacher
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - K Hara
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - M Hare
- Tufts University, Medford, MA 02155, USA
| | - R F Harr
- Wayne State University, Detroit, MI 48201, USA
| | | | | | - C Hays
- University of Oxford, Oxford OX1 3RH, UK
| | - J Heinrich
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - M Herndon
- University of Wisconsin-Madison, Madison, WI 53706, USA
| | - A Hocker
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - Z Hong
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - W Hopkins
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - S Hou
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - R E Hughes
- The Ohio State University, Columbus, OH 43210, USA
| | - U Husemann
- Yale University, New Haven, CT 06520, USA
| | - M Hussein
- Michigan State University, East Lansing, MI 48824, USA
| | - J Huston
- Michigan State University, East Lansing, MI 48824, USA
| | - G Introzzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,Istituto Nazionale di Fisica Nucleare Pavia, I-27100 Pavia, Italy.,University of Pavia, I-27100 Pavia, Italy
| | - M Iori
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy.,Sapienza Università di Roma, I-00185 Roma, Italy
| | - A Ivanov
- University of California, Davis, Davis, CA 95616, USA
| | - E James
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - D Jang
- Carnegie Mellon University, Pittsburgh, PA 15213, USA
| | - B Jayatilaka
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - E J Jeon
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - S Jindariani
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Jones
- Purdue University, West Lafayette, IN 47907, USA
| | - K K Joo
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - S Y Jun
- Carnegie Mellon University, Pittsburgh, PA 15213, USA
| | - T R Junk
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Kambeitz
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - T Kamon
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA.,Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - P E Karchin
- Wayne State University, Detroit, MI 48201, USA
| | - A Kasmi
- Baylor University, Waco, TX 76798, USA
| | - Y Kato
- Osaka City University, Osaka 558-8585, Japan
| | - W Ketchum
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - J Keung
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - B Kilminster
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - D H Kim
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - H S Kim
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J E Kim
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - M J Kim
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - S H Kim
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S B Kim
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - Y J Kim
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - Y K Kim
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - N Kimura
- Waseda University, Tokyo 169, Japan
| | - M Kirby
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - K Kondo
- Waseda University, Tokyo 169, Japan
| | - D J Kong
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - J Konigsberg
- University of Florida, Gainesville, FL 32611, USA
| | | | - M Kreps
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - J Kroll
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - M Kruse
- Duke University, Durham, NC 27708, USA
| | - T Kuhr
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - M Kurata
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A T Laasanen
- Purdue University, West Lafayette, IN 47907, USA
| | - S Lammel
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Lancaster
- University College London, London WC1E 6BT, UK
| | - K Lannon
- The Ohio State University, Columbus, OH 43210, USA
| | - G Latino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Siena, I-53100 Siena, Italy
| | - H S Lee
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - J S Lee
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - S Leo
- University of Illinois, Urbana, IL 61801, USA
| | - S Leone
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - J D Lewis
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | | | - E Lipeles
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - A Lister
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - Q Liu
- Purdue University, West Lafayette, IN 47907, USA
| | - T Liu
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - S Lockwitz
- Yale University, New Haven, CT 06520, USA
| | - A Loginov
- Yale University, New Haven, CT 06520, USA
| | - D Lucchesi
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy.,University of Padova, I-35131 Padova, Italy
| | - A Lucà
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA.,Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Lueck
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Lujan
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - P Lukens
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - G Lungu
- The Rockefeller University, New York, NY 10065, USA
| | - J Lys
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - R Lysak
- Comenius University, 842 48 Bratislava, Slovakia.,Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - R Madrak
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - P Maestro
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Siena, I-53100 Siena, Italy
| | - S Malik
- The Rockefeller University, New York, NY 10065, USA
| | - G Manca
- University of Liverpool, Liverpool L69 7ZE, UK
| | | | - L Marchese
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - F Margaroli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - P Marino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,Scuola Normale Superiore, I-56126 Pisa, Italy
| | - K Matera
- University of Illinois, Urbana, IL 61801, USA
| | - M E Mattson
- Wayne State University, Detroit, MI 48201, USA
| | - A Mazzacane
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - P Mazzanti
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - R McNulty
- University of Liverpool, Liverpool L69 7ZE, UK
| | - A Mehta
- University of Liverpool, Liverpool L69 7ZE, UK
| | - P Mehtala
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland.,Helsinki Institute of Physics, FIN-00014, Helsinki, Finland
| | - A Menzione
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - C Mesropian
- The Rockefeller University, New York, NY 10065, USA
| | - T Miao
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - E Michielin
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy.,University of Padova, I-35131 Padova, Italy
| | - D Mietlicki
- University of Michigan, Ann Arbor, MI 48109, USA
| | - A Mitra
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - H Miyake
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Moed
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - N Moggi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - C S Moon
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - R Moore
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M J Morello
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,Scuola Normale Superiore, I-56126 Pisa, Italy
| | - A Mukherjee
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - Th Muller
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Murat
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - M Mussini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy.,University of Bologna, I-40127 Bologna, Italy
| | - J Nachtman
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - Y Nagai
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | | | - I Nakano
- Okayama University, Okayama 700-8530, Japan
| | - A Napier
- Tufts University, Medford, MA 02155, USA
| | - J Nett
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - T Nigmanov
- University of Pittsburgh, Pittsburgh, PA 15260, USA
| | - L Nodulman
- Argonne National Laboratory, Argonne, IL 60439, USA
| | - S Y Noh
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - O Norniella
- University of Illinois, Urbana, IL 61801, USA
| | - L Oakes
- University of Oxford, Oxford OX1 3RH, UK
| | - S H Oh
- Duke University, Durham, NC 27708, USA
| | - Y D Oh
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - T Okusawa
- Osaka City University, Osaka 558-8585, Japan
| | - R Orava
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland.,Helsinki Institute of Physics, FIN-00014, Helsinki, Finland
| | - L Ortolan
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193 Bellaterra (Barcelona), Spain
| | - C Pagliarone
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy
| | - E Palencia
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - P Palni
- University of New Mexico, Albuquerque, NM 87131, USA
| | - V Papadimitriou
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - W Parker
- University of Wisconsin-Madison, Madison, WI 53706, USA
| | - G Pauletta
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy.,Gruppo Collegato di Udine, I-33100 Udine, Italy.,University of Udine, I-33100 Udine, Italy
| | - M Paulini
- Carnegie Mellon University, Pittsburgh, PA 15213, USA
| | - C Paus
- Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | | | - G Piacentino
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - E Pianori
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - J Pilot
- University of California, Davis, Davis, CA 95616, USA
| | - K Pitts
- University of Illinois, Urbana, IL 61801, USA
| | - C Plager
- University of California, Los Angeles, Los Angeles, CA 90024, USA
| | - L Pondrom
- University of Wisconsin-Madison, Madison, WI 53706, USA
| | - S Poprocki
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - K Potamianos
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - A Pranko
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - F Prokoshin
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - F Ptohos
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - G Punzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - I Redondo Fernández
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - P Renton
- University of Oxford, Oxford OX1 3RH, UK
| | - M Rescigno
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - F Rimondi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - L Ristori
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA.,Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - A Robson
- Glasgow University, Glasgow G12 8QQ, UK
| | - T Rodriguez
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - S Rolli
- Tufts University, Medford, MA 02155, USA
| | - M Ronzani
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - R Roser
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J L Rosner
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - F Ruffini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Siena, I-53100 Siena, Italy
| | - A Ruiz
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Russ
- Carnegie Mellon University, Pittsburgh, PA 15213, USA
| | - V Rusu
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - W K Sakumoto
- University of Rochester, Rochester, NY 14627, USA
| | | | - L Santi
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy.,Gruppo Collegato di Udine, I-33100 Udine, Italy.,University of Udine, I-33100 Udine, Italy
| | - K Sato
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - V Saveliev
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - A Savoy-Navarro
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - P Schlabach
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - E E Schmidt
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - T Schwarz
- University of Michigan, Ann Arbor, MI 48109, USA
| | - L Scodellaro
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - F Scuri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Seidel
- University of New Mexico, Albuquerque, NM 87131, USA
| | - Y Seiya
- Osaka City University, Osaka 558-8585, Japan
| | - A Semenov
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - F Sforza
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,University of Pisa, I-56126 Pisa, Italy
| | - S Z Shalhout
- University of California, Davis, Davis, CA 95616, USA
| | - T Shears
- University of Liverpool, Liverpool L69 7ZE, UK
| | - P F Shepard
- University of Pittsburgh, Pittsburgh, PA 15260, USA
| | - M Shimojima
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - M Shochet
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - I Shreyber-Tecker
- Institution for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - A Simonenko
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - K Sliwa
- Tufts University, Medford, MA 02155, USA
| | - J R Smith
- University of California, Davis, Davis, CA 95616, USA
| | - F D Snider
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - H Song
- University of Pittsburgh, Pittsburgh, PA 15260, USA
| | - V Sorin
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193 Bellaterra (Barcelona), Spain
| | | | - M Stancari
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - D Stentz
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J Strologas
- University of New Mexico, Albuquerque, NM 87131, USA
| | - Y Sudo
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A Sukhanov
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - I Suslov
- Joint Institute for Nuclear Research, Dubna RU-141980, Russia
| | - K Takemasa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - Y Takeuchi
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - J Tang
- Enrico Fermi Institute, University of Chicago, Chicago, IL 60637, USA
| | - M Tecchio
- University of Michigan, Ann Arbor, MI 48109, USA
| | - P K Teng
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - J Thom
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - E Thomson
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - V Thukral
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - D Toback
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, TX 77843, USA
| | - S Tokar
- Comenius University, 842 48 Bratislava, Slovakia.,Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - K Tollefson
- Michigan State University, East Lansing, MI 48824, USA
| | - T Tomura
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Torre
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - D Torretta
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - P Totaro
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
| | - M Trovato
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,Scuola Normale Superiore, I-56126 Pisa, Italy
| | - F Ukegawa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Uozumi
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - F Vázquez
- University of Florida, Gainesville, FL 32611, USA
| | - G Velev
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - K Vellidis
- National and Kapodistrian University of Athens, 157 71 Athens, Greece
| | - C Vernieri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy.,Scuola Normale Superiore, I-56126 Pisa, Italy
| | - M Vidal
- Purdue University, West Lafayette, IN 47907, USA
| | - R Vilar
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Vizán
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Vogel
- University of New Mexico, Albuquerque, NM 87131, USA
| | - G Volpi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - P Wagner
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - R Wallny
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - S M Wang
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - D Waters
- University College London, London WC1E 6BT, UK
| | - W C Wester
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - D Whiteson
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - A B Wicklund
- Argonne National Laboratory, Argonne, IL 60439, USA
| | - S Wilbur
- University of California, Davis, Davis, CA 95616, USA
| | - H H Williams
- University of Pennsylvania, Philadelphia, PA 19104, USA
| | - J S Wilson
- University of Michigan, Ann Arbor, MI 48109, USA
| | - P Wilson
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - B L Winer
- The Ohio State University, Columbus, OH 43210, USA
| | - P Wittich
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - S Wolbers
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | | | - T Wright
- University of Michigan, Ann Arbor, MI 48109, USA
| | - X Wu
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - Z Wu
- Baylor University, Waco, TX 76798, USA
| | - K Yamamoto
- Osaka City University, Osaka 558-8585, Japan
| | - D Yamato
- Osaka City University, Osaka 558-8585, Japan
| | - T Yang
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - U K Yang
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - Y C Yang
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - W-M Yao
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - G P Yeh
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - K Yi
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - J Yoh
- Fermi National Accelerator Laboratory, Batavia, IL 60510, USA
| | - K Yorita
- Waseda University, Tokyo 169, Japan
| | - T Yoshida
- Osaka City University, Osaka 558-8585, Japan
| | - G B Yu
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - I Yu
- Center for High Energy Physics, Kyungpook National University, Daegu 702-701, Korea.,Seoul National University, Seoul 151-742, Korea.,Sungkyunkwan University, Suwon 440-746, Korea.,Korea Institute of Science and Technology Information, Daejeon 305-806, Korea.,Chonnam National University, Gwangju 500-757, Korea.,Chonbuk National University, Jeonju 561-756, Korea.,Ewha Womans University, Seoul 120-750, Korea
| | - A M Zanetti
- Istituto Nazionale di Fisica Nucleare Trieste, I-34127 Trieste, Italy
| | - Y Zeng
- Duke University, Durham, NC 27708, USA
| | - C Zhou
- Duke University, Durham, NC 27708, USA
| | - S Zucchelli
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy.,University of Bologna, I-40127 Bologna, Italy
| |
Collapse
|
17
|
Abman SH, Armstrong S, Baker S, Bogue CW, Carlo W, Chalak L, Daniels SR, Davis S, Debaun MR, Fike C, Frazer L, Gibson K, Gill M, Glass H, Gordon CM, Goyal M, Hirschhorn J, Holtz L, Hunstad DA, Leonard MB, Maitre N, Markham L, McAllister-Lucas L, Orange J, Shah P, Simon T, Steinhorn RH, Tarini B, Walker-Harding LR. The american pediatric society and society for pediatric research joint statement against racism and social injustice. Pediatr Res 2022; 91:72. [PMID: 32882704 PMCID: PMC7492687 DOI: 10.1038/s41390-020-01107-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/23/2020] [Revised: 06/29/2020] [Accepted: 07/21/2020] [Indexed: 11/09/2022]
|
18
|
Glenn DA, Zee J, Hegde A, Henderson C, O'Shaughnessy MM, Bomback A, Gibson K, Greenbaum LA, Mansfield S, Hu Y, Mariani L, Falk R, Hogan S, Denburg M, Mottl A. Validation of Diagnosis Codes to Identify Infection-Related Acute Care Events in Patients With Glomerular Disease. Kidney Int Rep 2021; 6:3079-3082. [PMID: 34901577 PMCID: PMC8640562 DOI: 10.1016/j.ekir.2021.08.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2021] [Revised: 08/13/2021] [Accepted: 08/16/2021] [Indexed: 11/29/2022] Open
Affiliation(s)
- Dorey A Glenn
- Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Jarcy Zee
- Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Anisha Hegde
- Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Candace Henderson
- Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | | | - Andrew Bomback
- Division of Nephrology, Columbia University, New York, New York, USA
| | - Keisha Gibson
- Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Larry A Greenbaum
- Division of Pediatric Nephrology, Department of Pediatrics, Emory University, Atlanta, Georgia, USA
| | - Sarah Mansfield
- Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA
| | - Yichun Hu
- Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Laura Mariani
- Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA
| | - Ronald Falk
- Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Susan Hogan
- Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Michelle Denburg
- Division of Nephrology, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Amy Mottl
- Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | | |
Collapse
|
19
|
Evans T, Liang B, Yan Z, Sun X, Yi Y, Vegter A, Guo L, Yang Y, Feng Z, Park S, Qi L, Bartels D, Gibson K, Meyerholz D, Engelhardt J. 658: In utero CFTR modulator therapy protects from meconium ileus and improves postnatal survival in F508del ferrets. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)02081-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
20
|
Bjornstad EC, Smith ZH, Muronya W, Munthali CK, Mottl AK, Marshall SW, Golightly YM, Gibson K, Charles A, Gower EW. High risk of acute kidney injury in Malawian trauma patients: a prospective observational cohort study. BMC Nephrol 2021; 22:354. [PMID: 34711197 PMCID: PMC8552973 DOI: 10.1186/s12882-021-02564-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2021] [Accepted: 10/14/2021] [Indexed: 02/08/2023] Open
Abstract
Background Trauma is a common cause of acute kidney injury (AKI). Yet little data exist regarding trauma-related-AKI in low-resourced settings, where the majority of deaths from AKI and trauma occur. We prospectively evaluated epidemiology of AKI in hospitalized Malawian trauma patients. Methods AKI was defined by creatinine-only Kidney Disease Improving Global Outcomes (KDIGO) criteria. Those with AKI were followed up 3–6 months later to determine persistent kidney abnormalities. We calculated univariate statistics with Wilcoxon rank sum tests, Fisher’s exact, and chi-square tests to compare those with and without AKI. Multivariate log-risk regression modelling was used to determine risk ratios (RR) and 95% confidence intervals (CI) for AKI development. Results Of 223 participants, 14.4% (n = 32) developed AKI. Most patients were young (median age 32) males (n = 193, 86.5%) involved in road traffic injuries (n = 120, 53.8%). After adjusting for confounders, those with severe anemia during their admission were 1.4 times (RR 1.4, 95% CI 1.1–1.8) more likely to develop AKI than those without. Overall mortality was 7.6% (n = 17), and those who developed AKI were more likely to die than those who did not (18.8% vs 5.6%, p-value = 0.02). Almost half of those with AKI (n = 32) either died (n = 6) or had persistent kidney dysfunction at follow-up (n = 8). Conclusion In one of the few African studies on trauma-related AKI, we found a high incidence of AKI (14.4%) in Malawian trauma patients with associated poor outcomes. Given AKI’s association with increased mortality and potential ramifications on long-term morbidity, urgent attention is needed to improve AKI-related outcomes. Supplementary Information The online version contains supplementary material available at 10.1186/s12882-021-02564-y.
Collapse
Affiliation(s)
- Erica C Bjornstad
- Department of Pediatrics, Division of Nephrology, University of Alabama at Birmingham, 1600 7th Avenue South, Lowder 516, Birmingham, AL, 35233, USA.
| | - Zachary H Smith
- Univeristy of North Carolina Project Malawi, Lilongwe, Malawi.,Division of Pediatric Critical Care Medicine, Stanford University School of Medicine, Stanford, USA
| | - William Muronya
- Department of Surgery, Kamuzu Central Hospital, Lilongwe, Malawi
| | - Charles K Munthali
- Department of Medicine, Renal Unit, Kamuzu Central Hospital, Lilongwe, Malawi
| | - Amy K Mottl
- Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, NC, USA
| | - Stephen W Marshall
- University of North Carolina Injury Prevention Research Center, Chapel Hill, USA.,Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA
| | - Yvonne M Golightly
- University of North Carolina Injury Prevention Research Center, Chapel Hill, USA.,Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA
| | - Keisha Gibson
- Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, NC, USA
| | - Anthony Charles
- Department of Surgery, University of North Carolina, Chapel Hill, NC, USA.,Malawi Surgical Initiative, Lilongwe, Malawi
| | - Emily W Gower
- Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA
| |
Collapse
|
21
|
Kandane-Rathnayake R, Louthrenoo W, Hoi A, Golder V, Chen YH, Luo SF, Jan Wu YJ, Lateef A, Cho J, Hamijoyo L, Lau CS, Navarra S, Zamora L, LI Z, An Y, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Kikuchi J, Takeuchi T, Basnayake B, Goldblatt F, Chan M, Ng K, Bae SC, Oon S, O’neill S, Gibson K, Kumar S, Tugnet N, Tanaka Y, Nikpour M, Morand EF. POS0028 DEFINING THE PREVALENCE OF UNMET NEED IN SLE: DATA FROM A LARGE MULTINATIONAL LONGITUDINAL SLE COHORT. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:The recent prospectively validated definition of the lupus low disease activity state (LLDAS) allows characterisation of patients not achieving a treatment goal, providing impetus for an analysis of unmet needs in SLE using formal definitions. Other recently described definitions of high disease burden include disease activity over time, high disease activity status (HDAS) episodes, and the combination of high disease activity, serological activity and glucocorticoid (GC) use (HDAS+SA+GC).Objectives:To determine the prevalence of formal categories of unmet need, and the association of these with adverse outcomes, in SLE.Methods:Data from a 13-country longitudinal SLE cohort (ACR/SLICC criteria) were collected between 2013 and 19 using standard templates. Unmet need was defined as (i) patients never attaining LLDAS defined as in Golder et al., 2019 [1], (ii) having persistently active disease (time adjusted mean SLEDAI-2K (AMS) > 4), (iii) ever exhibiting high disease activity status (HDAS; SLEDAI-2K ≥10[2]), or (iv) ever exhibiting all of SLEDAI≥10, serological activity, and glucocorticoid use (HDAS+SA+GC)[3]. Health-related quality of life (HRQoL) was assessed using SF36 (v2) surveys and damage accrual using SLE Damage Index (SDI).Results:3,384 SLE patients were followed for 30,313 visits over median [IQR] 2.4 [0.4, 4.3] years. 53% of all visits were not in LLDAS; 813 patients (24%) never achieved LLDAS during observation. Median AMS was 3.0 [1.4, 4.9] and 34% of patients had AMS > 4 throughout the study. 25% of patients had at least one episode of HDAS, representing 8% of visits. 702 patients (21%) had at least one episode of HDAS+SA+GC, representing 8% of visits. Each of never-LLDAS, AMS>4, ever-HDAS, and ever-HDAS+SA+GC were associated with significantly greater number of physician visits, higher mean glucocorticoid dose, lower HRQoL and higher mortality. 31%, 58% and 83% of never-LLDAS, AMS>4, and ever-HDAS patients respectively were also HDAS+SA+GC on at least one occasion.Conclusion:Data from a multinational longitudinal SLE cohort indicate that unmet need, defined by LLDAS-never, AMS>4, HDAS, or HDAS+SA+GC, is prevalent in SLE, and that these definitions are associated with poor outcomes.References:[1]Golder, V., et al., Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study. The Lancet Rheumatology, 2019. 1(2): p. e95-e102.[2]Koelmeyer, R., et al., High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus. Lupus Sci Med, 2020. 7(1).[3]van Vollenhoven, R.F., et al., Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response. Annals of the Rheumatic Diseases, 2012. 71(8): p. 1343-1349.Acknowledgements:The APLC acknowledges all the Data Collectors and Patients for their valuable contributions to research.Disclosure of Interests:Rangi Kandane-Rathnayake: None declared, Worawit Louthrenoo: None declared, Alberta Hoi Consultant of: Abbvie and GSK, Grant/research support from: AstraZeneca, GSK, BMS, Janssen, and Merck Serono, Vera Golder: None declared, Yi-Hsing Chen Speakers bureau: Pfizer, Novartis, Abbvie, Johnson & Johnson, BMS, Roche, Lilly, AstraZeneca, Sanofi, MSD, Guigai, Astellas, Inova Diagnostics, UCB, Agnitio Science Technology, United Biopharma, Thermo Fisher, Consultant of: Pfizer, Novartis, Abbvie, Johnson & Johnson, BMS, Roche, Lilly, AstraZeneca, Sanofi, MSD, Guigai, Astellas, Inova Diagnostics, UCB, Agnitio Science Technology, United Biopharma, Thermo Fisher, Gilead, Grant/research support from: Pfizer, Norvatis, BMS, Abbevie, Johnson & Johnson, Roche, Sanofi, Guigai, Roche, Boehringer Ingelheim, UCB, MSD, Astra-Zeneca, Astellas, Gilead, Shue Fen Luo: None declared, Yeong-Jian Jan Wu Speakers bureau: Pfizer, Lilly, Novartis, Abbvie, Aisha Lateef: None declared, Jiacai Cho: None declared, Laniyati Hamijoyo Speakers bureau: Pfizer, Novartis, Abbot, Chak Sing Lau Shareholder of: Pfizer, Sanofi, and Janssen, Sandra Navarra Speakers bureau: Pfizer, Johnson & Johnson, Novartis, Astellas, Grant/research support from: Astellas, Johnson & Johnson, Leonid Zamora: None declared, Zhanguo Li Speakers bureau: Eli, Lilly, Novartis, GSK, AbbVie, Paid instructor for: Pfizer, Roche, Johnson., Consultant of: Lilly, Pfizer, Grant/research support from: Pfizer, Yuan An: None declared, Sargunan Sockalingam Speakers bureau: Pfizer, Roche, Novartis, Grant/research support from: Roche and Novartis, Yasuhiro Katsumata Speakers bureau: Chugai Pharmaceutical Co., Ltd., Glaxo-Smithkline K.K., and Sanofi K.K., masayoshi harigai Speakers bureau: AbbVie Japan GK, Ayumi Pharmaceutical Co., Boehringer Ingelheim Japan, Inc.,Bristol Myers Squibb Co., Ltd., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., GlaxoSmithKline K.K., Kissei Pharmaceutical Co., Ltd., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd., Consultant of: AbbVie, Boehringer-ingelheim, Bristol Myers Squibb Co., Kissei Pharmaceutical Co.,Ltd. and Teijin Pharma., Grant/research support from: AbbVie Japan GK, Asahi Kasei Corp., Astellas Pharma Inc., Ayumi Pharmaceutical Co., Bristol Myers Squibb Co., Ltd., Chugai Pharmaceutical Co., Daiichi-Sankyo, Inc.,Eisai Co., Ltd., Kissei Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Nippon Kayaku Co., Ltd., Sekiui Medical, Shionogi & Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd., Yanjie Hao: None declared, Zhuoli Zhang Speakers bureau: Norvatis, GSK, Pfizer, Jun Kikuchi: None declared, Tsutomu Takeuchi Speakers bureau: AbbVie AYUMI Pharmaceutical Corp. Bristol-Myers Squibb Chugai Pharmaceutical Co, Ltd. Daiichi Sankyo Co., Ltd. Eisai Co., Ltd. Eli Lilly Japan, Gilead Sciences, Inc. Mitsubishi-Tanabe Pharma Corp. Pfizer Japan Inc. Sanofi K.K., Consultant of: Astellas Pharma, Inc. Chugai Pharmaceutical Co, Ltd. Eli Lilly Japan, Mitsubishi-Tanabe Pharma Corp., Grant/research support from: AbbVie, Asahikasei Pharma Corp. Chugai Pharmaceutical Co, Ltd. Mitsubishi-Tanabe Pharma Corp. Sanofi K.K., BMDB Basnayake: None declared, Fiona Goldblatt: None declared, Madelynn Chan Speakers bureau: AbbVie, Novartis, Consultant of: Pfizer, Eli-Lilly, Kristine Ng Speakers bureau: Abbvie, Novartis, Janssen, Sang-Cheol Bae: None declared, Shereen Oon: None declared, Sean O’Neill Consultant of: GSK, Kathryn Gibson Speakers bureau: UCB, Consultant of: Novartis, Janssen, Grant/research support from: Novartis, Sunil Kumar: None declared, Nicola Tugnet: None declared, Yoshiya Tanaka Speakers bureau: Daiichi-Sankyo, Eli Lilly, Novartis, YL Biologics, Bristol-Myers, Eisai, Chugai, Abbvie, Astellas, Pfizer, Sanofi, Asahi-kasei, GSK, Mitsubishi-Tanabe, Gilead, Janssen, Grant/research support from: Abbvie, Mitsubishi-Tanabe, Chugai, Asahi-Kasei, Eisai, Takeda, Daiichi-Sankyo, Mandana Nikpour Speakers bureau: Actelion, GSK, Janssen, Pfizer, UCB, Paid instructor for: UCB, Consultant of: Actelion, Boehringer Ingelheim, Certa Therapeutics, Eli Lilly, GSK, Janssen, Pfizer, UCB, Grant/research support from: Actelion, Astra Zeneca, BMS, GSK, Janssen, UCB, Eric F. Morand Speakers bureau: AstraZeneca, Paid instructor for: Eli Lilly, Consultant of: AstraZeneca, Amgen, Biogen, BristolMyersSquibb, Eli Lilly, EMD Serono, Genentech, Janssen, Grant/research support from: AstraZeneca, BristolMyersSquibb, Eli Lilly, EMD Serono, Janssen.
Collapse
|
22
|
Rovin BH, Teng YKO, Ginzler EM, Arriens C, Caster DJ, Romero-Diaz J, Gibson K, Kaplan J, Lisk L, Navarra S, Parikh SV, Randhawa S, Solomons N, Huizinga RB. Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 2021; 397:2070-2080. [PMID: 33971155 DOI: 10.1016/s0140-6736(21)00578-x] [Citation(s) in RCA: 217] [Impact Index Per Article: 72.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/30/2020] [Revised: 02/25/2021] [Accepted: 03/02/2021] [Indexed: 12/15/2022]
Abstract
BACKGROUND Voclosporin, a novel calcineurin inhibitor approved for the treatment of adults with lupus nephritis, improved complete renal response rates in patients with lupus nephritis in a phase 2 trial. This study aimed to evaluate the efficacy and safety of voclosporin for the treatment of lupus nephritis. METHODS This multicentre, double-blind, randomised phase 3 trial was done in 142 hospitals and clinics across 27 countries. Patients with a diagnosis of systemic lupus erythematosus with lupus nephritis according to the American College of Rheumatology criteria, and a kidney biopsy within 2 years that showed class III, IV, or V (alone or in combination with class III or IV) were eligible. Patients were randomly assigned (1:1) to oral voclosporin (23·7 mg twice daily) or placebo, on a background of mycophenolate mofetil (1 g twice daily) and rapidly tapered low-dose oral steroids, by use of an interactive web response system. The primary endpoint was complete renal response at 52 weeks defined as a composite of urine protein creatinine ratio of 0·5 mg/mg or less, stable renal function (defined as estimated glomerular filtration rate [eGFR] ≥60 mL/min/1·73 m2 or no confirmed decrease from baseline in eGFR of >20%), no administration of rescue medication, and no more than 10 mg prednisone equivalent per day for 3 or more consecutive days or for 7 or more days during weeks 44 through 52, just before the primary endpoint assessment. Safety was also assessed. Efficacy analysis was by intention-to-treat and safety analysis by randomised patients receiving at least one dose of study treatment. The trial is registered with ClinicalTrials.gov, NCT03021499. FINDINGS Between April 13, 2017, and Oct 10, 2019, 179 patients were assigned to the voclosporin group and 178 to the placebo group. The primary endpoint of complete renal response at week 52 was achieved in significantly more patients in the voclosporin group than in the placebo group (73 [41%] of 179 patients vs 40 [23%] of 178 patients; odds ratio 2·65; 95% CI 1·64-4·27; p<0·0001). The adverse event profile was balanced between the two groups; serious adverse events occurred in 37 (21%) of 178 in the voclosporin group and 38 (21%) of 178 patients in the placebo group. The most frequent serious adverse event involving infection was pneumonia, occurring in 7 (4%) patients in the voclosporin group and in 8 (4%) patients in the placebo group. A total of six patients died during the study or study follow-up period (one [<1%] patient in the voclosporin group and five [3%] patients in the placebo group). None of the events leading to death were considered by the investigators to be related to the study treatments. INTERPRETATION Voclosporin in combination with MMF and low-dose steroids led to a clinically and statistically superior complete renal response rate versus MMF and low-dose steroids alone, with a comparable safety profile. This finding is an important advancement in the treatment of patients with active lupus nephritis. FUNDING Aurinia Pharmaceuticals.
Collapse
Affiliation(s)
- Brad H Rovin
- Department of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, USA
| | - Y K Onno Teng
- Department of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands
| | - Ellen M Ginzler
- Department of Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY, USA
| | - Cristina Arriens
- Department of Arthritis & Clinical Immunology, Rheumatology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA
| | - Dawn J Caster
- Department of Medicine, Division of Nephrology and Hypertension, University of Louisville School of Medicine, Louisville, KY, USA
| | - Juanita Romero-Diaz
- Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
| | - Keisha Gibson
- Department of Medicine, UNC Kidney Center, Chapel Hill, NC, United States
| | - Joshua Kaplan
- Department of Medicine, Rutgers University, Newark, NJ, USA
| | - Laura Lisk
- Clinical Development, Aurinia Pharmaceuticals, Victoria, BC, Canada
| | - Sandra Navarra
- University of Santo Tomas, Manila and St Luke's Medical Center, Quezon City, Philippines
| | - Samir V Parikh
- Department of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, USA
| | - Simrat Randhawa
- Clinical Development, Aurinia Pharmaceuticals, Victoria, BC, Canada
| | - Neil Solomons
- Clinical Development, Aurinia Pharmaceuticals, Victoria, BC, Canada
| | | |
Collapse
|
23
|
Warady B, Chadha V, Chin M, Gbadagesin RA, Gibson K, Gipson D, Goldsberry A, Lieberman K, Meyer C, Meyers K, Nozu K, O'Grady M, Rheault M, Kashtan C. FC 023SAFETY OF BARDOXOLONE METHYL IN PEDIATRIC PATIENTS WITH ALPORT SYNDROME IN CARDINAL PHASE 3 TRIAL. Nephrol Dial Transplant 2021. [DOI: 10.1093/ndt/gfab133.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background and Aims
Alport syndrome is a genetic disease accounting for an estimated 3% of children with end-stage kidney disease (ESKD) in the US (USRDS, 2014). Current management recommendations include the use of renin-angiotensin-aldosterone system inhibitors (RAASi) in patients with proteinuria, but no specific therapies have been approved for this disease. A Phase 3 study (CARDINAL; NCT03019185) assessed the safety and efficacy of bardoxolone methyl (Bard) in adult and adolescent patients with Alport syndrome.
Method
CARDINAL was an international, multicenter, double-blind, placebo-controlled, randomized trial. Eligible participants were 12 to 70 years old, had confirmed diagnosis of Alport syndrome, baseline eGFR 30-90 mL/min/1.73 m2 and urinary albumin to creatinine ratio (UACR) ≤ 3500 mg/g. For pediatric patients (12 to < 18 years of age), eGFR was calculated using the Bedside Schwartz equation. Patients were randomized 1:1 to Bard or placebo and were to be followed for up to 104 weeks (2 treatment periods of 48 weeks and 4 weeks off treatment between Weeks 48 and 52). The primary efficacy endpoints were changes from baseline in eGFR in patients randomized to Bard compared to placebo at Week 48 and Week 100. The key secondary endpoints were the off-treatment changes from baseline in eGFR in patients randomized to Bard compared to placebo at Week 52 and Week 104, 4 weeks after withdrawal.
Results
A total of 23 (15%) pediatric patients were randomized to Bard (n=11) or placebo (n=12). The average age was 15.3 years, mean (± SD) baseline eGFR was 69.9 ± 15.4 mL/min/1.73 m2 and geometric mean (± SE) baseline UACR was 230.9 ± 95.8 mg/g. A total of 19 of 23 (83%) pediatric patients were male, and 14 (61%) patients had X-linked Alport syndrome, while 6 (26%) patients had autosomal disease. Mean (± SD) baseline body weight was 65.5 ± 10.2 kg and 57.8 ± 16.0 kg and baseline height was 171.7 ± 5.9 cm and 166.3 ± 14.9 cm for Bard and placebo patients, respectively. Seventeen (74%) pediatric patients were on RAASi treatment.
Treatment of pediatric patients with Bard resulted in a significantly higher mean change from baseline in on-treatment eGFR relative to placebo at Week 100 (13.8 mL/min/1.73 m2; p = 0.017) and higher mean off-treatment eGFR relative to placebo at Week 104 (14.6 mL/min/1.73 m2; p = 0.0035).
In pediatric patients treated with Bard, UACR remained generally unchanged relative to baseline at Week 100 (geometric mean ± SE to baseline ratio: 0.7 ± 0.3), while placebo patients had an increase in UACR (geometric mean ± SE to baseline ratio: 2.1 ± 0.9).
Pediatric patients generally continued along their baseline growth curves for height and weight in both treatment groups. At Week 100, mean ± SD changes from baseline in body weight were 0.5 ± 3.9 kg and 3.2 ± 3.5 kg and those for height were 1.6 ± 1.4 cm and 4.3 ± 5.1 cm for Bard and placebo patients, respectively. Changes in blood pressure (BP) were similar across treatment groups.
As seen in the adult population, treatment with Bard resulted in transient increases in mean aminotransferase levels in pediatric patients that remained below 3 x ULN for a majority (8/11 [73%]) of patients and returned to baseline at Week 104, 4 weeks after drug withdrawal (mean ± SD change from baseline in ALT: 0.4 ± 3.7 U/L; AST: -0.9 ± 5.6 U/L). Increases in ALT did not coincide with increases in total bilirubin and no Hy’s law cases were reported.
No serious adverse events (AEs) were reported in pediatric patients treated with Bard and reported AEs were consistent with those observed in previous studies. One placebo-treated pediatric patient and no Bard patients developed ESKD during the trial.
Conclusion
In CARDINAL, the addition of Bard to RAASi in pediatric patients with chronic kidney disease due to Alport syndrome appeared to preserve kidney function and very importantly from a safety standpoint, was safe and well-tolerated.
Collapse
Affiliation(s)
- Bradley Warady
- Children’s Mercy Kansas City, Pediatric Nephrology, Kansas City, United States of America
| | - Vimal Chadha
- Children’s Mercy Kansas City, Nephrology, Kansas City, United States of America
| | - Melanie Chin
- Reata Pharmaceuticals, Product Development, Plano , United States of America
| | - Rasheed A Gbadagesin
- Duke University School of Medicine, Pediatrics, Durham, United States of America
| | - Keisha Gibson
- University of North Carolina at Chapel Hill, Medicine and Pediatrics, Chapel Hill, United States of America
| | - Debbie Gipson
- University of Michigan, Pediatric Nephrology, Ann Arbor, United States of America
| | - Angie Goldsberry
- Reata Pharmaceuticals, Product Development, Plano , United States of America
| | - Kenneth Lieberman
- Hackensack University Medical Center, Pediatrics, Hackensack, United States of America
| | - Colin Meyer
- Reata Pharmaceuticals, Product Development, Plano , United States of America
| | - Kevin Meyers
- CHOP and UPENN, Pediatric Nephrology, Philadelphia, United States of America
| | - Kandai Nozu
- Kobe University Graduate School of Medicine, Pediatrics, Hyogo, United States of America
| | - Megan O'Grady
- Reata Pharmaceuticals, Product Development, Plano , United States of America
| | - Michelle Rheault
- University of Minnesota, Pediatrics, Saint Louis Park, United States of America
| | - Clifford Kashtan
- University of Minnesota, Pediatrics, Saint Louis Park, United States of America
| |
Collapse
|
24
|
Franz BJ, Petraroia R, Faust CD, Crawford T, Smalls S, Vongsavanh C, Gibson K, Schmitz JL. Abrogating biologics interference in flow cytometric crossmatching. Hum Immunol 2021; 82:574-580. [PMID: 33934934 DOI: 10.1016/j.humimm.2021.01.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2020] [Revised: 01/04/2021] [Accepted: 01/27/2021] [Indexed: 10/21/2022]
Abstract
The flow cytometric crossmatch is currently the gold standard for evaluating donor and recipient histocompatibility. The assay however does have limitations and is sensitive to false positive reactions resulting from the presence of non-HLA antibodies or therapy related immune biologics. Such false positive reactions can lead to the inappropriate decline of an acceptable donor organ or unnecessary therapeutic intervention. Here we describe the successful validation of anti-idiotype blocking antibodies in prevention of false positive flow crossmatch results caused by biologic therapy. Blocking antibodies specific for the Fab portion of Rituximab and/or Alemtuzumab were incubated with biologic containing patient serum prior to use in flow cytometric crossmatching. Biologic blocking successfully negated false positive crossmatch results with Rituximab (B cell ave. % change = -97%) or Alemtuzumab (T cell ave. % change = -99%, B cell ave. % change = -95%) infused sera respectively. Simultaneous blocking of these biologics was also successful. A complex case is presented to demonstrate the application of this procedure.
Collapse
Affiliation(s)
- Brian J Franz
- Histocompatibility Laboratory, McLendon Clinical Laboratories, UNC Hospitals, Chapel Hill, NC, USA
| | - Rosanne Petraroia
- Histocompatibility Laboratory, McLendon Clinical Laboratories, UNC Hospitals, Chapel Hill, NC, USA
| | - Cynthia D Faust
- Histocompatibility Laboratory, McLendon Clinical Laboratories, UNC Hospitals, Chapel Hill, NC, USA
| | - Tricia Crawford
- Histocompatibility Laboratory, McLendon Clinical Laboratories, UNC Hospitals, Chapel Hill, NC, USA
| | - Shari Smalls
- Histocompatibility Laboratory, McLendon Clinical Laboratories, UNC Hospitals, Chapel Hill, NC, USA
| | - Candy Vongsavanh
- Histocompatibility Laboratory, McLendon Clinical Laboratories, UNC Hospitals, Chapel Hill, NC, USA
| | - Keisha Gibson
- Division Pediatric Nephrology, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC, USA
| | - John L Schmitz
- Histocompatibility Laboratory, McLendon Clinical Laboratories, UNC Hospitals, Chapel Hill, NC, USA; Department of Pathology & Laboratory Medicine, UNC School of Medicine, Chapel Hill, NC, USA.
| |
Collapse
|
25
|
Raina R, DeCoy M, Chakraborty R, Mahajan S, Moran R, Gibson K, Kumar D, Bergmann C. Renal cystic diseases during the perinatal and neonatal period. J Neonatal Perinatal Med 2021; 14:163-176. [PMID: 32986687 DOI: 10.3233/npm-200520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Renal cystic diseases are a clinically and genetically diverse group of renal diseases that can manifest in utero, infancy, or throughout childhood and adulthood. These diseases may be unilateral or bilateral with a single cyst or multiple cysts, or with increased echogenicity of the renal cortex without macroscopic cysts. Certain cystic renal diseases are life-threatening, with many developing chronic kidney and hepatic disease if not recognized early enough. Therefore, due to the prevalence and life-altering complications of this specific group of diseases in vulnerable populations, it is crucial for clinicians and healthcare providers to have an overall understanding of cystic diseases and how to pre-emptively detect and manage these conditions. In this review, we discuss in detail the epidemiology, genetics and pathophysiology, diagnosis, presentation, and management of numerous genetic and sporadic renal cystic diseases, such as polycystic kidney disease, multicystic dysplastic kidney, and calyceal diverticula, with an emphasis on prenatal care and pregnancy counseling.
Collapse
Affiliation(s)
- R Raina
- Department of Nephrology, Akron Children's Hospital, Akron, OH, USA
- Akron Nephrology Associates/Cleveland Clinic Akron General, Akron, OH, USA
| | - M DeCoy
- Department of Pediatrics, Akron Children's Hospital, Akron, OH, USA
| | - R Chakraborty
- Department of Nephrology, Akron Children's Hospital, Akron, OH, USA
- Akron Nephrology Associates/Cleveland Clinic Akron General, Akron, OH, USA
| | - S Mahajan
- Revere High School, Richfield, OH, USA
| | - R Moran
- Department of Genetics, MetroHealth Medical Center/Case Western Reserve University, Cleveland, OH, USA
| | - K Gibson
- Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, MetroHealth Medical Center/Case Western Reserve University, Cleveland, OH, USA
| | - D Kumar
- Department of Pediatrics, Division of Neonatology, MetroHealth Medical Center/Case Western Reserve University, Cleveland, OH, USA
| | - C Bergmann
- Department of Medicine, Nephrology, University Hospital Freiburg, Freiburg, Germany
| |
Collapse
|
26
|
Glenn DA, Henderson CD, O'Shaughnessy M, Hu Y, Bomback A, Gibson K, Greenbaum LA, Zee J, Mariani L, Falk R, Hogan S, Mottl A. Infection-Related Acute Care Events among Patients with Glomerular Disease. Clin J Am Soc Nephrol 2020; 15:1749-1761. [PMID: 33082200 PMCID: PMC7769021 DOI: 10.2215/cjn.05900420] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2020] [Accepted: 09/17/2020] [Indexed: 11/23/2022]
Abstract
BACKGROUND AND OBJECTIVES Infections contribute to patient morbidity and mortality in glomerular disease. We sought to describe the incidence of, and identify risk factors for, infection-related acute care events among Cure Glomerulonephropathy Network (CureGN) study participants. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS CureGN is a prospective, multicenter, cohort study of children and adults with biopsy sample-proven minimal change disease, FSGS, membranous nephropathy, or IgA nephropathy/vasculitis. Risk factors for time to first infection-related acute care events (hospitalization or emergency department visit) were identified using multivariable Cox proportional hazards regression. RESULTS Of 1741 participants (43% female, 41% <18 years, 68% White), 163 (9%) experienced infection-related acute care events over a median follow-up of 17 months (interquartile range, 9-26 months). Unadjusted incidence rates of infection-related acute care events were 13.2 and 6.2 events per 100 person-years among pediatric and adult participants, respectively. Among participants with versus without corticosteroid exposure at enrollment, unadjusted incidence rates were 50.6 and 28.6 per 100 person-years, respectively, during the first year of follow-up (adjusted hazard ratio for time to first infection, 1.31; 95% CI, 0.89 to 1.93), and 4.1 and 1.1 per 100 person-years, respectively, after 1 year of follow-up (hazard ratio, 2.99; 95% CI, 1.54 to 5.79). Hypoalbuminemia combined with nephrotic-range proteinuria (serum albumin ≤2.5 g/dl and urinary protein-creatinine ratio >3.5 mg/mg), compared with serum albumin >2.5 g/dl and urinary protein-creatinine ratio ≤3.5 mg/mg, was associated with higher risk of time to first infection (adjusted hazard ratio, 2.49; 95% CI, 1.51 to 4.12). CONCLUSIONS Among CureGN participants, infection-related acute care events were common and associated with younger age, corticosteroid exposure, and hypoalbuminemia with proteinuria.
Collapse
Affiliation(s)
- Dorey A Glenn
- Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, North Carolina
| | - Candace D Henderson
- Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, North Carolina
| | | | - Yichun Hu
- Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, North Carolina
| | - Andrew Bomback
- Division of Nephrology, Columbia University, New York, New York
| | - Keisha Gibson
- Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, North Carolina
| | | | - Jarcy Zee
- Arbor Research Collaborative for Health, Ann Arbor, Michigan
| | - Laura Mariani
- Department of Medicine, University of Michigan, Ann Arbor, Michigan
| | - Ronald Falk
- Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, North Carolina
| | - Susan Hogan
- Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, North Carolina
| | - Amy Mottl
- Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, North Carolina
| | | |
Collapse
|
27
|
Bjornstad EC, Muronya W, Kamija M, Smith Z, Munthali CK, Gibson K, Mottl AK, Charles A, Marshall SW, Golightly YM, Gower EW. Validity of Urine NGALds Dipstick for Acute Kidney Injury in a Malawian Trauma Cohort. Kidney Int Rep 2020; 5:1791-1798. [PMID: 33102973 PMCID: PMC7569698 DOI: 10.1016/j.ekir.2020.07.019] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2020] [Revised: 06/24/2020] [Accepted: 07/17/2020] [Indexed: 01/11/2023] Open
Abstract
Introduction Acute kidney injury (AKI) is a major cause of mortality worldwide, particularly in low-resource settings with limited diagnostic testing. Neutrophil gelatinase-associated lipocalin (NGAL) has shown promise in predicting AKI. Nested within a larger, prospective cohort study evaluating AKI incidence in admitted trauma patients, our objective was to evaluate a novel dipstick, NGALds, for the prediction of AKI in Malawi, Africa. Methods Participants were >6 months of age. Spearman rank correlation coefficients (R) assessed NGAL categories (negative [≤50 ng/ml], low risk [51−149 ng/ml], moderate risk [150−299 ng/ml], and high risk [≥300 ng/ml]) for the urine NGALds dipstick and laboratory-based NGAL Test. Results We enrolled 285 participants (one-third children). Thirteen percent developed AKI. The dipstick captured 45 of 52 participants (86.5%) with moderate- or high-risk NGAL values on laboratory-based testing (R = 0.74). The dipstick had sensitivity of 44.4%, specificity of 73.5%, positive predictive value of 19.5%, and negative predictive value of 90.2% for predicting AKI. Acute kidney injury was associated with an increased risk of mortality (relative risk [RR] = 3.9, 95% confidence interval [CI] = 1.9−8.2), but mortality risk greatly increased among children who first had a positive (≥150 ng/ml) NGALds result (RR = 12.0, 95% CI = 1.8−78.4). Conclusions The NGALds dipstick performed similarly to the NGAL Test in this low-resource setting and may be a useful tool to rule out AKI. It may be even more important in predicting high mortality risk among children.
Collapse
Affiliation(s)
- Erica C Bjornstad
- Department of Pediatrics, Division of Nephrology, University of Alabama Birmingham, Alabama, USA.,Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Public Health, Chapel Hill, North Carolina, USA
| | - William Muronya
- Department of Surgery, Kamuzu Central Hospital, Lilongwe, Malawi
| | - Manly Kamija
- Univeristy of North Carolina Project Malawi, Lilongwe, Malawi
| | - Zachary Smith
- Univeristy of North Carolina Project Malawi, Lilongwe, Malawi.,Division of Pediatric Critical Care Medicine, Stanford University School of Medicine, Stanford, California, USA
| | - Charles K Munthali
- Department of Medicine, Renal Unit, Kamuzu Central Hospital, Lilongwe, Malawi
| | - Keisha Gibson
- Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Amy K Mottl
- Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Anthony Charles
- Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.,Malawi Surgical Initiative, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Stephen W Marshall
- Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Public Health, Chapel Hill, North Carolina, USA.,University of North Carolina Injury Prevention Research Center, Chapel Hill, North Carolina, USA
| | - Yvonne M Golightly
- Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Public Health, Chapel Hill, North Carolina, USA.,University of North Carolina Injury Prevention Research Center, Chapel Hill, North Carolina, USA
| | - Emily W Gower
- Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Public Health, Chapel Hill, North Carolina, USA
| |
Collapse
|
28
|
Ng B, Wong P, Hassett G, Gibson K. FRI0354 FACTORS AFFECTING SELF-REPORTED PHYSICAL CTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.6678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Despite the known benefits of exercise1, patients with osteoarthritis (OA) and rheumatoid arthritis (RA) are reported to have low levels of physical activity2. Exercise participation is not well studied in psoriatic arthritis (PsA) cohorts. This study aims to explore which factors predict exercise participation across cohorts and specifically in the PsA cohort.Objectives:The primary aim of this study was to determine which clinical factors were predictive of self- reported physical activity levels in patients with PsA. A secondary aim was to explore differences in self-reported physical activity levels amongst patients with PsA, OA and RA.Methods:Patients with the diagnosis of PsA, RA or OA are recruited prospectively at two tertiary hospital rheumatology clinics over 12 months. Demographic data is captured by the multi-dimensional health assessment questionnaire, the international physical activity questionnaire short form captures self-reported physical activity and self-efficacy for exercise (SEE) is assessed using the SEE scale. Clinical data including joint count, body mass index and co-morbidities including fibromyalgia are collected for all patients, in addition to PsA specific data including skin and enthesitis indices.Results:205 patients (PsA n=62, RA n=83, OA n=60) were recruited across two sites. There was no significant difference in self-reported physical activity between OA, RA and PsA cohorts. Fibromyalgia was present in 30% of each cohort. In patients with PsA, univariate analysis showed that co-existent fibromyalgia, age and self-efficacy for exercise were predictors of physical activity levels. Skin disease and enthesitis were not predictors of physical activity in the PsA cohort.Table 1.Univariate Analyses of effect of Clinical Features on Physical Activity levels in PsANon-exercisers versus ExercisersOR (95% CI)P-valueLEI1.35 (0.92-1.97)0.127PASI0.8 (0.6-1.07)0.133DLQI1.03 (0.92-1.16)0.589BMI0.97 (0.91-1.04)0.415DAS280.79 (0.55-1.14)0.205Concurrent Fibromyalgia4.46 (1.37-14.49)0.012Age1.05 (1.00-1.10)0.013Self-efficacy for exercise0.97 (0.95-0.99)0.019Pain1.17 (0.99-1.37)0.061Function1.3 (1.02-1.65)0.031Patient global1.14 (0.96-1.34)0.128Depression0.97 (0.51-1.84)0.930Table 2.Multivariable Analysis on Physical Activity in PsANon-exercisers vs ExercisersOR (95% CI)P-valueConcurrent fibromyalgia5.1 (1.44-18.08)0.0117Age1.05 (1.00-1.11)0.0342Conclusion:In the PsA cohort, fibromyalgia and age were associated with lower levels of physical activity. DLQI, PASI, LEI did not predict physical activity in PsA. Multivariate analysis showed higher pain levels and lower self-efficacy scores were associated with lower physical activity across arthritis groups.References:[1]Der Ananian C, Wilcox S, Watkins K, Saunders RP, Evans AE. (2008). Factors Associated with Exercise Participation in Adults with Arthritis.Journal of Aging and Physical Activity, 16: 125-143[2]Wilcox S, Der Ananian C, Abbott J, Vrazel J, Ramsey C, Sharpe PA, Brady T. (2006). Perceived Exercise Barriers, Enablers, and Benefits Among Exercising and Nonexercising Adults With Arthritis: Results from a Qualitative Study.Arthritis & Rheumatism, 55(4): 616-627Acknowledgments:Joseph DescallarDana GeorgevskyDr Michael OliffeDr Diana ChessmanDepartment of Rheumatology, Liverpool Hospital NSW AustraliaDepartment of Rheumatology, Westmead Hospital NSW AustraliaDisclosure of Interests:None declared
Collapse
|
29
|
Delbarba E, Marasa M, Canetta PA, Piva SE, Chatterjee D, Kil BH, Mu X, Gibson KL, Hladunewich MA, Hogan JJ, Julian BA, Kidd JM, Laurin LP, Nachman PH, Rheault MN, Rizk DV, Sanghani NS, Trachtman H, Wenderfer SE, Gharavi AG, Bomback AS, Ahn W, Appel GB, Babayev R, Batal I, Bomback AS, Brown E, Campenot ES, Canetta P, Chan B, Chatterjee D, D’Agati VD, Delbarba E, Fernandez H, Foroncewicz B, Gharavi AG, Ghiggeri GM, Hines WH, Jain NG, Kil BH, Kiryluk K, Lau WL, Lin F, Lugani F, Marasa M, Markowitz G, Mohan S, Mu X, Mucha K, Nickolas TL, Piva S, Radhakrishnan J, Rao MK, Sanna-Cherchi S, Santoriello D, Stokes MB, Yu N, Valeri AM, Zviti R, Greenbaum LA, Smoyer WE, Al-Uzri A, Ashoor I, Aviles D, Baracco R, Barcia J, Bartosh S, Belsha C, Bowers C, Braun MC, Chishti A, Claes D, Cramer C, Davis K, Erkan E, Feig D, Freundlich M, Gbadegesin R, Hanna M, Hidalgo G, Hunley TE, Jain A, Kallash M, Khalid M, Klein JB, Lane JC, Mahan J, Mathews N, Nester C, Pan C, Patterson L, Patel H, Revell A, Rheault MN, Silva C, Sreedharan R, Srivastava T, Steinke J, Twombley K, Wenderfer SE, Vasylyeva TL, Weaver DJ, Wong CS, Almaani S, Ayoub I, Budisavljevic M, Derebail V, Fatima H, Falk R, Fogo A, Gehr T, Gibson K, Glenn D, Harris R, Hogan S, Jain K, Jennette JC, Julian B, Kidd J, Laurin LP, Massey HD, Mottl A, Nachman P, Nadasdy T, Novak J, Parikh S, Pichette V, Poulton C, Powell TB, Renfrow M, Rizk D, Rovin B, Royal V, Saha M, Sanghani N, Self S, Adler S, Alpers C, Matar RB, Brown E, Cattran D, Choi M, Dell KM, Dukkipati R, Fervenza FC, Fornoni A, Gadegbeku C, Gipson P, Hasely L, Hingorani S, Hladunewich M, Hogan J, Holzman LB, Jefferson JA, Jhaveri K, Johnstone DB, Kaskel F, Kogan A, Kopp J, Lafayette R, Lemley KV, Malaga-Dieguez L, Meyers K, Neu A, O’Shaughnessy MM, O’Toole JF, Parekh R, Reich H, Reidy K, Rondon H, Sambandam KK, Sedor JR, Selewski DT, Sethna CB, Schelling J, Sperati JC, Swiatecka-Urban A, Trachtman H, Tuttle KR, Weisstuch J, Vento S, Zhdanova O, Gillespie B, Gipson DS, Hill-Callahan P, Helmuth M, Herreshoff E, Kretzler M, Lienczewski C, Mansfield S, Mariani L, Nast CC, Robinson BM, Troost J, Wladkowski M, Zee J, Zinsser D, Guay-Woodford LM. Persistent Disease Activity in Patients With Long-Standing Glomerular Disease. Kidney Int Rep 2020; 5:860-871. [PMID: 32518868 PMCID: PMC7270998 DOI: 10.1016/j.ekir.2020.03.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2019] [Revised: 02/11/2020] [Accepted: 03/09/2020] [Indexed: 11/03/2022] Open
Abstract
Introduction Methods Results Conclusion
Collapse
|
30
|
Devarajan P, Block G, Gibson K, McKay J, Meyer C, Robinson K, Warady B, Chang A. P0066KIDNEYCODE: A GENETIC TESTING PROGRAM FOR PATIENTS WITH CHRONIC KIDNEY DISEASE. Nephrol Dial Transplant 2020. [DOI: 10.1093/ndt/gfaa142.p0066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and Aims
Knowledge about genetic causes of chronic kidney disease (CKD) is one of the key gaps in global kidney research and recent International Society of Nephrology recommendations encourage the adoption of genetic testing to enable a goal of providing precision medicine based on individual risk (1). A recent whole-exome sequencing study showed that genetic inheritance may be responsible for up to 10% of CKD diagnoses, many of which may be previously undiagnosed or mis-diagnosed (2). Continued advances in DNA sequencing technology have made genetic testing, even whole-exome sequencing, applicable to routine clinical diagnoses. In order to test the hypothesis that genetic testing can provide valuable information to increase the accuracy and precision of diagnosis in CKD, we designed a gene panel to prospectively provide genetic testing in a subset of patients with CKD defined by a specific set of inclusion criteria.
Method
Reata Pharmaceuticals is partnering with Invitae on a program called KidneyCode, which provides no-charge genetic testing to enable diagnosis of three specific rare monogenic causes of CKD: Alport syndrome (AS), autosomal dominant polycystic kidney disease (ADPKD) due to PKD2 mutations, and focal segmental glomerulosclerosis (FSGS), as well as detection of variants in one of the autosomal recessive polycystic kidney disease gene, PKHD1. Invitae’s renal disease panel includes 17 genes (ACTN4, ANLN, CD2AP, COL4A3, COL4A4, COL4A5, CRB2, HNF1A, INF2, LMX1B, MYO1E, NPHS1, NPHS2, PAX2, PKD2, PKHD1, and TRPC6), and its assay includes both full-gene sequencing and intragenic deletion/duplication analysis using next-generation sequencing (NGS). The assay targets the coding exons and flanking 10bp of intronic sequences. Invitae’s method of variant classification uses a systematic process for assessing evidence based on guidelines published by the American College of Medical Genetics (3). Patients in the US at risk for hereditary CKD (eGFR ≤ 90 mL/min/1.73m2 plus hematuria or a family history of CKD) or with a known diagnosis of AS or FSGS are eligible. Family members of those with suspected or known AS or FSGS are also eligible. All participants in the KidneyCode program have access to genetic counseling follow-up at no additional charge.
Results
In the first five months of the KidneyCode program, 152 genetic tests have been completed. A genetic variant was reported in 87 patients. Of those 87 patients, 67 patients had 75 variants in COL4A3, 4, or 5 genes (34 Pathogenic/Likely Pathogenic (P/LP), 41 Variants of Uncertain Significance (VUS)), 20 patients had 24 variants in genes associated with FSGS (3 P/LP, 21 VUS), 15 patients had 20 variants in PKHD1 (1 P/LP, 19 VUS), and 2 patients had variants in PKD2 (1 P/LP, 1 VUS).
Of the 34 patients with Pathogenic or Likely Pathogenic COL4A variants, 19 reported a previous diagnosis of Alport syndrome. Other diagnoses in patients with COL4A mutations included FSGS, thin basement membrane disease, and familial hematuria. Extra-renal manifestations such as hearing loss and eye disease were reported in 7 of the 34 patients with COL4A variants.
Conclusion
Initial results with the KidneyCode panel demonstrate the utility of NGS and support the hypothesis that combining genetic testing with clinical presentation and medical history can significantly improve accuracy and precision of diagnosis in patients with hereditary CKD.
Collapse
Affiliation(s)
- Prasad Devarajan
- Cincinnati Children's Hospital Medical Center, Department of Pediatrics, Cincinnati, United States of America
| | - Geoffrey Block
- Reata Pharmaceuticals, Clinical Development, Plano, United States of America
| | - Keisha Gibson
- University of North Carolina at Chapel Hill, Department of Medicine, United States of America
| | - Jim McKay
- Reata Pharmaceuticals, Inc., Medical Affairs, Plano, United States of America
| | - Colin Meyer
- Reata Pharmaceuticals, Product Development, Plano, United States of America
| | | | - Bradley Warady
- Children's Mercy Kansas City, Department of Nephrology, Kansas City, United States of America
| | - Alexander Chang
- Geisinger Medical Center, Department of Nephrology, Danville, United States of America
| |
Collapse
|
31
|
Bjornstad EC, Muronya W, Smith ZH, Gibson K, Mottl AK, Charles A, Marshall SW, Golightly YM, Munthali CK, Gower EW. Incidence and epidemiology of acute kidney injury in a pediatric Malawian trauma cohort: a prospective observational study. BMC Nephrol 2020; 21:98. [PMID: 32169046 PMCID: PMC7071651 DOI: 10.1186/s12882-020-01755-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2020] [Accepted: 03/02/2020] [Indexed: 12/18/2022] Open
Abstract
Background Acute kidney injury (AKI) is highly associated with mortality risk in children worldwide. Trauma can lead to AKI and is a leading cause of pediatric death in Africa. However, there is no information regarding the epidemiology of pediatric, trauma-associated AKI in Africa. Methods Prospective cohort study of pediatric trauma patients admitted to a tertiary referral hospital in Malawi. Participants enrolled at admission were followed prospectively throughout their hospitalization. AKI was defined by creatinine-only Kidney Disease Improving Global Outcomes criteria. We calculated descriptive statistics and univariate relative risks (RR) for hypothesis-generation of potential risk factors associated with AKI. Results We analyzed data from 114 participants. Depending on baseline creatinine definition, AKI incidence ranged from 4 to 10%. The new Schwartz equation estimated baseline creatinine values best and yielded an AKI incidence of 9.7%. Almost one in ten children died during hospitalization, but those with AKI (n = 4) were at significantly higher risk of death compared to those without AKI (40.0% vs 6.2%; RR 6.5, 95% CI 2.2–19.1). Burn injuries were most commonly associated with AKI (63.6%). Other potential AKI risk factors included multiple injuries, trunk or facial injuries, and recent consumption of herbal remedies. Conclusions AKI occurs in up to 10% of admitted pediatric trauma patients in Malawi and increases the risk of death 7-fold compared to those without AKI. This large unrecognized burden in trauma requires further investment by researchers, clinicians and policymakers to develop evidenced-based triage, recognition, and management approaches to prevent the associated sequelae and potential mortality from AKI.
Collapse
Affiliation(s)
- Erica C Bjornstad
- Department of Pediatrics, Division of Nephrology, University of Alabama Birmingham, 1600 7th Avenue South, Lowder 516, Birmingham, AL, 35233, USA. .,Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Public Health, Chapel Hill, NC, USA.
| | - William Muronya
- Department of Surgery, Kamuzu Central Hospital, Lilongwe, Malawi
| | - Zachary H Smith
- Univeristy of North Carolina Project Malawi, Lilongwe, Malawi.,Division of Pediatric Critical Care Medicine, Stanford University School of Medicine, Stanford, CA, USA
| | - Keisha Gibson
- Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, NC, USA
| | - Amy K Mottl
- Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, NC, USA
| | - Anthony Charles
- Department of Surgery, University of North Carolina, Chapel Hill, NC, USA.,Malawi Surgical Initiative, Lilongwe, Malawi
| | - Stephen W Marshall
- Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Public Health, Chapel Hill, NC, USA.,University of North Carolina Injury Prevention Research Center, Carrboro, NC, USA
| | - Yvonne M Golightly
- Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Public Health, Chapel Hill, NC, USA.,University of North Carolina Injury Prevention Research Center, Carrboro, NC, USA
| | - Charles K Munthali
- Department of Medicine, Renal Unit, Kamuzu Central Hospital, Lilongwe, Malawi
| | - Emily W Gower
- Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Public Health, Chapel Hill, NC, USA
| |
Collapse
|
32
|
Jane B, Gibson K. Corporate sponsorship of physical activity promotion programmes: part of the solution or part of the problem? J Public Health (Oxf) 2019; 40:279-288. [PMID: 28591792 DOI: 10.1093/pubmed/fdx065] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2017] [Accepted: 05/18/2017] [Indexed: 11/12/2022] Open
Abstract
Background Parklives is a programme intended to raise levels of physical activity across the UK, funded by Coca-Cola GB and delivered in association with Local Authorities and other organizations. Such public-private partnerships have been advocated by many however critics suggest that the conflict between stakeholder motives is too great. Methods This study conducted a content analysis of twitter content related to the ParkLives physical activity programme. Images and text were analysed from two separate weeks, one from the school vacation period and one during school term time. Results Three hundred and eighteen tweets were analysed. Content analysis revealed 79% of images contained children and 45% of these images contained prominent Coca-Cola branding, a level of exposure that suggests ParkLives simultaneously provides opportunities for children's physical activity and for targeted marketing. Content analysis also demonstrated that the programme allowed increased access to policy-makers. Conclusions The sponsorship of a physical activity promotion campaign can allow a corporation to target its marketing at children and gain access to health-related policy development networks. This study reinforces the need for independent evaluation of all potential impacts of such a partnership and calls on those responsible for community health to fully consider the ethical implications of such relationships.
Collapse
Affiliation(s)
- B Jane
- Faculty of Sport and Health, The University of St Mark & St John, Derriford Rd, Derriford, Plymouth, UK
| | - K Gibson
- Faculty of Sport and Health, The University of St Mark & St John, Derriford Rd, Derriford, Plymouth, UK
| |
Collapse
|
33
|
Lee QWS, Gibson K, Chan SL, Rathnaweera HP, Chong TT, Tang TY. A comparison between Caucasian and Asian superficial venous anatomy and reflux patterns – Implications for potential precision endovenous ablation therapy. Phlebology 2019; 35:39-45. [DOI: 10.1177/0268355519845984] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Objectives The aim of this study is to investigate whether there are differences between predominantly Caucasians and Asians from two disparate cohorts around the globe, with regard to their pre-operative venous reflux patterns and truncal vein characteristics, which could potentially help clinicians tailor venous treatment for chronic venous insufficiency on a more individualised basis in different parts of the world. Methods A total of 200 lower limb chronic venous insufficiency duplex studies (127 Singaporean (predominantly Asian) patients) and 200 lower limb chronic venous insufficiency duplex scans (137 Americans predominantly Caucasians) were analysed and compared for differences in venous anatomy and reflux characteristics. Results Asian patients from Singapore presented with higher CEAP scores compared to the predominantly Caucasian cohort from the US (30% CEAP 4a or greater vs. 17.5%; p < 0.01). Singaporeans had more great saphenous vein reflux starting at the sapheno-femoral junction (86% vs. 73%; p < 0.01) and ending at the ankle (93% vs. 46%; p < 0.01). Vein diameters were generally larger in the US cohort of patients (median 5.7 mm vs. 2.9 mm; p < 0.01). Conclusions The predominantly Asian cohort from Singapore had smaller diameter truncal veins, longer segments of truncal vein reflux and present later with more advanced chronic venous insufficiency compared to their American counterparts. This information could help tailor endovenous ablation on a more individualised basis in the future.
Collapse
Affiliation(s)
- QWS Lee
- Department of Vascular Surgery, Singapore General Hospital, Singapore, Singapore
| | - K Gibson
- Lake Washington Vascular Surgeons, Bellevue, WA, USA
| | - SL Chan
- Health Services Research Center, SingHealth, Singapore, Singapore
| | - HP Rathnaweera
- Department of General Surgery, Changi General Hospital, Singapore, Singapore
| | - TT Chong
- Department of Vascular Surgery, Singapore General Hospital, Singapore, Singapore
| | - TY Tang
- Department of Vascular Surgery, Singapore General Hospital, Singapore, Singapore
| |
Collapse
|
34
|
Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA. Correction to: Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings : A Midwest Pediatric Nephrology Consortium (MWPNC) study. Pediatr Nephrol 2019; 34:539. [PMID: 30443740 DOI: 10.1007/s00467-018-4103-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
The original version of this article unfortunately contained a mistake. The subtitle "A Midwest Pediatric Nephrology Consortium (MWPNC) study" was missing. The correct title including subtitle is given above.
Collapse
Affiliation(s)
- Jonathan H Pelletier
- Department of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA
| | - Karan R Kumar
- Department of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA
| | - Rachel Engen
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois and Children's Hospital, Seattle, Washington, USA
| | - Adam Bensimhon
- Department of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA
| | - Jennifer D Varner
- Department of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA
| | - Michelle N Rheault
- University of Minnesota Masonic Children's Hospitals, Minneapolis, MN, USA
| | | | | | - Cynthia Silva
- Connecticut Children's Medical Center, Hartford, CT, USA
| | | | - Scott E Wenderfer
- Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA
| | - Keisha Gibson
- North Carolina Children's Hospital, Chapel Hill, NC, USA
| | | | - John Barcia
- University of Virginia Children's Hospital, Charlottesville, VA, USA
| | - Patricia Weng
- Mattel Children's Hospital University of California, Los Angeles, CA, USA
| | | | - Natasha Jawa
- The Hospital for Sick Children, Toronto, ON, Canada
| | | | - John W Foreman
- Department of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA
| | - Delbert R Wigfall
- Department of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA
| | - Annabelle N Chua
- Department of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA
| | - Eileen Chambers
- Department of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA
| | - Christoph P Hornik
- Department of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA
| | - Eileen D Brewer
- Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA
| | - Shashi K Nagaraj
- Department of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA
| | - Larry A Greenbaum
- Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA
| | - Rasheed A Gbadegesin
- Department of Pediatrics, Divisions of Nephrology and Critical Care, Duke University Medical Center, Durham, NC, 27710, USA.
| |
Collapse
|
35
|
Taylor-Stokes G, Mitra D, Waller J, Gibson K, Milligan G, Zhan L, Iyer S. Abstract P6-18-36: Real world treatment patterns and outcomes of patients receiving palbociclib plus aromatase inhibitor in the United States: Sub-groups analysis based on age, performance status and sites of metastases from the IRIS study. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p6-18-36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Ibrance Real World Insights (IRIS) is a multi-country study aimed to describe clinical characteristics, treatment patterns and clinical outcomes of patients receiving palbociclib plus aromatase inhibitor. Previously the results on the overall population within the US have been communicated. The current analysis focuses on subgroups stratified by age, performance status and visceral status.
Materials and methods: A retrospective chart review of HR+/HER2- ABC/MBC patients who received palbociclib plus aromatase inhibitor as initial endocrine based therapy for their advanced disease was conducted between June and October 2017. Physicians completed electronic case report forms, extracting data on patient demographics, clinical characteristics, treatment history/patterns and clinical outcomes.Progression free and survival rates at 12 and 24 months were estimated via Kaplan-Meier analysis.
Results: Data for the US are reported here. In total 63 physicians completed 360 eCRFs with a mean follow up time since palbociclib initiation of 12 months. Majority of the patients were >65 years (53%), and had ECOG status of 0 (30%) or 1 (56%). Overall 293 (81%) patients had metastatic disease, of which 50% had visceral metastases. Across all sub-groups, majority of patients prescribed an initial palbociclib dose of 125mg did not require a change of dose while on treatment. The 12-month and 24-month progression free and overall survival rates across subgroups are presented in Table 1. Patients with a performance status of ECOG=1 had a slightly lower progression and survival rates at 12 and 24 months compared to those with a score =0. Likewise, patients with visceral disease were observed to have slightly lower progression free and survival rates than others.
Table 1:Clinical Outcomes for the different sub-groups.Patient Sub-groups AgeECOG statusVisceral Status Up to 65 n=169Over 65 n=1910 n=1071 n=200Visceral metastases n=147Non-visceral metastases n=146Progression free survival rate at 12 months, %86.382.194.386.580.285.8Progression free survival rate at 24 months, %59.769.071.267.450.780.6Overall survival rate At 12 months, %97.992.8100.099.590.599.3Overall survival rate at 24 months, %95.185.695.796.487.290.7
Conclusions: The analysis indicates consistent trends in different clinical outcomes were observed with palbociclib plus aromatase inhibitor across patients sub-groups based on age, performance status and visceral metastases.
Citation Format: Taylor-Stokes G, Mitra D, Waller J, Gibson K, Milligan G, Zhan L, Iyer S. Real world treatment patterns and outcomes of patients receiving palbociclib plus aromatase inhibitor in the United States: Sub-groups analysis based on age, performance status and sites of metastases from the IRIS study [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P6-18-36.
Collapse
Affiliation(s)
- G Taylor-Stokes
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| | - D Mitra
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| | - J Waller
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| | - K Gibson
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| | - G Milligan
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| | - L Zhan
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| | - S Iyer
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| |
Collapse
|
36
|
Waller J, Mitra D, Taylor-Stokes G, Gibson K, Milligan G, Zhan L, Iyer S. Abstract P6-18-21: Real world treatment patterns and outcomes of patients receiving palbociclib plus fulvestrant in the United States: Sub-groups analysis based on age, performance status and sites of metastases. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p6-18-21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Ibrance Real World Insights (IRIS) is a multi-country study aimed to describe the clinical characteristics and understand treatment patterns and clinical outcomes of patients receiving palbociclib plus fulvestrant in real world clinical practice. Previously the results on the overall population within the US have been communicated. The current analyses focus on subgroups stratified by age, performance status and visceral status.
Materials and methods: A retrospective chart review of HR+/HER2- ABC/MBC patients was conducted between June and October 2017. Physicians extracted data from patient medical records for HR+/HER2- ABC patients who received palbociclib plus fulvestrant following disease progression with endocrine based therapy for their advanced disease. Electronic case report forms collected data covering patient demographics, clinical characteristics, treatment history/patterns and clinical outcomes.Progression free rates and survival rates at 6 and 12 months were estimated via Kaplan-Meier analysis.
Results: Data for the US are reported here. In total, 65 physicians extracted data for 292 patients who had a mean follow up time of 7.4 months. Majority of the patients were >65 years (54%), and had ECOG status of 0 (32%) or 1 (48%). Overall 224 (77%) patients had metastatic disease, of which 93 (42%) had visceral metastases. Across all sub-groups, majority of patients prescribed an initial palbociclib dose of 125mg did not require a change of dose while on treatment. The 6-month and 12-month progression free and survival rates across subgroups are presented in Table 1. Patients with a performance status of ECOG ≥ 2 had a slightly lower progression and survival rates at 6 and 12 months compared to those with a score <1. Likewise, patients with visceral disease were observed to have slightly lower progression free and survival rates than others.
Table 1:Clinical Outcomes by Patient Sub-groups.Patient Sub-groups AgeECOGstatusVisceral Status Up to 65 n=158Over 65 n=1340 n=931 n=1392+ n=60Visceral Metastases n=93Non-visceral Metastases n=131Progression free survival rate at 6 months, %95.293.297.893.490.689.694.8Progression free survival rate at 12 months, %81.277.884.683.0-73.276.5Survival rate at 6 months, %98.096.3100.098.290.692.298.9Survival rate at 12 months, %90.085.197.695.1-80.892.7
Conclusions: The analysis indicates consistent trends in different clinical outcomes were observed with palbociclib plus fulvestrant across patients sub-groups based on age, performance status and visceral metastases.
Citation Format: Waller J, Mitra D, Taylor-Stokes G, Gibson K, Milligan G, Zhan L, Iyer S. Real world treatment patterns and outcomes of patients receiving palbociclib plus fulvestrant in the United States: Sub-groups analysis based on age, performance status and sites of metastases [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P6-18-21.
Collapse
Affiliation(s)
- J Waller
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| | - D Mitra
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| | - G Taylor-Stokes
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| | - K Gibson
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| | - G Milligan
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| | - L Zhan
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| | - S Iyer
- Adelphi Real World, Bollington, United Kingdom; Pfizer, New York, NY
| |
Collapse
|
37
|
Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheaul MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings. Pediatr Nephrol 2018; 33:1773-1780. [PMID: 29982878 PMCID: PMC6129203 DOI: 10.1007/s00467-018-3994-3] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/13/2018] [Revised: 05/25/2018] [Accepted: 06/05/2018] [Indexed: 01/07/2023]
Abstract
BACKGROUND AND OBJECTIVES Steroid-resistant nephrotic syndrome (SRNS) due to focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) is a leading cause of end-stage kidney disease in children. Recurrence of primary disease following transplantation is a major cause of allograft loss. The clinical determinants of disease recurrence are not completely known. Our objectives were to determine risk factors for recurrence of FSGS/MCD following kidney transplantation and factors that predict response to immunosuppression following recurrence. METHODS Multicenter study of pediatric patients with kidney transplants performed for ESKD due to SRNS between 1/2006 and 12/2015. Demographics, clinical course, and biopsy data were collected. Patients with primary-SRNS (PSRNS) were defined as those initially resistant to corticosteroid therapy at diagnosis, and patients with late-SRNS (LSRNS) as those initially responsive to steroids who subsequently developed steroid resistance. We performed logistic regression to determine risk factors associated with nephrotic syndrome (NS) recurrence. RESULTS We analyzed 158 patients; 64 (41%) had recurrence of NS in their renal allograft. Disease recurrence occurred in 78% of patients with LSRNS compared to 39% of those with PSRNS. Patients with MCD on initial native kidney biopsy had a 76% recurrence rate compared with a 40% recurrence rate in those with FSGS. Multivariable analysis showed that MCD histology (OR; 95% CI 5.6; 1.3-23.7) compared to FSGS predicted disease recurrence. CONCLUSIONS Pediatric patients with MCD and LSRNS are at higher risk of disease recurrence following kidney transplantation. These findings may be useful for designing studies to test strategies for preventing recurrence.
Collapse
Affiliation(s)
- Jonathan H. Pelletier
- Department of Pediatrics, Divisions of Nephrology and Critical Care Duke University Medical Center, Durham, NC
| | - Karan R. Kumar
- Department of Pediatrics, Divisions of Nephrology and Critical Care Duke University Medical Center, Durham, NC
| | - Rachel Engen
- Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois and Children’s Hospital Seattle, Washington
| | - Adam Bensimhon
- Department of Pediatrics, Divisions of Nephrology and Critical Care Duke University Medical Center, Durham, NC
| | - Jennifer D. Varner
- Department of Pediatrics, Divisions of Nephrology and Critical Care Duke University Medical Center, Durham, NC
| | | | | | | | - Cynthia Silva
- Connecticut Children’s Medical Center, Hartford, Connecticut
| | | | - Scott E. Wenderfer
- Baylor College of Medicine, and Texas Children’s Hospital, Houston, Texas
| | | | | | - John Barcia
- University of Virginia Children’s Hospital, Charlottesville, Virginia
| | - Patricia Weng
- Mattel Children’s Hospital University of California, Los Angeles, California
| | | | - Natasha Jawa
- The Hospital for Sick Children, Toronto, Ontario, Canada
| | | | - John W. Foreman
- Department of Pediatrics, Divisions of Nephrology and Critical Care Duke University Medical Center, Durham, NC
| | - Delbert R. Wigfall
- Department of Pediatrics, Divisions of Nephrology and Critical Care Duke University Medical Center, Durham, NC
| | - Annabelle N. Chua
- Department of Pediatrics, Divisions of Nephrology and Critical Care Duke University Medical Center, Durham, NC
| | - Eileen Chambers
- Department of Pediatrics, Divisions of Nephrology and Critical Care Duke University Medical Center, Durham, NC
| | - Christoph P. Hornik
- Department of Pediatrics, Divisions of Nephrology and Critical Care Duke University Medical Center, Durham, NC
| | - Eileen D. Brewer
- Baylor College of Medicine, and Texas Children’s Hospital, Houston, Texas
| | - Shashi K. Nagaraj
- Department of Pediatrics, Divisions of Nephrology and Critical Care Duke University Medical Center, Durham, NC
| | | | - Rasheed A. Gbadegesin
- Department of Pediatrics, Divisions of Nephrology and Critical Care Duke University Medical Center, Durham, NC,To whom correspondence should be addressed: Rasheed Gbadegesin, Department of Pediatrics, Divisions of Nephrology, Duke University Medical Center, Durham, NC 27710, Phone: +19196815543,
| |
Collapse
|
38
|
Mitra D, Taylor-Stokes G, Waller J, Gibson K, Milligan G, Iyer S. Real world treatment patterns associated with palbociclib combination therapy in Germany: Results from the IRIS study. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy272.328] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
39
|
Paterson A, Wilson SJ, Hill M, Gibson K, Cruden NLM, Uren NG. P802Same day discharge is safe in selected patients undergoing NSTE-ACS. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.p802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- A Paterson
- University of Edinburgh, College of Medicine, Edinburgh, United Kingdom
| | - S J Wilson
- Royal Infirmary of Edinburgh, Cardiology, Edinburgh, United Kingdom
| | - M Hill
- Royal Infirmary of Edinburgh, Cardiology, Edinburgh, United Kingdom
| | - K Gibson
- Royal Infirmary of Edinburgh, Cardiology, Edinburgh, United Kingdom
| | - N L M Cruden
- Royal Infirmary of Edinburgh, Cardiology, Edinburgh, United Kingdom
| | - N G Uren
- Royal Infirmary of Edinburgh, Cardiology, Edinburgh, United Kingdom
| |
Collapse
|
40
|
Aaltonen T, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Appel JA, Arisawa T, Artikov A, Asaadi J, Ashmanskas W, Auerbach B, Aurisano A, Azfar F, Badgett W, Bae T, Barbaro-Galtieri A, Barnes VE, Barnett BA, Barria P, Bartos P, Bauce M, Bedeschi F, Behari S, Bellettini G, Bellinger J, Benjamin D, Beretvas A, Bhatti A, Bland KR, Blumenfeld B, Bocci A, Bodek A, Bortoletto D, Boudreau J, Boveia A, Brigliadori L, Bromberg C, Brucken E, Budagov J, Budd HS, Burkett K, Busetto G, Bussey P, Butti P, Buzatu A, Calamba A, Camarda S, Campanelli M, Canelli F, Carls B, Carlsmith D, Carosi R, Carrillo S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavaliere V, Cerri A, Cerrito L, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Cho K, Chokheli D, Clark A, Clarke C, Convery ME, Conway J, Corbo M, Cordelli M, Cox CA, Cox DJ, Cremonesi M, Cruz D, Cuevas J, Culbertson R, d'Ascenzo N, Datta M, de Barbaro P, Demortier L, Deninno M, D'Errico M, Devoto F, Di Canto A, Di Ruzza B, Dittmann JR, Donati S, D'Onofrio M, Dorigo M, Driutti A, Ebina K, Edgar R, Elagin A, Erbacher R, Errede S, Esham B, Farrington S, Fernández Ramos JP, Field R, Flanagan G, Forrest R, Franklin M, Freeman JC, Frisch H, Funakoshi Y, Galloni C, Garfinkel AF, Garosi P, Gerberich H, Gerchtein E, Giagu S, Giakoumopoulou V, Gibson K, Ginsburg CM, Giokaris N, Giromini P, Glagolev V, Glenzinski D, Gold M, Goldin D, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González López O, Gorelov I, Goshaw AT, Goulianos K, Gramellini E, Grosso-Pilcher C, Guimaraes da Costa J, Hahn SR, Han JY, Happacher F, Hara K, Hare M, Harr RF, Harrington-Taber T, Hatakeyama K, Hays C, Heinrich J, Herndon M, Hocker A, Hong Z, Hopkins W, Hou S, Hughes RE, Husemann U, Hussein M, Huston J, Introzzi G, Iori M, Ivanov A, James E, Jang D, Jayatilaka B, Jeon EJ, Jindariani S, Jones M, Joo KK, Jun SY, Junk TR, Kambeitz M, Kamon T, Karchin PE, Kasmi A, Kato Y, Ketchum W, Keung J, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SH, Kim SB, Kim YJ, Kim YK, Kimura N, Kirby M, Kondo K, Kong DJ, Konigsberg J, Kotwal AV, Kreps M, Kroll J, Kruse M, Kuhr T, Kurata M, Laasanen AT, Lammel S, Lancaster M, Lannon K, Latino G, Lee HS, Lee JS, Leo S, Leone S, Lewis JD, Limosani A, Lipeles E, Lister A, Liu Q, Liu T, Lockwitz S, Loginov A, Lucchesi D, Lucà A, Lueck J, Lujan P, Lukens P, Lungu G, Lys J, Lysak R, Madrak R, Maestro P, Malik S, Manca G, Manousakis-Katsikakis A, Marchese L, Margaroli F, Marino P, Matera K, Mattson ME, Mazzacane A, Mazzanti P, McNulty R, Mehta A, Mehtala P, Mesropian C, Miao T, Mietlicki D, Mitra A, Miyake H, Moed S, Moggi N, Moon CS, Moore R, Morello MJ, Mukherjee A, Muller T, Murat P, Mussini M, Nachtman J, Nagai Y, Naganoma J, Nakano I, Napier A, Nett J, Nigmanov T, Nodulman L, Noh SY, Norniella O, Oakes L, Oh SH, Oh YD, Okusawa T, Orava R, Ortolan L, Pagliarone C, Palencia E, Palni P, Papadimitriou V, Parker W, Pauletta G, Paulini M, Paus C, Phillips TJ, Piacentino G, Pianori E, Pilot J, Pitts K, Plager C, Pondrom L, Poprocki S, Potamianos K, Pranko A, Prokoshin F, Ptohos F, Punzi G, Redondo Fernández I, Renton P, Rescigno M, Rimondi F, Ristori L, Robson A, Rodriguez T, Rolli S, Ronzani M, Roser R, Rosner JL, Ruffini F, Ruiz A, Russ J, Rusu V, Sakumoto WK, Sakurai Y, Santi L, Sato K, Saveliev V, Savoy-Navarro A, Schlabach P, Schmidt EE, Schwarz T, Scodellaro L, Scuri F, Seidel S, Seiya Y, Semenov A, Sforza F, Shalhout SZ, Shears T, Shepard PF, Shimojima M, Shochet M, Shreyber-Tecker I, Simonenko A, Sliwa K, Smith JR, Snider FD, Song H, Sorin V, St Denis R, Stancari M, Stentz D, Strologas J, Sudo Y, Sukhanov A, Suslov I, Takemasa K, Takeuchi Y, Tang J, Tecchio M, Teng PK, Thom J, Thomson E, Thukral V, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Totaro P, Trovato M, Ukegawa F, Uozumi S, Vázquez F, Velev G, Vellidis C, Vernieri C, Vidal M, Vilar R, Vizán J, Vogel M, Volpi G, Wagner P, Wallny R, Wang SM, Waters D, Wester WC, Whiteson D, Wicklund AB, Wilbur S, Williams HH, Wilson JS, Wilson P, Winer BL, Wittich P, Wolbers S, Wolfmeister H, Wright T, Wu X, Wu Z, Yamamoto K, Yamato D, Yang T, Yang UK, Yang YC, Yao WM, Yeh GP, Yi K, Yoh J, Yorita K, Yoshida T, Yu GB, Yu I, Zanetti AM, Zeng Y, Zhou C, Zucchelli S. Search for the Exotic Meson X(5568) with the Collider Detector at Fermilab. Phys Rev Lett 2018; 120:202006. [PMID: 29864341 DOI: 10.1103/physrevlett.120.202006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/29/2017] [Revised: 03/05/2018] [Indexed: 06/08/2023]
Abstract
A search for the exotic meson X(5568) decaying into the B_{s}^{0}π^{±} final state is performed using data corresponding to 9.6 fb^{-1} from pp[over ¯] collisions at sqrt[s]=1960 GeV recorded by the Collider Detector at Fermilab. No evidence for this state is found and an upper limit of 6.7% at the 95% confidence level is set on the fraction of B_{s}^{0} produced through the X(5568)→B_{s}^{0}π^{±} process.
Collapse
Affiliation(s)
- T Aaltonen
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - S Amerio
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - D Amidei
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Anastassov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Annovi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Antos
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - G Apollinari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J A Appel
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - A Artikov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - J Asaadi
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - W Ashmanskas
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B Auerbach
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - A Aurisano
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - F Azfar
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - W Badgett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - T Bae
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - A Barbaro-Galtieri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - V E Barnes
- Purdue University, West Lafayette, Indiana 47907, USA
| | - B A Barnett
- The Johns Hopkins University, Baltimore, Maryland 21218, USA
| | - P Barria
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - P Bartos
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - M Bauce
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - F Bedeschi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Behari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Bellettini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - J Bellinger
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - D Benjamin
- Duke University, Durham, North Carolina 27708, USA
| | - A Beretvas
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Bhatti
- The Rockefeller University, New York, New York 10065, USA
| | - K R Bland
- Baylor University, Waco, Texas 76798, USA
| | - B Blumenfeld
- The Johns Hopkins University, Baltimore, Maryland 21218, USA
| | - A Bocci
- Duke University, Durham, North Carolina 27708, USA
| | - A Bodek
- University of Rochester, Rochester, New York 14627, USA
| | - D Bortoletto
- Purdue University, West Lafayette, Indiana 47907, USA
| | - J Boudreau
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - A Boveia
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - L Brigliadori
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - C Bromberg
- Michigan State University, East Lansing, Michigan 48824, USA
| | - E Brucken
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - J Budagov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - H S Budd
- University of Rochester, Rochester, New York 14627, USA
| | - K Burkett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Busetto
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - P Bussey
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - P Butti
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - A Buzatu
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - A Calamba
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - S Camarda
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193, Bellaterra (Barcelona), Spain
| | - M Campanelli
- University College London, London WC1E 6BT, United Kingdom
| | - F Canelli
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - B Carls
- University of Illinois, Urbana, Illinois 61801, USA
| | - D Carlsmith
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - R Carosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Carrillo
- University of Florida, Gainesville, Florida 32611, USA
| | - B Casal
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Casarsa
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - A Castro
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - P Catastini
- Harvard University, Cambridge, Massachusetts 02138, USA
| | - D Cauz
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - V Cavaliere
- University of Illinois, Urbana, Illinois 61801, USA
| | - A Cerri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - L Cerrito
- University College London, London WC1E 6BT, United Kingdom
| | - Y C Chen
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - M Chertok
- University of California, Davis, Davis, California 95616, USA
| | - G Chiarelli
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - G Chlachidze
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Cho
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - D Chokheli
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - A Clark
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - C Clarke
- Wayne State University, Detroit, Michigan 48201, USA
| | - M E Convery
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Conway
- University of California, Davis, Davis, California 95616, USA
| | - M Corbo
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Cordelli
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - C A Cox
- University of California, Davis, Davis, California 95616, USA
| | - D J Cox
- University of California, Davis, Davis, California 95616, USA
| | - M Cremonesi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - D Cruz
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - J Cuevas
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - R Culbertson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N d'Ascenzo
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Datta
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P de Barbaro
- University of Rochester, Rochester, New York 14627, USA
| | - L Demortier
- The Rockefeller University, New York, New York 10065, USA
| | - M Deninno
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - M D'Errico
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - F Devoto
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - A Di Canto
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - B Di Ruzza
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - S Donati
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - M D'Onofrio
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - M Dorigo
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- University of Trieste, I-34127 Trieste, Italy
| | - A Driutti
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - K Ebina
- Waseda University, Tokyo 169, Japan
| | - R Edgar
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Elagin
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - R Erbacher
- University of California, Davis, Davis, California 95616, USA
| | - S Errede
- University of Illinois, Urbana, Illinois 61801, USA
| | - B Esham
- University of Illinois, Urbana, Illinois 61801, USA
| | - S Farrington
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - J P Fernández Ramos
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - R Field
- University of Florida, Gainesville, Florida 32611, USA
| | - G Flanagan
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Forrest
- University of California, Davis, Davis, California 95616, USA
| | - M Franklin
- Harvard University, Cambridge, Massachusetts 02138, USA
| | - J C Freeman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Frisch
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | | | - C Galloni
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - A F Garfinkel
- Purdue University, West Lafayette, Indiana 47907, USA
| | - P Garosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - H Gerberich
- University of Illinois, Urbana, Illinois 61801, USA
| | - E Gerchtein
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Giagu
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | | | - K Gibson
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - C M Ginsburg
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Giokaris
- University of Athens, 157 71 Athens, Greece
| | - P Giromini
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - V Glagolev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - D Glenzinski
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Gold
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - D Goldin
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - A Golossanov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Gomez
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - G Gomez-Ceballos
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - M Goncharov
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - O González López
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - I Gorelov
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - A T Goshaw
- Duke University, Durham, North Carolina 27708, USA
| | - K Goulianos
- The Rockefeller University, New York, New York 10065, USA
| | - E Gramellini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - C Grosso-Pilcher
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | | | - S R Hahn
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Y Han
- University of Rochester, Rochester, New York 14627, USA
| | - F Happacher
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - K Hara
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - M Hare
- Tufts University, Medford, Massachusetts 02155, USA
| | - R F Harr
- Wayne State University, Detroit, Michigan 48201, USA
| | | | | | - C Hays
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - J Heinrich
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - M Herndon
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - A Hocker
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Z Hong
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - W Hopkins
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Hou
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - R E Hughes
- The Ohio State University, Columbus, Ohio 43210, USA
| | - U Husemann
- Yale University, New Haven, Connecticut 06520, USA
| | - M Hussein
- Michigan State University, East Lansing, Michigan 48824, USA
| | - J Huston
- Michigan State University, East Lansing, Michigan 48824, USA
| | - G Introzzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- INFN Pavia, I-27100 Pavia, Italy
| | - M Iori
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
- Sapienza Università di Roma, I-00185 Roma, Italy
| | - A Ivanov
- University of California, Davis, Davis, California 95616, USA
| | - E James
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Jang
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - B Jayatilaka
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E J Jeon
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - S Jindariani
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Jones
- Purdue University, West Lafayette, Indiana 47907, USA
| | - K K Joo
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - S Y Jun
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - T R Junk
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Kambeitz
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - T Kamon
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - P E Karchin
- Wayne State University, Detroit, Michigan 48201, USA
| | - A Kasmi
- Baylor University, Waco, Texas 76798, USA
| | - Y Kato
- Osaka City University, Osaka 558-8585, Japan
| | - W Ketchum
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - J Keung
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - B Kilminster
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D H Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - H S Kim
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J E Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - M J Kim
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - S H Kim
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S B Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - Y J Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - Y K Kim
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - N Kimura
- Waseda University, Tokyo 169, Japan
| | - M Kirby
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Kondo
- Waseda University, Tokyo 169, Japan
| | - D J Kong
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - J Konigsberg
- University of Florida, Gainesville, Florida 32611, USA
| | - A V Kotwal
- Duke University, Durham, North Carolina 27708, USA
| | - M Kreps
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - J Kroll
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - M Kruse
- Duke University, Durham, North Carolina 27708, USA
| | - T Kuhr
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - M Kurata
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A T Laasanen
- Purdue University, West Lafayette, Indiana 47907, USA
| | - S Lammel
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Lancaster
- University College London, London WC1E 6BT, United Kingdom
| | - K Lannon
- The Ohio State University, Columbus, Ohio 43210, USA
| | - G Latino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - H S Lee
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - J S Lee
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - S Leo
- University of Illinois, Urbana, Illinois 61801, USA
| | - S Leone
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - J D Lewis
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Limosani
- Duke University, Durham, North Carolina 27708, USA
| | - E Lipeles
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - A Lister
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - Q Liu
- Purdue University, West Lafayette, Indiana 47907, USA
| | - T Liu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Lockwitz
- Yale University, New Haven, Connecticut 06520, USA
| | - A Loginov
- Yale University, New Haven, Connecticut 06520, USA
| | - D Lucchesi
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - A Lucà
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Lueck
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Lujan
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - P Lukens
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Lungu
- The Rockefeller University, New York, New York 10065, USA
| | - J Lys
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R Lysak
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - R Madrak
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Maestro
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - S Malik
- The Rockefeller University, New York, New York 10065, USA
| | - G Manca
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | | | - L Marchese
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - F Margaroli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - P Marino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - K Matera
- University of Illinois, Urbana, Illinois 61801, USA
| | - M E Mattson
- Wayne State University, Detroit, Michigan 48201, USA
| | - A Mazzacane
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Mazzanti
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - R McNulty
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - A Mehta
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - P Mehtala
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - C Mesropian
- The Rockefeller University, New York, New York 10065, USA
| | - T Miao
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Mietlicki
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Mitra
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - H Miyake
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Moed
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Moggi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - C S Moon
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Moore
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M J Morello
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - A Mukherjee
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Th Muller
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Murat
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Mussini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - J Nachtman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Nagai
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | | | - I Nakano
- Okayama University, Okayama 700-8530, Japan
| | - A Napier
- Tufts University, Medford, Massachusetts 02155, USA
| | - J Nett
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - T Nigmanov
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - L Nodulman
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Y Noh
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - O Norniella
- University of Illinois, Urbana, Illinois 61801, USA
| | - L Oakes
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - S H Oh
- Duke University, Durham, North Carolina 27708, USA
| | - Y D Oh
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - T Okusawa
- Osaka City University, Osaka 558-8585, Japan
| | - R Orava
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - L Ortolan
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193, Bellaterra (Barcelona), Spain
| | - C Pagliarone
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - E Palencia
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - P Palni
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - V Papadimitriou
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - W Parker
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - G Pauletta
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - M Paulini
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - C Paus
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - T J Phillips
- Duke University, Durham, North Carolina 27708, USA
| | - G Piacentino
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E Pianori
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - J Pilot
- University of California, Davis, Davis, California 95616, USA
| | - K Pitts
- University of Illinois, Urbana, Illinois 61801, USA
| | - C Plager
- University of California, Los Angeles, Los Angeles, California 90024, USA
| | - L Pondrom
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - S Poprocki
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Potamianos
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Pranko
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - F Prokoshin
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - F Ptohos
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - G Punzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - I Redondo Fernández
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - P Renton
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - M Rescigno
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - F Rimondi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - L Ristori
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - A Robson
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - T Rodriguez
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - S Rolli
- Tufts University, Medford, Massachusetts 02155, USA
| | - M Ronzani
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - R Roser
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J L Rosner
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - F Ruffini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - A Ruiz
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Russ
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - V Rusu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - W K Sakumoto
- University of Rochester, Rochester, New York 14627, USA
| | | | - L Santi
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - K Sato
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - V Saveliev
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Savoy-Navarro
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Schlabach
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E E Schmidt
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - T Schwarz
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - L Scodellaro
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - F Scuri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Seidel
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Y Seiya
- Osaka City University, Osaka 558-8585, Japan
| | - A Semenov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - F Sforza
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - S Z Shalhout
- University of California, Davis, Davis, California 95616, USA
| | - T Shears
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - P F Shepard
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - M Shimojima
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - M Shochet
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - I Shreyber-Tecker
- Institution for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - A Simonenko
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - K Sliwa
- Tufts University, Medford, Massachusetts 02155, USA
| | - J R Smith
- University of California, Davis, Davis, California 95616, USA
| | - F D Snider
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Song
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - V Sorin
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193, Bellaterra (Barcelona), Spain
| | - R St Denis
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - M Stancari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Stentz
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Strologas
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Y Sudo
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A Sukhanov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - I Suslov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - K Takemasa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - Y Takeuchi
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - J Tang
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - M Tecchio
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - P K Teng
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - J Thom
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E Thomson
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - V Thukral
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - D Toback
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - S Tokar
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - K Tollefson
- Michigan State University, East Lansing, Michigan 48824, USA
| | - T Tomura
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - D Tonelli
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Torre
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - D Torretta
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Totaro
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
| | - M Trovato
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - F Ukegawa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Uozumi
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - F Vázquez
- University of Florida, Gainesville, Florida 32611, USA
| | - G Velev
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Vellidis
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Vernieri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - M Vidal
- Purdue University, West Lafayette, Indiana 47907, USA
| | - R Vilar
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Vizán
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Vogel
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - G Volpi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - P Wagner
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - R Wallny
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S M Wang
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - D Waters
- University College London, London WC1E 6BT, United Kingdom
| | - W C Wester
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Whiteson
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - A B Wicklund
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Wilbur
- University of California, Davis, Davis, California 95616, USA
| | - H H Williams
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - J S Wilson
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - P Wilson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B L Winer
- The Ohio State University, Columbus, Ohio 43210, USA
| | - P Wittich
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Wolbers
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Wolfmeister
- The Ohio State University, Columbus, Ohio 43210, USA
| | - T Wright
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - X Wu
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - Z Wu
- Baylor University, Waco, Texas 76798, USA
| | - K Yamamoto
- Osaka City University, Osaka 558-8585, Japan
| | - D Yamato
- Osaka City University, Osaka 558-8585, Japan
| | - T Yang
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - U K Yang
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - Y C Yang
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - W-M Yao
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - G P Yeh
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yi
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Yoh
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yorita
- Waseda University, Tokyo 169, Japan
| | - T Yoshida
- Osaka City University, Osaka 558-8585, Japan
| | - G B Yu
- Duke University, Durham, North Carolina 27708, USA
| | - I Yu
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - A M Zanetti
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - Y Zeng
- Duke University, Durham, North Carolina 27708, USA
| | - C Zhou
- Duke University, Durham, North Carolina 27708, USA
| | - S Zucchelli
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| |
Collapse
|
41
|
Taylor-Stokes G, Mitra D, Waller J, Gibson K, Milligan G, Iyer S. Real world treatment patterns and clinical outcomes of advanced/metastatic breast cancer patients receiving palbociclib in combination with an aromatase inhibitor: Results from the IRIS Study. Eur J Cancer 2018. [DOI: 10.1016/s0959-8049(18)30562-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
42
|
Aaltonen T, Abazov VM, Abbott B, Acharya BS, Adams M, Adams T, Agnew JP, Alexeev GD, Alkhazov G, Alton A, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Appel JA, Arisawa T, Artikov A, Asaadi J, Ashmanskas W, Askew A, Atkins S, Auerbach B, Augsten K, Aurisano A, Aushev V, Aushev Y, Avila C, Azfar F, Badaud F, Badgett W, Bae T, Bagby L, Baldin B, Bandurin DV, Banerjee S, Barbaro-Galtieri A, Barberis E, Baringer P, Barnes VE, Barnett BA, Barria P, Bartlett JF, Bartos P, Bassler U, Bauce M, Bazterra V, Bean A, Bedeschi F, Begalli M, Behari S, Bellantoni L, Bellettini G, Bellinger J, Benjamin D, Beretvas A, Beri SB, Bernardi G, Bernhard R, Bertram I, Besançon M, Beuselinck R, Bhat PC, Bhatia S, Bhatnagar V, Bhatti A, Bland KR, Blazey G, Blessing S, Bloom K, Blumenfeld B, Bocci A, Bodek A, Boehnlein A, Boline D, Boos EE, Borissov G, Bortoletto D, Borysova M, Boudreau J, Boveia A, Brandt A, Brandt O, Brigliadori L, Brochmann M, Brock R, Bromberg C, Bross A, Brown D, Brucken E, Bu XB, Budagov J, Budd HS, Buehler M, Buescher V, Bunichev V, Burdin S, Burkett K, Busetto G, Bussey P, Buszello CP, Butti P, Buzatu A, Calamba A, Camacho-Pérez E, Camarda S, Campanelli M, Canelli F, Carls B, Carlsmith D, Carosi R, Carrillo S, Casal B, Casarsa M, Casey BCK, Castilla-Valdez H, Castro A, Catastini P, Caughron S, Cauz D, Cavaliere V, Cerri A, Cerrito L, Chakrabarti S, Chan KM, Chandra A, Chapelain A, Chapon E, Chen G, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Cho K, Cho SW, Choi S, Chokheli D, Choudhary B, Cihangir S, Claes D, Clark A, Clarke C, Clutter J, Convery ME, Conway J, Cooke M, Cooper WE, Corbo M, Corcoran M, Cordelli M, Couderc F, Cousinou MC, Cox CA, Cox DJ, Cremonesi M, Cruz D, Cuevas J, Culbertson R, Cuth J, Cutts D, Das A, d'Ascenzo N, Datta M, Davies G, de Barbaro P, de Jong SJ, De La Cruz-Burelo E, Déliot F, Demina R, Demortier L, Deninno M, Denisov D, Denisov SP, D'Errico M, Desai S, Deterre C, DeVaughan K, Devoto F, Di Canto A, Di Ruzza B, Diehl HT, Diesburg M, Ding PF, Dittmann JR, Dominguez A, Donati S, D'Onofrio M, Dorigo M, Driutti A, Drutskoy A, Dubey A, Dudko LV, Duperrin A, Dutt S, Eads M, Ebina K, Edgar R, Edmunds D, Elagin A, Ellison J, Elvira VD, Enari Y, Erbacher R, Errede S, Esham B, Evans H, Evdokimov A, Evdokimov VN, Farrington S, Fauré A, Feng L, Ferbel T, Fernández Ramos JP, Fiedler F, Field R, Filthaut F, Fisher W, Fisk HE, Flanagan G, Forrest R, Fortner M, Fox H, Franc J, Franklin M, Freeman JC, Frisch H, Fuess S, Funakoshi Y, Galloni C, Garbincius PH, Garcia-Bellido A, García-González JA, Garfinkel AF, Garosi P, Gavrilov V, Geng W, Gerber CE, Gerberich H, Gerchtein E, Gershtein Y, Giagu S, Giakoumopoulou V, Gibson K, Ginsburg CM, Ginther G, Giokaris N, Giromini P, Glagolev V, Glenzinski D, Gogota O, Gold M, Goldin D, Golossanov A, Golovanov G, Gomez G, Gomez-Ceballos G, Goncharov M, González López O, Gorelov I, Goshaw AT, Goulianos K, Gramellini E, Grannis PD, Greder S, Greenlee H, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grosso-Pilcher C, Grünendahl S, Grünewald MW, Guillemin T, Guimaraes da Costa J, Gutierrez G, Gutierrez P, Hahn SR, Haley J, Han JY, Han L, Happacher F, Hara K, Harder K, Hare M, Harel A, Harr RF, Harrington-Taber T, Hatakeyama K, Hauptman JM, Hays C, Hays J, Head T, Hebbeker T, Hedin D, Hegab H, Heinrich J, Heinson AP, Heintz U, Hensel C, Heredia-De La Cruz I, Herndon M, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hoang T, Hobbs JD, Hocker A, Hoeneisen B, Hogan J, Hohlfeld M, Holzbauer JL, Hong Z, Hopkins W, Hou S, Howley I, Hubacek Z, Hughes RE, Husemann U, Hussein M, Huston J, Hynek V, Iashvili I, Ilchenko Y, Illingworth R, Introzzi G, Iori M, Ito AS, Ivanov A, Jabeen S, Jaffré M, James E, Jang D, Jayasinghe A, Jayatilaka B, Jeon EJ, Jeong MS, Jesik R, Jiang P, Jindariani S, Johns K, Johnson E, Johnson M, Jonckheere A, Jones M, Jonsson P, Joo KK, Joshi J, Jun SY, Jung AW, Junk TR, Juste A, Kajfasz E, Kambeitz M, Kamon T, Karchin PE, Karmanov D, Kasmi A, Kato Y, Katsanos I, Kaur M, Kehoe R, Kermiche S, Ketchum W, Keung J, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YN, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SH, Kim SB, Kim YJ, Kim YK, Kimura N, Kirby M, Kiselevich I, Kohli JM, Kondo K, Kong DJ, Konigsberg J, Kotwal AV, Kozelov AV, Kraus J, Kreps M, Kroll J, Kruse M, Kuhr T, Kumar A, Kupco A, Kurata M, Kurča T, Kuzmin VA, Laasanen AT, Lammel S, Lammers S, Lancaster M, Lannon K, Latino G, Lebrun P, Lee HS, Lee HS, Lee JS, Lee SW, Lee WM, Lei X, Lellouch J, Leo S, Leone S, Lewis JD, Li D, Li H, Li L, Li QZ, Lim JK, Limosani A, Lincoln D, Linnemann J, Lipaev VV, Lipeles E, Lipton R, Lister A, Liu H, Liu Q, Liu T, Liu Y, Lobodenko A, Lockwitz S, Loginov A, Lokajicek M, Lopes de Sa R, Lucchesi D, Lucà A, Lueck J, Lujan P, Lukens P, Luna-Garcia R, Lungu G, Lyon AL, Lys J, Lysak R, Maciel AKA, Madar R, Madrak R, Maestro P, Magaña-Villalba R, Malik S, Malik S, Malyshev VL, Manca G, Manousakis-Katsikakis A, Mansour J, Marchese L, Margaroli F, Marino P, Martínez-Ortega J, Matera K, Mattson ME, Mazzacane A, Mazzanti P, McCarthy R, McGivern CL, McNulty R, Mehta A, Mehtala P, Meijer MM, Melnitchouk A, Menezes D, Mercadante PG, Merkin M, Mesropian C, Meyer A, Meyer J, Miao T, Miconi F, Mietlicki D, Mitra A, Miyake H, Moed S, Moggi N, Mondal NK, Moon CS, Moore R, Morello MJ, Mukherjee A, Mulhearn M, Muller T, Murat P, Mussini M, Nachtman J, Nagai Y, Naganoma J, Nagy E, Nakano I, Napier A, Narain M, Nayyar R, Neal HA, Negret JP, Nett J, Neustroev P, Nguyen HT, Nigmanov T, Nodulman L, Noh SY, Norniella O, Nunnemann T, Oakes L, Oh SH, Oh YD, Okusawa T, Orava R, Orduna J, Ortolan L, Osman N, Pagliarone C, Pal A, Palencia E, Palni P, Papadimitriou V, Parashar N, Parihar V, Park SK, Parker W, Partridge R, Parua N, Patwa A, Pauletta G, Paulini M, Paus C, Penning B, Perfilov M, Peters Y, Petridis K, Petrillo G, Pétroff P, Phillips TJ, Piacentino G, Pianori E, Pilot J, Pitts K, Plager C, Pleier MA, Podstavkov VM, Pondrom L, Popov AV, Poprocki S, Potamianos K, Pranko A, Prewitt M, Price D, Prokopenko N, Prokoshin F, Ptohos F, Punzi G, Qian J, Quadt A, Quinn B, Ratoff PN, Razumov I, Redondo Fernández I, Renton P, Rescigno M, Rimondi F, Ripp-Baudot I, Ristori L, Rizatdinova F, Robson A, Rodriguez T, Rolli S, Rominsky M, Ronzani M, Roser R, Rosner JL, Ross A, Royon C, Rubinov P, Ruchti R, Ruffini F, Ruiz A, Russ J, Rusu V, Sajot G, Sakumoto WK, Sakurai Y, Sánchez-Hernández A, Sanders MP, Santi L, Santos AS, Sato K, Savage G, Saveliev V, Savitskyi M, Savoy-Navarro A, Sawyer L, Scanlon T, Schamberger RD, Scheglov Y, Schellman H, Schlabach P, Schmidt EE, Schott M, Schwanenberger C, Schwarz T, Schwienhorst R, Scodellaro L, Scuri F, Seidel S, Seiya Y, Sekaric J, Semenov A, Severini H, Sforza F, Shabalina E, Shalhout SZ, Shary V, Shaw S, Shchukin AA, Shears T, Shepard PF, Shimojima M, Shkola O, Shochet M, Shreyber-Tecker I, Simak V, Simonenko A, Skubic P, Slattery P, Sliwa K, Smith JR, Snider FD, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Song H, Sonnenschein L, Sorin V, Soustruznik K, St Denis R, Stancari M, Stark J, Stefaniuk N, Stentz D, Stoyanova DA, Strauss M, Strologas J, Sudo Y, Sukhanov A, Suslov I, Suter L, Svoisky P, Takemasa K, Takeuchi Y, Tang J, Tecchio M, Teng PK, Thom J, Thomson E, Thukral V, Titov M, Toback D, Tokar S, Tokmenin VV, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Totaro P, Trovato M, Tsai YT, Tsybychev D, Tuchming B, Tully C, Ukegawa F, Uozumi S, Uvarov L, Uvarov S, Uzunyan S, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vasilyev IA, Vázquez F, Velev G, Vellidis C, Verkheev AY, Vernieri C, Vertogradov LS, Verzocchi M, Vesterinen M, Vidal M, Vilanova D, Vilar R, Vizán J, Vogel M, Vokac P, Volpi G, Wagner P, Wahl HD, Wallny R, Wang MHLS, Wang SM, Warchol J, Waters D, Watts G, Wayne M, Weichert J, Welty-Rieger L, Wester WC, Whiteson D, Wicklund AB, Wilbur S, Williams HH, Williams MRJ, Wilson GW, Wilson JS, Wilson P, Winer BL, Wittich P, Wobisch M, Wolbers S, Wolfmeister H, Wood DR, Wright T, Wu X, Wu Z, Wyatt TR, Xie Y, Yamada R, Yamamoto K, Yamato D, Yang S, Yang T, Yang UK, Yang YC, Yao WM, Yasuda T, Yatsunenko YA, Ye W, Ye Z, Yeh GP, Yi K, Yin H, Yip K, Yoh J, Yorita K, Yoshida T, Youn SW, Yu GB, Yu I, Yu JM, Zanetti AM, Zeng Y, Zennamo J, Zhao TG, Zhou B, Zhou C, Zhu J, Zielinski M, Zieminska D, Zivkovic L, Zucchelli S. Combined Forward-Backward Asymmetry Measurements in Top-Antitop Quark Production at the Tevatron. Phys Rev Lett 2018; 120:042001. [PMID: 29437406 DOI: 10.1103/physrevlett.120.042001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/13/2017] [Indexed: 06/08/2023]
Abstract
The CDF and D0 experiments at the Fermilab Tevatron have measured the asymmetry between yields of forward- and backward-produced top and antitop quarks based on their rapidity difference and the asymmetry between their decay leptons. These measurements use the full data sets collected in proton-antiproton collisions at a center-of-mass energy of sqrt[s]=1.96 TeV. We report the results of combinations of the inclusive asymmetries and their differential dependencies on relevant kinematic quantities. The combined inclusive asymmetry is A_{FB}^{tt[over ¯]}=0.128±0.025. The combined inclusive and differential asymmetries are consistent with recent standard model predictions.
Collapse
Affiliation(s)
- T Aaltonen
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - V M Abazov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - B Abbott
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - B S Acharya
- Tata Institute of Fundamental Research, Mumbai-400 005, India
| | - M Adams
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - T Adams
- Florida State University, Tallahassee, Florida 32306, USA
| | - J P Agnew
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - G D Alexeev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - G Alkhazov
- Petersburg Nuclear Physics Institute, St. Petersburg 188300, Russia
| | - A Alton
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - S Amerio
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - D Amidei
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Anastassov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Annovi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Antos
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - G Apollinari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J A Appel
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - A Artikov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - J Asaadi
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - W Ashmanskas
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Askew
- Florida State University, Tallahassee, Florida 32306, USA
| | - S Atkins
- Louisiana Tech University, Ruston, Louisiana 71272, USA
| | - B Auerbach
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - K Augsten
- Czech Technical University in Prague, 116 36 Prague 6, Czech Republic
| | - A Aurisano
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - V Aushev
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - Y Aushev
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - C Avila
- Universidad de los Andes, Bogotá 111711, Colombia
| | - F Azfar
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - F Badaud
- LPC, Université Blaise Pascal, CNRS/IN2P3, Clermont, F-63178 Aubière Cedex, France
| | - W Badgett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - T Bae
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - L Bagby
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B Baldin
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D V Bandurin
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - S Banerjee
- Tata Institute of Fundamental Research, Mumbai-400 005, India
| | - A Barbaro-Galtieri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - E Barberis
- Northeastern University, Boston, Massachusetts 02115, USA
| | - P Baringer
- University of Kansas, Lawrence, Kansas 66045, USA
| | - V E Barnes
- Purdue University, West Lafayette, Indiana 47907, USA
| | - B A Barnett
- The Johns Hopkins University, Baltimore, Maryland 21218, USA
| | - P Barria
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - J F Bartlett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Bartos
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - U Bassler
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - M Bauce
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - V Bazterra
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - A Bean
- University of Kansas, Lawrence, Kansas 66045, USA
| | - F Bedeschi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - M Begalli
- Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ 20550, Brazil
| | - S Behari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - L Bellantoni
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Bellettini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - J Bellinger
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - D Benjamin
- Duke University, Durham, North Carolina 27708, USA
| | - A Beretvas
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S B Beri
- Panjab University, Chandigarh 160014, India
| | - G Bernardi
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, F-75005 Paris, France
| | - R Bernhard
- Physikalisches Institut, Universität Freiburg, 79085 Freiburg, Germany
| | - I Bertram
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - M Besançon
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - R Beuselinck
- Imperial College London, London SW7 2AZ, United Kingdom
| | - P C Bhat
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Bhatia
- University of Mississippi, University, Mississippi 38677, USA
| | | | - A Bhatti
- The Rockefeller University, New York, New York 10065, USA
| | - K R Bland
- Baylor University, Waco, Texas 76798, USA
| | - G Blazey
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - S Blessing
- Florida State University, Tallahassee, Florida 32306, USA
| | - K Bloom
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - B Blumenfeld
- The Johns Hopkins University, Baltimore, Maryland 21218, USA
| | - A Bocci
- Duke University, Durham, North Carolina 27708, USA
| | - A Bodek
- University of Rochester, Rochester, New York 14627, USA
| | - A Boehnlein
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Boline
- State University of New York, Stony Brook, New York 11794, USA
| | - E E Boos
- Moscow State University, Moscow 119991, Russia
| | - G Borissov
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - D Bortoletto
- Purdue University, West Lafayette, Indiana 47907, USA
| | - M Borysova
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - J Boudreau
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - A Boveia
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - A Brandt
- University of Texas, Arlington, Texas 76019, USA
| | - O Brandt
- II. Physikalisches Institut, Georg-August-Universität Göttingen, 37073 Göttingen, Germany
| | - L Brigliadori
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - M Brochmann
- University of Washington, Seattle, Washington 98195, USA
| | - R Brock
- Michigan State University, East Lansing, Michigan 48824, USA
| | - C Bromberg
- Michigan State University, East Lansing, Michigan 48824, USA
| | - A Bross
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Brown
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, F-75005 Paris, France
| | - E Brucken
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - X B Bu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Budagov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - H S Budd
- University of Rochester, Rochester, New York 14627, USA
| | - M Buehler
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - V Buescher
- Institut für Physik, Universität Mainz, 55099 Mainz, Germany
| | - V Bunichev
- Moscow State University, Moscow 119991, Russia
| | - S Burdin
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - K Burkett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Busetto
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - P Bussey
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | | | - P Butti
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - A Buzatu
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - A Calamba
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | | | - S Camarda
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193, Bellaterra (Barcelona), Spain
| | - M Campanelli
- University College London, London WC1E 6BT, United Kingdom
| | - F Canelli
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - B Carls
- University of Illinois, Urbana, Illinois 61801, USA
| | - D Carlsmith
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - R Carosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Carrillo
- University of Florida, Gainesville, Florida 32611, USA
| | - B Casal
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Casarsa
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - B C K Casey
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - A Castro
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - P Catastini
- Harvard University, Cambridge, Massachusetts 02138, USA
| | - S Caughron
- Michigan State University, East Lansing, Michigan 48824, USA
| | - D Cauz
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - V Cavaliere
- University of Illinois, Urbana, Illinois 61801, USA
| | - A Cerri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - L Cerrito
- University College London, London WC1E 6BT, United Kingdom
| | - S Chakrabarti
- State University of New York, Stony Brook, New York 11794, USA
| | - K M Chan
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - A Chandra
- Rice University, Houston, Texas 77005, USA
| | - A Chapelain
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - E Chapon
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - G Chen
- University of Kansas, Lawrence, Kansas 66045, USA
| | - Y C Chen
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - M Chertok
- University of California, Davis, Davis, California 95616, USA
| | - G Chiarelli
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - G Chlachidze
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Cho
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - S W Cho
- Korea Detector Laboratory, Korea University, Seoul 02841, Korea
| | - S Choi
- Korea Detector Laboratory, Korea University, Seoul 02841, Korea
| | - D Chokheli
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | | | - S Cihangir
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Claes
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - A Clark
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - C Clarke
- Wayne State University, Detroit, Michigan 48201, USA
| | - J Clutter
- University of Kansas, Lawrence, Kansas 66045, USA
| | - M E Convery
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Conway
- University of California, Davis, Davis, California 95616, USA
| | - M Cooke
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - W E Cooper
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Corbo
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Corcoran
- Rice University, Houston, Texas 77005, USA
| | - M Cordelli
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - F Couderc
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - M-C Cousinou
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - C A Cox
- University of California, Davis, Davis, California 95616, USA
| | - D J Cox
- University of California, Davis, Davis, California 95616, USA
| | - M Cremonesi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - D Cruz
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - J Cuevas
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - R Culbertson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Cuth
- Institut für Physik, Universität Mainz, 55099 Mainz, Germany
| | - D Cutts
- Brown University, Providence, Rhode Island 02912, USA
| | - A Das
- Southern Methodist University, Dallas, Texas 75275, USA
| | - N d'Ascenzo
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Datta
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Davies
- Imperial College London, London SW7 2AZ, United Kingdom
| | - P de Barbaro
- University of Rochester, Rochester, New York 14627, USA
| | - S J de Jong
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
- Radboud University Nijmegen, 6525 AJ Nijmegen, The Netherlands
| | | | - F Déliot
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - R Demina
- University of Rochester, Rochester, New York 14627, USA
| | - L Demortier
- The Rockefeller University, New York, New York 10065, USA
| | - M Deninno
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - D Denisov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S P Denisov
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - M D'Errico
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - S Desai
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Deterre
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - K DeVaughan
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - F Devoto
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - A Di Canto
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - B Di Ruzza
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H T Diehl
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Diesburg
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P F Ding
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | | | - A Dominguez
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - S Donati
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - M D'Onofrio
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - M Dorigo
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- University of Trieste, I-34127 Trieste, Italy
| | - A Driutti
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - A Drutskoy
- Institute for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - A Dubey
- Delhi University, Delhi-110 007, India
| | - L V Dudko
- Moscow State University, Moscow 119991, Russia
| | - A Duperrin
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - S Dutt
- Panjab University, Chandigarh 160014, India
| | - M Eads
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - K Ebina
- Waseda University, Tokyo 169, Japan
| | - R Edgar
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - D Edmunds
- Michigan State University, East Lansing, Michigan 48824, USA
| | - A Elagin
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - J Ellison
- University of California Riverside, Riverside, California 92521, USA
| | - V D Elvira
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Enari
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, F-75005 Paris, France
| | - R Erbacher
- University of California, Davis, Davis, California 95616, USA
| | - S Errede
- University of Illinois, Urbana, Illinois 61801, USA
| | - B Esham
- University of Illinois, Urbana, Illinois 61801, USA
| | - H Evans
- Indiana University, Bloomington, Indiana 47405, USA
| | - A Evdokimov
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - V N Evdokimov
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - S Farrington
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - A Fauré
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - L Feng
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - T Ferbel
- University of Rochester, Rochester, New York 14627, USA
| | - J P Fernández Ramos
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - F Fiedler
- Institut für Physik, Universität Mainz, 55099 Mainz, Germany
| | - R Field
- University of Florida, Gainesville, Florida 32611, USA
| | - F Filthaut
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
- Radboud University Nijmegen, 6525 AJ Nijmegen, The Netherlands
| | - W Fisher
- Michigan State University, East Lansing, Michigan 48824, USA
| | - H E Fisk
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Flanagan
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Forrest
- University of California, Davis, Davis, California 95616, USA
| | - M Fortner
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - H Fox
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - J Franc
- Czech Technical University in Prague, 116 36 Prague 6, Czech Republic
| | - M Franklin
- Harvard University, Cambridge, Massachusetts 02138, USA
| | - J C Freeman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Frisch
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - S Fuess
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - C Galloni
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - P H Garbincius
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | | | - A F Garfinkel
- Purdue University, West Lafayette, Indiana 47907, USA
| | - P Garosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - V Gavrilov
- Institute for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - W Geng
- Michigan State University, East Lansing, Michigan 48824, USA
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - C E Gerber
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - H Gerberich
- University of Illinois, Urbana, Illinois 61801, USA
| | - E Gerchtein
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Gershtein
- Rutgers University, Piscataway, New Jersey 08855, USA
| | - S Giagu
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | | | - K Gibson
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - C M Ginsburg
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Ginther
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Giokaris
- University of Athens, 157 71 Athens, Greece
| | - P Giromini
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - V Glagolev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - D Glenzinski
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - O Gogota
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - M Gold
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - D Goldin
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - A Golossanov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Golovanov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - G Gomez
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - G Gomez-Ceballos
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - M Goncharov
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - O González López
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - I Gorelov
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - A T Goshaw
- Duke University, Durham, North Carolina 27708, USA
| | - K Goulianos
- The Rockefeller University, New York, New York 10065, USA
| | - E Gramellini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - P D Grannis
- State University of New York, Stony Brook, New York 11794, USA
| | - S Greder
- IPHC, Université de Strasbourg, CNRS/IN2P3, F-67037 Strasbourg, France
| | - H Greenlee
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Grenier
- IPNL, Université Lyon 1, CNRS/IN2P3, F-69622 Villeurbanne Cedex, France and Université de Lyon, F-69361 Lyon CEDEX 07, France
| | - Ph Gris
- LPC, Université Blaise Pascal, CNRS/IN2P3, Clermont, F-63178 Aubière Cedex, France
| | - J-F Grivaz
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay Cedex, France
| | - A Grohsjean
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - C Grosso-Pilcher
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - S Grünendahl
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - T Guillemin
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay Cedex, France
| | | | - G Gutierrez
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Gutierrez
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - S R Hahn
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Haley
- Oklahoma State University, Stillwater, Oklahoma 74078, USA
| | - J Y Han
- University of Rochester, Rochester, New York 14627, USA
| | - L Han
- University of Science and Technology of China, Hefei 230026, People's Republic of China
| | - F Happacher
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - K Hara
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - K Harder
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - M Hare
- Tufts University, Medford, Massachusetts 02155, USA
| | - A Harel
- University of Rochester, Rochester, New York 14627, USA
| | - R F Harr
- Wayne State University, Detroit, Michigan 48201, USA
| | | | | | | | - C Hays
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - J Hays
- Imperial College London, London SW7 2AZ, United Kingdom
| | - T Head
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - T Hebbeker
- III. Physikalisches Institut A, RWTH Aachen University, 52056 Aachen, Germany
| | - D Hedin
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - H Hegab
- Oklahoma State University, Stillwater, Oklahoma 74078, USA
| | - J Heinrich
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - A P Heinson
- University of California Riverside, Riverside, California 92521, USA
| | - U Heintz
- Brown University, Providence, Rhode Island 02912, USA
| | - C Hensel
- LAFEX, Centro Brasileiro de Pesquisas Físicas, Rio de Janeiro, RJ 22290, Brazil
| | | | - M Herndon
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - K Herner
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Hesketh
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - M D Hildreth
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - R Hirosky
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - T Hoang
- Florida State University, Tallahassee, Florida 32306, USA
| | - J D Hobbs
- State University of New York, Stony Brook, New York 11794, USA
| | - A Hocker
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B Hoeneisen
- Universidad San Francisco de Quito, Quito 170157, Ecuador
| | - J Hogan
- Rice University, Houston, Texas 77005, USA
| | - M Hohlfeld
- Institut für Physik, Universität Mainz, 55099 Mainz, Germany
| | - J L Holzbauer
- University of Mississippi, University, Mississippi 38677, USA
| | - Z Hong
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - W Hopkins
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Hou
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - I Howley
- University of Texas, Arlington, Texas 76019, USA
| | - Z Hubacek
- Czech Technical University in Prague, 116 36 Prague 6, Czech Republic
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - R E Hughes
- The Ohio State University, Columbus, Ohio 43210, USA
| | - U Husemann
- Yale University, New Haven, Connecticut 06520, USA
| | - M Hussein
- Michigan State University, East Lansing, Michigan 48824, USA
| | - J Huston
- Michigan State University, East Lansing, Michigan 48824, USA
| | - V Hynek
- Czech Technical University in Prague, 116 36 Prague 6, Czech Republic
| | - I Iashvili
- State University of New York, Buffalo, New York 14260, USA
| | - Y Ilchenko
- Southern Methodist University, Dallas, Texas 75275, USA
| | - R Illingworth
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Introzzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- INFN Pavia, I-27100 Pavia, Italy
- University of Pavia, I-27100 Pavia, Italy
| | - M Iori
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
- Sapienza Università di Roma, I-00185 Roma, Italy
| | - A S Ito
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Ivanov
- University of California, Davis, Davis, California 95616, USA
| | - S Jabeen
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Jaffré
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay Cedex, France
| | - E James
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Jang
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - A Jayasinghe
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - B Jayatilaka
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E J Jeon
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - M S Jeong
- Korea Detector Laboratory, Korea University, Seoul 02841, Korea
| | - R Jesik
- Imperial College London, London SW7 2AZ, United Kingdom
| | - P Jiang
- University of Science and Technology of China, Hefei 230026, People's Republic of China
| | - S Jindariani
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Johns
- University of Arizona, Tucson, Arizona 85721, USA
| | - E Johnson
- Michigan State University, East Lansing, Michigan 48824, USA
| | - M Johnson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Jonckheere
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Jones
- Purdue University, West Lafayette, Indiana 47907, USA
| | - P Jonsson
- Imperial College London, London SW7 2AZ, United Kingdom
| | - K K Joo
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - J Joshi
- University of California Riverside, Riverside, California 92521, USA
| | - S Y Jun
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - A W Jung
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - T R Junk
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Juste
- Institució Catalana de Recerca i Estudis Avançats (ICREA) and Institut de Física d'Altes Energies (IFAE), 08193 Bellaterra (Barcelona), Spain
| | - E Kajfasz
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - M Kambeitz
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - T Kamon
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - P E Karchin
- Wayne State University, Detroit, Michigan 48201, USA
| | - D Karmanov
- Moscow State University, Moscow 119991, Russia
| | - A Kasmi
- Baylor University, Waco, Texas 76798, USA
| | - Y Kato
- Osaka City University, Osaka 558-8585, Japan
| | - I Katsanos
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - M Kaur
- Panjab University, Chandigarh 160014, India
| | - R Kehoe
- Southern Methodist University, Dallas, Texas 75275, USA
| | - S Kermiche
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - W Ketchum
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - J Keung
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - N Khalatyan
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Khanov
- Oklahoma State University, Stillwater, Oklahoma 74078, USA
| | - A Kharchilava
- State University of New York, Buffalo, New York 14260, USA
| | - Y N Kharzheev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - B Kilminster
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D H Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - H S Kim
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J E Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - M J Kim
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - S H Kim
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S B Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - Y J Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - Y K Kim
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - N Kimura
- Waseda University, Tokyo 169, Japan
| | - M Kirby
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - I Kiselevich
- Institute for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - J M Kohli
- Panjab University, Chandigarh 160014, India
| | - K Kondo
- Waseda University, Tokyo 169, Japan
| | - D J Kong
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - J Konigsberg
- University of Florida, Gainesville, Florida 32611, USA
| | - A V Kotwal
- Duke University, Durham, North Carolina 27708, USA
| | - A V Kozelov
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - J Kraus
- University of Mississippi, University, Mississippi 38677, USA
| | - M Kreps
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - J Kroll
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - M Kruse
- Duke University, Durham, North Carolina 27708, USA
| | - T Kuhr
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - A Kumar
- State University of New York, Buffalo, New York 14260, USA
| | - A Kupco
- Institute of Physics, Academy of Sciences of the Czech Republic, 182 21 Prague, Czech Republic
| | - M Kurata
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - T Kurča
- IPNL, Université Lyon 1, CNRS/IN2P3, F-69622 Villeurbanne Cedex, France and Université de Lyon, F-69361 Lyon CEDEX 07, France
| | - V A Kuzmin
- Moscow State University, Moscow 119991, Russia
| | - A T Laasanen
- Purdue University, West Lafayette, Indiana 47907, USA
| | - S Lammel
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Lammers
- Indiana University, Bloomington, Indiana 47405, USA
| | - M Lancaster
- University College London, London WC1E 6BT, United Kingdom
| | - K Lannon
- The Ohio State University, Columbus, Ohio 43210, USA
| | - G Latino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - P Lebrun
- IPNL, Université Lyon 1, CNRS/IN2P3, F-69622 Villeurbanne Cedex, France and Université de Lyon, F-69361 Lyon CEDEX 07, France
| | - H S Lee
- Korea Detector Laboratory, Korea University, Seoul 02841, Korea
| | - H S Lee
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - J S Lee
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - S W Lee
- Iowa State University, Ames, Iowa 50011, USA
| | - W M Lee
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - X Lei
- University of Arizona, Tucson, Arizona 85721, USA
| | - J Lellouch
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, F-75005 Paris, France
| | - S Leo
- University of Illinois, Urbana, Illinois 61801, USA
| | - S Leone
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - J D Lewis
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Li
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, F-75005 Paris, France
| | - H Li
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - L Li
- University of California Riverside, Riverside, California 92521, USA
| | - Q Z Li
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J K Lim
- Korea Detector Laboratory, Korea University, Seoul 02841, Korea
| | - A Limosani
- Duke University, Durham, North Carolina 27708, USA
| | - D Lincoln
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Linnemann
- Michigan State University, East Lansing, Michigan 48824, USA
| | - V V Lipaev
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - E Lipeles
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - R Lipton
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Lister
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - H Liu
- Southern Methodist University, Dallas, Texas 75275, USA
| | - Q Liu
- Purdue University, West Lafayette, Indiana 47907, USA
| | - T Liu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Liu
- University of Science and Technology of China, Hefei 230026, People's Republic of China
| | - A Lobodenko
- Petersburg Nuclear Physics Institute, St. Petersburg 188300, Russia
| | - S Lockwitz
- Yale University, New Haven, Connecticut 06520, USA
| | - A Loginov
- Yale University, New Haven, Connecticut 06520, USA
| | - M Lokajicek
- Institute of Physics, Academy of Sciences of the Czech Republic, 182 21 Prague, Czech Republic
| | - R Lopes de Sa
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Lucchesi
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - A Lucà
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Lueck
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Lujan
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - P Lukens
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - G Lungu
- The Rockefeller University, New York, New York 10065, USA
| | - A L Lyon
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Lys
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R Lysak
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - A K A Maciel
- LAFEX, Centro Brasileiro de Pesquisas Físicas, Rio de Janeiro, RJ 22290, Brazil
| | - R Madar
- Physikalisches Institut, Universität Freiburg, 79085 Freiburg, Germany
| | - R Madrak
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Maestro
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | | | - S Malik
- The Rockefeller University, New York, New York 10065, USA
| | - S Malik
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - V L Malyshev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - G Manca
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | | | - J Mansour
- II. Physikalisches Institut, Georg-August-Universität Göttingen, 37073 Göttingen, Germany
| | - L Marchese
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - F Margaroli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - P Marino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | | | - K Matera
- University of Illinois, Urbana, Illinois 61801, USA
| | - M E Mattson
- Wayne State University, Detroit, Michigan 48201, USA
| | - A Mazzacane
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Mazzanti
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - R McCarthy
- State University of New York, Stony Brook, New York 11794, USA
| | - C L McGivern
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - R McNulty
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - A Mehta
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - P Mehtala
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - M M Meijer
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
- Radboud University Nijmegen, 6525 AJ Nijmegen, The Netherlands
| | - A Melnitchouk
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Menezes
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - P G Mercadante
- Universidade Federal do ABC, Santo André, São Paulo, SP 09210, Brazil
| | - M Merkin
- Moscow State University, Moscow 119991, Russia
| | - C Mesropian
- The Rockefeller University, New York, New York 10065, USA
| | - A Meyer
- III. Physikalisches Institut A, RWTH Aachen University, 52056 Aachen, Germany
| | - J Meyer
- II. Physikalisches Institut, Georg-August-Universität Göttingen, 37073 Göttingen, Germany
| | - T Miao
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - F Miconi
- IPHC, Université de Strasbourg, CNRS/IN2P3, F-67037 Strasbourg, France
| | - D Mietlicki
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Mitra
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - H Miyake
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Moed
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Moggi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - N K Mondal
- Tata Institute of Fundamental Research, Mumbai-400 005, India
| | - C S Moon
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Moore
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M J Morello
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - A Mukherjee
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Mulhearn
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - Th Muller
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Murat
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Mussini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - J Nachtman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Nagai
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | | | - E Nagy
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - I Nakano
- Okayama University, Okayama 700-8530, Japan
| | - A Napier
- Tufts University, Medford, Massachusetts 02155, USA
| | - M Narain
- Brown University, Providence, Rhode Island 02912, USA
| | - R Nayyar
- University of Arizona, Tucson, Arizona 85721, USA
| | - H A Neal
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - J P Negret
- Universidad de los Andes, Bogotá 111711, Colombia
| | - J Nett
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - P Neustroev
- Petersburg Nuclear Physics Institute, St. Petersburg 188300, Russia
| | - H T Nguyen
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - T Nigmanov
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - L Nodulman
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Y Noh
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - O Norniella
- University of Illinois, Urbana, Illinois 61801, USA
| | - T Nunnemann
- Ludwig-Maximilians-Universität München, 80539 München, Germany
| | - L Oakes
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - S H Oh
- Duke University, Durham, North Carolina 27708, USA
| | - Y D Oh
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - T Okusawa
- Osaka City University, Osaka 558-8585, Japan
| | - R Orava
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - J Orduna
- Brown University, Providence, Rhode Island 02912, USA
| | - L Ortolan
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193, Bellaterra (Barcelona), Spain
| | - N Osman
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - C Pagliarone
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - A Pal
- University of Texas, Arlington, Texas 76019, USA
| | - E Palencia
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - P Palni
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - V Papadimitriou
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Parashar
- Purdue University Calumet, Hammond, Indiana 46323, USA
| | - V Parihar
- Brown University, Providence, Rhode Island 02912, USA
| | - S K Park
- Korea Detector Laboratory, Korea University, Seoul 02841, Korea
| | - W Parker
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - R Partridge
- Brown University, Providence, Rhode Island 02912, USA
| | - N Parua
- Indiana University, Bloomington, Indiana 47405, USA
| | - A Patwa
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - G Pauletta
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - M Paulini
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - C Paus
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - B Penning
- Imperial College London, London SW7 2AZ, United Kingdom
| | - M Perfilov
- Moscow State University, Moscow 119991, Russia
| | - Y Peters
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - K Petridis
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - G Petrillo
- University of Rochester, Rochester, New York 14627, USA
| | - P Pétroff
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay Cedex, France
| | - T J Phillips
- Duke University, Durham, North Carolina 27708, USA
| | - G Piacentino
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E Pianori
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - J Pilot
- University of California, Davis, Davis, California 95616, USA
| | - K Pitts
- University of Illinois, Urbana, Illinois 61801, USA
| | - C Plager
- University of California, Los Angeles, Los Angeles, California 90024, USA
| | - M-A Pleier
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - V M Podstavkov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - L Pondrom
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - A V Popov
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - S Poprocki
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Potamianos
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Pranko
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Prewitt
- Rice University, Houston, Texas 77005, USA
| | - D Price
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - N Prokopenko
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - F Prokoshin
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - F Ptohos
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - G Punzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - J Qian
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Quadt
- II. Physikalisches Institut, Georg-August-Universität Göttingen, 37073 Göttingen, Germany
| | - B Quinn
- University of Mississippi, University, Mississippi 38677, USA
| | - P N Ratoff
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - I Razumov
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - I Redondo Fernández
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - P Renton
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - M Rescigno
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - F Rimondi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - I Ripp-Baudot
- IPHC, Université de Strasbourg, CNRS/IN2P3, F-67037 Strasbourg, France
| | - L Ristori
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - F Rizatdinova
- Oklahoma State University, Stillwater, Oklahoma 74078, USA
| | - A Robson
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - T Rodriguez
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - S Rolli
- Tufts University, Medford, Massachusetts 02155, USA
| | - M Rominsky
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Ronzani
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - R Roser
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J L Rosner
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - A Ross
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - C Royon
- Institute of Physics, Academy of Sciences of the Czech Republic, 182 21 Prague, Czech Republic
| | - P Rubinov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Ruchti
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - F Ruffini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - A Ruiz
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Russ
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - V Rusu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Sajot
- LPSC, Université Joseph Fourier Grenoble 1, CNRS/IN2P3, Institut National Polytechnique de Grenoble, F-38026 Grenoble Cedex, France
| | - W K Sakumoto
- University of Rochester, Rochester, New York 14627, USA
| | | | | | - M P Sanders
- Ludwig-Maximilians-Universität München, 80539 München, Germany
| | - L Santi
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - A S Santos
- LAFEX, Centro Brasileiro de Pesquisas Físicas, Rio de Janeiro, RJ 22290, Brazil
| | - K Sato
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - G Savage
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - V Saveliev
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Savitskyi
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - A Savoy-Navarro
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - L Sawyer
- Louisiana Tech University, Ruston, Louisiana 71272, USA
| | - T Scanlon
- Imperial College London, London SW7 2AZ, United Kingdom
| | - R D Schamberger
- State University of New York, Stony Brook, New York 11794, USA
| | - Y Scheglov
- Petersburg Nuclear Physics Institute, St. Petersburg 188300, Russia
| | - H Schellman
- Northwestern University, Evanston, Illinois 60208, USA
- Oregon State University, Corvallis, Oregon 97331, USA
| | - P Schlabach
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E E Schmidt
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Schott
- Institut für Physik, Universität Mainz, 55099 Mainz, Germany
| | - C Schwanenberger
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - T Schwarz
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - R Schwienhorst
- Michigan State University, East Lansing, Michigan 48824, USA
| | - L Scodellaro
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - F Scuri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Seidel
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Y Seiya
- Osaka City University, Osaka 558-8585, Japan
| | - J Sekaric
- University of Kansas, Lawrence, Kansas 66045, USA
| | - A Semenov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - H Severini
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - F Sforza
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - E Shabalina
- II. Physikalisches Institut, Georg-August-Universität Göttingen, 37073 Göttingen, Germany
| | - S Z Shalhout
- University of California, Davis, Davis, California 95616, USA
| | - V Shary
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - S Shaw
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - A A Shchukin
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - T Shears
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - P F Shepard
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - M Shimojima
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - O Shkola
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - M Shochet
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - I Shreyber-Tecker
- Institute for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - V Simak
- Czech Technical University in Prague, 116 36 Prague 6, Czech Republic
| | - A Simonenko
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - P Skubic
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - P Slattery
- University of Rochester, Rochester, New York 14627, USA
| | - K Sliwa
- Tufts University, Medford, Massachusetts 02155, USA
| | - J R Smith
- University of California, Davis, Davis, California 95616, USA
| | - F D Snider
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G R Snow
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - J Snow
- Langston University, Langston, Oklahoma 73050, USA
| | - S Snyder
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | | | - H Song
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - L Sonnenschein
- III. Physikalisches Institut A, RWTH Aachen University, 52056 Aachen, Germany
| | - V Sorin
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193, Bellaterra (Barcelona), Spain
| | - K Soustruznik
- Faculty of Mathematics and Physics, Center for Particle Physics, Charles University, 116 36 Prague 1, Czech Republic
| | - R St Denis
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - M Stancari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Stark
- LPSC, Université Joseph Fourier Grenoble 1, CNRS/IN2P3, Institut National Polytechnique de Grenoble, F-38026 Grenoble Cedex, France
| | - N Stefaniuk
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - D Stentz
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D A Stoyanova
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - M Strauss
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - J Strologas
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Y Sudo
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A Sukhanov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - I Suslov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - L Suter
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - P Svoisky
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - K Takemasa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - Y Takeuchi
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - J Tang
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - M Tecchio
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - P K Teng
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - J Thom
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E Thomson
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - V Thukral
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - M Titov
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - D Toback
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - S Tokar
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - V V Tokmenin
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - K Tollefson
- Michigan State University, East Lansing, Michigan 48824, USA
| | - T Tomura
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - D Tonelli
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Torre
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - D Torretta
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Totaro
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
| | - M Trovato
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - Y-T Tsai
- University of Rochester, Rochester, New York 14627, USA
| | - D Tsybychev
- State University of New York, Stony Brook, New York 11794, USA
| | - B Tuchming
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - C Tully
- Princeton University, Princeton, New Jersey 08544, USA
| | - F Ukegawa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Uozumi
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - L Uvarov
- Petersburg Nuclear Physics Institute, St. Petersburg 188300, Russia
| | - S Uvarov
- Petersburg Nuclear Physics Institute, St. Petersburg 188300, Russia
| | - S Uzunyan
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - R Van Kooten
- Indiana University, Bloomington, Indiana 47405, USA
| | | | - N Varelas
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - E W Varnes
- University of Arizona, Tucson, Arizona 85721, USA
| | - I A Vasilyev
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - F Vázquez
- University of Florida, Gainesville, Florida 32611, USA
| | - G Velev
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Vellidis
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Y Verkheev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - C Vernieri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - L S Vertogradov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - M Verzocchi
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Vesterinen
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - M Vidal
- Purdue University, West Lafayette, Indiana 47907, USA
| | - D Vilanova
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - R Vilar
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Vizán
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Vogel
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - P Vokac
- Czech Technical University in Prague, 116 36 Prague 6, Czech Republic
| | - G Volpi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - P Wagner
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - H D Wahl
- Florida State University, Tallahassee, Florida 32306, USA
| | - R Wallny
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M H L S Wang
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S M Wang
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - J Warchol
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - D Waters
- University College London, London WC1E 6BT, United Kingdom
| | - G Watts
- University of Washington, Seattle, Washington 98195, USA
| | - M Wayne
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - J Weichert
- Institut für Physik, Universität Mainz, 55099 Mainz, Germany
| | | | - W C Wester
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Whiteson
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - A B Wicklund
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Wilbur
- University of California, Davis, Davis, California 95616, USA
| | - H H Williams
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | | | - G W Wilson
- University of Kansas, Lawrence, Kansas 66045, USA
| | - J S Wilson
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - P Wilson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B L Winer
- The Ohio State University, Columbus, Ohio 43210, USA
| | - P Wittich
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Wobisch
- Louisiana Tech University, Ruston, Louisiana 71272, USA
| | - S Wolbers
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Wolfmeister
- The Ohio State University, Columbus, Ohio 43210, USA
| | - D R Wood
- Northeastern University, Boston, Massachusetts 02115, USA
| | - T Wright
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - X Wu
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - Z Wu
- Baylor University, Waco, Texas 76798, USA
| | - T R Wyatt
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - Y Xie
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Yamada
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yamamoto
- Osaka City University, Osaka 558-8585, Japan
| | - D Yamato
- Osaka City University, Osaka 558-8585, Japan
| | - S Yang
- University of Science and Technology of China, Hefei 230026, People's Republic of China
| | - T Yang
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - U K Yang
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - Y C Yang
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - W-M Yao
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - T Yasuda
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y A Yatsunenko
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - W Ye
- State University of New York, Stony Brook, New York 11794, USA
| | - Z Ye
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G P Yeh
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yi
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Yin
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yip
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J Yoh
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yorita
- Waseda University, Tokyo 169, Japan
| | - T Yoshida
- Osaka City University, Osaka 558-8585, Japan
| | - S W Youn
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G B Yu
- Duke University, Durham, North Carolina 27708, USA
| | - I Yu
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - J M Yu
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A M Zanetti
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - Y Zeng
- Duke University, Durham, North Carolina 27708, USA
| | - J Zennamo
- State University of New York, Buffalo, New York 14260, USA
| | - T G Zhao
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - B Zhou
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - C Zhou
- Duke University, Durham, North Carolina 27708, USA
| | - J Zhu
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - M Zielinski
- University of Rochester, Rochester, New York 14627, USA
| | - D Zieminska
- Indiana University, Bloomington, Indiana 47405, USA
| | - L Zivkovic
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, F-75005 Paris, France
| | - S Zucchelli
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| |
Collapse
|
43
|
Aaltonen T, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Appel J, Arisawa T, Artikov A, Asaadi J, Ashmanskas W, Auerbach B, Aurisano A, Azfar F, Badgett W, Bae T, Barbaro-Galtieri A, Barnes V, Barnett B, Barria P, Bartos P, Bauce M, Bedeschi F, Behari S, Bellettini G, Bellinger J, Benjamin D, Beretvas A, Bhatti A, Bland K, Blumenfeld B, Bocci A, Bodek A, Bortoletto D, Boudreau J, Boveia A, Brigliadori L, Bromberg C, Brucken E, Budagov J, Budd H, Burkett K, Busetto G, Bussey P, Butti P, Buzatu A, Calamba A, Camarda S, Campanelli M, Canelli F, Carls B, Carlsmith D, Carosi R, Carrillo S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavaliere V, Cavalli-Sforza M, Cerri A, Cerrito L, Chen Y, Chertok M, Chiarelli G, Chlachidze G, Cho K, Chokheli D, Clark A, Clarke C, Convery M, Conway J, Corbo M, Cordelli M, Cox C, Cox D, Cremonesi M, Cruz D, Cuevas J, Culbertson R, d’Ascenzo N, Datta M, De Barbaro P, Demortier L, Deninno M, Devoto F, d’Errico M, Di Canto A, Di Ruzza B, Dittmann J, D’Onofrio M, Donati S, Dorigo M, Driutti A, Ebina K, Edgar R, Elagin A, Erbacher R, Errede S, Esham B, Eusebi R, Farrington S, Fernández Ramos J, Field R, Flanagan G, Forrest R, Franklin M, Freeman J, Frisch H, Funakoshi Y, Garfinkel A, Garosi P, Gerberich H, Gerchtein E, Giagu S, Giakoumopoulou V, Gibson K, Ginsburg C, Giokaris N, Giromini P, Giurgiu G, Glagolev V, Glenzinski D, Gold M, Goldin D, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González López O, Gorelov I, Goshaw A, Goulianos K, Gramellini E, Grinstein S, Grosso-Pilcher C, Group R, Guimaraes da Costa J, Hahn S, Han J, Happacher F, Hara K, Hare M, Harr R, Harrington-Taber T, Hatakeyama K, Hays C, Heinrich J, Herndon M, Hocker A, Hong Z, Hopkins W, Hou S, Hughes R, Husemann U, Huston J, Introzzi G, Iori M, Ivanov A, James E, Jang D, Jayatilaka B, Jeon E, Jindariani S, Jones M, Joo K, Jun S, Junk T, Kambeitz M, Kamon T, Karchin P, Kasmi A, Kato Y, Ketchum W, Keung J, Kilminster B, Kim D, Kim H, Kim J, Kim M, Kim S, Kim S, Kim Y, Kim Y, Kimura N, Kirby M, Knoepfel K, Kondo K, Kong D, Konigsberg J, Kotwal A, Kreps M, Kroll J, Kruse M, Kuhr T, Kurata M, Laasanen A, Lammel S, Lancaster M, Lannon K, Latino G, Lee H, Lee J, Leone S, Lewis J, Limosani A, Lipeles E, Liu H, Liu Q, Liu T, Lockwitz S, Loginov A, Lucchesi D, Lueck J, Lujan P, Lukens P, Lungu G, Lys J, Lysak R, Madrak R, Maestro P, Malik S, Manca G, Manousakis-Katsikakis A, Margaroli F, Marino P, Martínez M, Matera K, Mattson M, Mazzacane A, Mazzanti P, McNulty R, Mehta A, Mehtala P, Mesropian C, Miao T, Mietlicki D, Mitra A, Miyake H, Moed S, Moggi N, Moon C, Moore R, Morello M, Mukherjee A, Muller T, Murat P, Mussini M, Nachtman J, Nagai Y, Naganoma J, Nakano I, Napier A, Nett J, Neu C, Nigmanov T, Nodulman L, Noh S, Norniella O, Oakes L, Oh S, Oh Y, Oksuzian I, Okusawa T, Orava R, Ortolan L, Pagliarone C, Palencia E, Palni P, Papadimitriou V, Parker W, Pauletta G, Paulini M, Paus C, Phillips T, Piacentino G, Pianori E, Pilot J, Pitts K, Plager C, Pondrom L, Poprocki S, Potamianos K, Prokoshin F, Pranko A, Ptohos F, Punzi G, Ranjan N, Redondo Fernández I, Renton P, Rescigno M, Riddick T, Rimondi F, Ristori L, Robson A, Rodriguez T, Rolli S, Ronzani M, Roser R, Rosner J, Ruffini F, Ruiz A, Russ J, Rusu V, Safonov A, Sakumoto W, Sakurai Y, Santi L, Sato K, Saveliev V, Savoy-Navarro A, Schlabach P, Schmidt E, Schwarz T, Scodellaro L, Seidel S, Seiya Y, Semenov A, Sforza F, Shalhout S, Shears T, Shepard P, Shimojima M, Shochet M, Shreyber-Tecker I, Simonenko A, Sinervo P, Sliwa K, Smith J, Snider F, Sorin V, Song H, Stancari M, St. Denis R, Stelzer B, Stelzer-Chilton O, Stentz D, Strologas J, Sudo Y, Sukhanov A, Suslov I, Takemasa K, Takeuchi Y, Tang J, Tecchio M, Teng P, Thom J, Thomson E, Thukral V, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Totaro P, Trovato M, Ukegawa F, Uozumi S, Vázquez F, Velev G, Vellidis C, Vernieri C, Vidal M, Vilar R, Vizán J, Vogel M, Volpi G, Wagner P, Wallny R, Wang S, Warburton A, Waters D, Wester W, Whiteson D, Wicklund A, Wilbur S, Williams H, Wilson J, Wilson P, Winer B, Wittich P, Wolbers S, Wolfe H, Wright T, Wu X, Wu Z, Yamamoto K, Yamato D, Yang T, Yang U, Yang Y, Yao WM, Yeh G, Yi K, Yoh J, Yorita K, Yoshida T, Yu G, Yu I, Zanetti A, Zeng Y, Zhou C, Zucchelli S. Measurement of the WWand WZproduction cross section using final states with a charged lepton and heavy-flavor jets in the full CDF Run II data set. Int J Clin Exp Med 2016. [DOI: 10.1103/physrevd.94.032008] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
44
|
Lemley KV, Faul C, Schramm K, Meyers K, Kaskel F, Dell KM, Gipson DS, Gibson K, Trachtman H. The Effect of a Gluten-Free Diet in Children With Difficult-to-Manage Nephrotic Syndrome. Pediatrics 2016; 138:peds.2015-4528. [PMID: 27338701 PMCID: PMC4983765 DOI: 10.1542/peds.2015-4528] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/27/2016] [Indexed: 12/18/2022] Open
Abstract
Case reports have linked childhood nephrotic syndrome to food sensitivity, including gluten. We report our experience with 8 children (6 boys, 2 girls; age at implementation of special diet 2-14 years) with difficult-to-manage nephrotic syndrome who were placed on a gluten-free diet for 3.4 ± 4.3 years (range, 0.6-14 years) and who had clinical improvement enabling reduction or discontinuation in steroid dosage.
Collapse
Affiliation(s)
- Kevin V. Lemley
- Division of Nephrology, Children’s Hospital Los Angeles, Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, California
| | - Christian Faul
- Division of Nephrology and Hypertension, Department of Medicine and Department of Cell Biology and Anatomy, University of Miami Leonard M. Miller School of Medicine, Miami, Florida
| | - Karla Schramm
- Division of Nephrology and Hypertension, Department of Medicine and Department of Cell Biology and Anatomy, University of Miami Leonard M. Miller School of Medicine, Miami, Florida
| | - Kevin Meyers
- Division of Nephrology, Department of Pediatrics, Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
| | - Frederick Kaskel
- Division of Nephrology, Department of Pediatrics, Children’s Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York
| | - Katherine M. Dell
- Center for Pediatric Nephrology, Department of Pediatrics, Cleveland Clinic Children’s, Case Western Reserve University, Cleveland, Ohio
| | - Debbie S. Gipson
- Division of Nephrology, Department of Pediatrics, CS Mott Children’s Hospital, University of Michigan, Ann Arbor, Michigan
| | - Keisha Gibson
- Division of Nephrology, Department of Medicine and Pediatrics, University of North Carolina, Chapel Hill, North Carolina;and
| | - Howard Trachtman
- Division of Nephrology, Department of Pediatrics, NYU Langone Medical Center, NYU School of Medicine, New York, New York
| |
Collapse
|
45
|
Aaltonen T, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Appel J, Arisawa T, Artikov A, Asaadi J, Ashmanskas W, Auerbach B, Aurisano A, Azfar F, Badgett W, Bae T, Barbaro-Galtieri A, Barnes V, Barnett B, Barria P, Bartos P, Bauce M, Bedeschi F, Behari S, Bellettini G, Bellinger J, Benjamin D, Beretvas A, Bhatti A, Bland K, Blumenfeld B, Bocci A, Bodek A, Bortoletto D, Boudreau J, Boveia A, Brigliadori L, Bromberg C, Brucken E, Budagov J, Budd H, Burkett K, Busetto G, Bussey P, Butti P, Buzatu A, Calamba A, Camarda S, Campanelli M, Canelli F, Carls B, Carlsmith D, Carosi R, Carrillo S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavaliere V, Cerri A, Cerrito L, Chen Y, Chertok M, Chiarelli G, Chlachidze G, Cho K, Chokheli D, Clark A, Clarke C, Convery M, Conway J, Corbo M, Cordelli M, Cox C, Cox D, Cremonesi M, Cruz D, Cuevas J, Culbertson R, d’Ascenzo N, Datta M, de Barbaro P, Demortier L, Deninno M, D’Errico M, Devoto F, Di Canto A, Di Ruzza B, Dittmann J, Donati S, D’Onofrio M, Dorigo M, Driutti A, Ebina K, Edgar R, Erbacher R, Errede S, Esham B, Farrington S, Fernández Ramos J, Field R, Flanagan G, Forrest R, Franklin M, Freeman J, Frisch H, Funakoshi Y, Galloni C, Garfinkel A, Garosi P, Gerberich H, Gerchtein E, Giagu S, Giakoumopoulou V, Gibson K, Ginsburg C, Giokaris N, Giromini P, Glagolev V, Glenzinski D, Gold M, Goldin D, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González López O, Gorelov I, Goshaw A, Goulianos K, Gramellini E, Grosso-Pilcher C, Guimaraes da Costa J, Hahn S, Han J, Happacher F, Hara K, Hare M, Harr R, Harrington-Taber T, Hatakeyama K, Hays C, Heinrich J, Herndon M, Hocker A, Hong Z, Hopkins W, Hou S, Hughes R, Husemann U, Hussein M, Huston J, Introzzi G, Iori M, Ivanov A, James E, Jang D, Jayatilaka B, Jeon E, Jindariani S, Jones M, Joo K, Jun S, Junk T, Kambeitz M, Kamon T, Karchin P, Kasmi A, Kato Y, Ketchum W, Keung J, Kilminster B, Kim D, Kim H, Kim J, Kim M, Kim S, Kim S, Kim Y, Kim Y, Kimura N, Kirby M, Knoepfel K, Kondo K, Kong D, Konigsberg J, Kotwal A, Kreps M, Kroll J, Kruse M, Kuhr T, Kurata M, Laasanen A, Lammel S, Lancaster M, Lannon K, Latino G, Lee H, Lee J, Leo S, Leone S, Lewis J, Limosani A, Lipeles E, Lister A, Liu Q, Liu T, Lockwitz S, Loginov A, Lucchesi D, Lucà A, Lueck J, Lujan P, Lukens P, Lungu G, Lys J, Lysak R, Madrak R, Maestro P, Malik S, Manca G, Manousakis-Katsikakis A, Marchese L, Margaroli F, Marino P, Matera K, Mattson M, Mazzacane A, Mazzanti P, McNulty R, Mehta A, Mehtala P, Mesropian C, Miao T, Mietlicki D, Mitra A, Miyake H, Moed S, Moggi N, Moon C, Moore R, Morello M, Mukherjee A, Muller T, Murat P, Mussini M, Nachtman J, Nagai Y, Naganoma J, Nakano I, Napier A, Nett J, Nigmanov T, Nodulman L, Noh S, Norniella O, Oakes L, Oh S, Oh Y, Okusawa T, Orava R, Ortolan L, Pagliarone C, Palencia E, Palni P, Papadimitriou V, Parker W, Pauletta G, Paulini M, Paus C, Phillips T, Piacentino G, Pianori E, Pilot J, Pitts K, Plager C, Pondrom L, Poprocki S, Potamianos K, Pranko A, Prokoshin F, Ptohos F, Punzi G, Redondo Fernández I, Renton P, Rescigno M, Rimondi F, Ristori L, Robson A, Rodriguez T, Rolli S, Ronzani M, Roser R, Rosner J, Ruffini F, Ruiz A, Russ J, Rusu V, Sakumoto W, Sakurai Y, Santi L, Sato K, Saveliev V, Savoy-Navarro A, Schlabach P, Schmidt E, Schwarz T, Scodellaro L, Scuri F, Seidel S, Seiya Y, Semenov A, Sforza F, Shalhout S, Shears T, Shepard P, Shimojima M, Shochet M, Shreyber-Tecker I, Simonenko A, Sliwa K, Smith J, Snider F, Song H, Sorin V, St. Denis R, Stancari M, Stentz D, Strologas J, Sudo Y, Sukhanov A, Suslov I, Takemasa K, Takeuchi Y, Tang J, Tecchio M, Teng P, Thom J, Thomson E, Thukral V, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Totaro P, Trovato M, Ukegawa F, Uozumi S, Vázquez F, Velev G, Vellidis C, Vernieri C, Vidal M, Vilar R, Vizán J, Vogel M, Volpi G, Wagner P, Wallny R, Wang S, Waters D, Wester W, Whiteson D, Wicklund A, Wilbur S, Williams H, Wilson J, Wilson P, Winer B, Wittich P, Wolbers S, Wolfe H, Wright T, Wu X, Wu Z, Yamamoto K, Yamato D, Yang T, Yang U, Yang Y, Yao WM, Yeh G, Yi K, Yoh J, Yorita K, Yoshida T, Yu G, Yu I, Zanetti A, Zeng Y, Zhou C, Zucchelli S. Search for a low-mass neutral Higgs boson with suppressed couplings to fermions using events with multiphoton final states. Int J Clin Exp Med 2016. [DOI: 10.1103/physrevd.93.112010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
46
|
Gibson K, Chua J, Castrejon I, Pincus T. SAT0588 MDHAQ as A Useful Screening Tool for fibromyalgia in Busy Clinical Settings: Table 1. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.6046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
47
|
Abstract
Chronic pelvic pain accounts for approximately 10% of outpatient gynecologic visits and among the varied causes, pelvic congestion syndrome is second only to endometriosis in frequency. Manifestations may include pelvic pain, dyspareunia, dysuria, and dysmenorrhea as well as external varices and a number of psychosocial symptoms. Although a variety of treatments have been proposed-including pharmacologic ovarian suppression, hysterectomy with or without oophorectomy, and ovarian vein resection-transcatheter embolization is the least invasive and most efficacious management option. Complete or partial symptom improvement has been reported in 68.2-100% of patients and there has been a consistent reduction in visual analog pain scores after treatment. Based upon these results, recommendation of either pharmacotherapy or other surgical procedures is difficult to justify. However, it is also clear that 6-31.8% of patients do not get substantial relief from pelvic venous embolization. Potential explanations for an inadequate response to treatment include patient variability, procedural variability, and inadequate outcome measures. The latter are particularly important and future investigation should focus on the development of disease-specific quality of life measures as well as identifying those aspects of the procedure, such as choice of embolic agents and extent of embolization, associated with the best clinical outcomes.
Collapse
Affiliation(s)
- M H Meissner
- Division of Vascular Surgery, Department of Surgery, University of Washington, Seattle, USA
| | - K Gibson
- Lake Washington Vascular Surgeons, Bellevue, USA
| |
Collapse
|
48
|
Ferris M, Gibson K, Plattner B, Gipson DS, Kotanko P, Marcelli D, Marelli C, Etter M, Carioni P, von Gersdorff G, Xu X, Kooman JP, Xiao Q, van der Sande FM, Power A, Picoits-Filho R, Sylvestre L, Westreich K, Usvyat L. Hemodialysis outcomes in a global sample of children and young adult hemodialysis patients: the PICCOLO MONDO cohort. Clin Kidney J 2016; 9:295-302. [PMID: 26985383 PMCID: PMC4792628 DOI: 10.1093/ckj/sfv157] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2015] [Accepted: 12/30/2015] [Indexed: 01/14/2023] Open
Abstract
BACKGROUND The aim of this study was to describe the experience of pediatric and young adult hemodialysis (HD) patients from a global cohort. METHODS The Pediatric Investigation and Close Collaborative Consortium for Ongoing Life Outcomes for MONitoring Dialysis Outcomes (PICCOLO MONDO) study provided de-identified electronic information of 3244 patients, ages 0-30 years from 2000 to 2012 in four regions: Asia, Europe, North America and South America. The study sample was categorized into pediatric (≤18 years old) and young adult (19-30 years old) groups based on the age at dialysis initiation. RESULTS For those with known end-stage renal disease etiology, glomerular disease was the most common diagnosis in children and young adults. Using Europe as a reference group, North America [odds ratio (OR) 2.69; CI 1.29, 5.63] and South America (OR 4.21; CI 2.32, 7.63) had the greatest mortality among young adults. North America also had higher rates of overweight, obesity, hypertension, cardiovascular disease, hospitalizations and secondary diabetes compared with all other regions. Initial catheter use was greater for North American (86.4% in pediatric patients and 75.2% in young adults) and South America (80.6% in pediatric patients and 75.9% in young adults). Catheter use at 1-year follow-up was most common in North American children (77.3%) and young adults (62.9%). Asia had the lowest rate of catheter use. For both age groups, dialysis adequacy (equilibrated Kt/V) ranged between 1.4 and 1.5. In Asia, patients in both age groups had significantly longer treatment times than in any other region. CONCLUSIONS The PICCOLO MONDO study has provided unique baseline and 1-year follow-up information on children and young adults receiving HD around the globe. This cohort has brought to light aspects of care in these age groups that warrant further investigation.
Collapse
Affiliation(s)
- Maria Ferris
- University of North Carolina at Chapel Hill Kidney Center , Chapel Hill, NC , USA
| | - Keisha Gibson
- University of North Carolina at Chapel Hill Kidney Center , Chapel Hill, NC , USA
| | - Brett Plattner
- University of Michigan at Ann Arbor , Ann Arbor, MI , USA
| | | | - Peter Kotanko
- Renal Research Institute, New York, NY, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Daniele Marcelli
- Fresenius Medical Care, Bad Homburg, Germany; Danube University, Krems, Austria
| | | | - Michael Etter
- Fresenius Medical Care Asia Pacific , Hong Kong , China
| | | | - Gero von Gersdorff
- Kuratorium für Dialyse und Nierentransplantation e.V., Neu-Isenburg, Germany; University of Cologne Medical Center, Cologne, Germany
| | - Xiaoqi Xu
- Fresenius Medical Care Asia Pacific , Hong Kong , China
| | - Jeroen P Kooman
- Maastricht University Medical Center , Maastricht , The Netherlands
| | | | | | | | | | | | - Katherine Westreich
- University of North Carolina at Chapel Hill Kidney Center , Chapel Hill, NC , USA
| | - Len Usvyat
- Renal Research Institute, New York, NY, USA; Fresenius Medical Care North America, Waltham, MA, USA
| |
Collapse
|
49
|
Aaltonen T, Albrow M, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Appel J, Arisawa T, Artikov A, Asaadi J, Ashmanskas W, Auerbach B, Aurisano A, Azfar F, Badgett W, Bae T, Barbaro-Galtieri A, Barnes V, Barnett B, Barria P, Bartos P, Bauce M, Bedeschi F, Behari S, Bellettini G, Bellinger J, Benjamin D, Beretvas A, Bhatti A, Bland K, Blumenfeld B, Bocci A, Bodek A, Bortoletto D, Boudreau J, Boveia A, Brigliadori L, Bromberg C, Brucken E, Budagov J, Budd H, Burkett K, Busetto G, Bussey P, Butti P, Buzatu A, Calamba A, Camarda S, Campanelli M, Canelli F, Carls B, Carlsmith D, Carosi R, Carrillo S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavaliere V, Cerri A, Cerrito L, Chen Y, Chertok M, Chiarelli G, Chlachidze G, Cho K, Chokheli D, Clark A, Clarke C, Convery M, Conway J, Corbo M, Cordelli M, Cox C, Cox D, Cremonesi M, Cruz D, Cuevas J, Culbertson R, d’Ascenzo N, Datta M, de Barbaro P, Demortier L, Deninno M, D’Errico M, Devoto F, Di Canto A, Di Ruzza B, Dittmann J, Donati S, D’Onofrio M, Dorigo M, Driutti A, Ebina K, Edgar R, Elagin A, Erbacher R, Errede S, Esham B, Farrington S, Fernández Ramos J, Field R, Flanagan G, Forrest R, Franklin M, Freeman J, Frisch H, Funakoshi Y, Galloni C, Garfinkel A, Garosi P, Gerberich H, Gerchtein E, Giagu S, Giakoumopoulou V, Gibson K, Ginsburg C, Giokaris N, Giromini P, Glagolev V, Glenzinski D, Gold M, Goldin D, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González López O, Gorelov I, Goshaw A, Goulianos K, Gramellini E, Grosso-Pilcher C, Group R, Guimaraes da Costa J, Hahn S, Han J, Happacher F, Hara K, Hare M, Harr R, Harrington-Taber T, Hatakeyama K, Hays C, Heinrich J, Herndon M, Hocker A, Hong Z, Hopkins W, Hou S, Hughes R, Husemann U, Hussein M, Huston J, Introzzi G, Iori M, Ivanov A, James E, Jang D, Jayatilaka B, Jeon E, Jindariani S, Jones M, Joo K, Jun S, Junk T, Kambeitz M, Kamon T, Karchin P, Kasmi A, Kato Y, Ketchum W, Keung J, Kilminster B, Kim D, Kim H, Kim J, Kim M, Kim S, Kim S, Kim Y, Kim Y, Kimura N, Kirby M, Knoepfel K, Kondo K, Kong D, Konigsberg J, Kotwal A, Kreps M, Kroll J, Kruse M, Kuhr T, Kurata M, Laasanen A, Lammel S, Lancaster M, Lannon K, Latino G, Lee H, Lee J, Leo S, Leone S, Lewis J, Limosani A, Lipeles E, Lister A, Liu H, Liu Q, Liu T, Lockwitz S, Loginov A, Lucchesi D, Lucá A, Lueck J, Lujan P, Lukens P, Lungu G, Lys J, Lysak R, Madrak R, Maestro P, Malik S, Manca G, Manousakis-Katsikakis A, Marchese L, Margaroli F, Marino P, Matera K, Mattson M, Mazzacane A, Mazzanti P, McNulty R, Mehta A, Mehtala P, Mesropian C, Miao T, Mietlicki D, Mitra A, Miyake H, Moed S, Moggi N, Moon C, Moore R, Morello M, Mukherjee A, Muller T, Murat P, Mussini M, Nachtman J, Nagai Y, Naganoma J, Nakano I, Napier A, Nett J, Neu C, Nigmanov T, Nodulman L, Noh S, Norniella O, Oakes L, Oh S, Oh Y, Oksuzian I, Okusawa T, Orava R, Ortolan L, Pagliarone C, Palencia E, Palni P, Papadimitriou V, Parker W, Pauletta G, Paulini M, Paus C, Phillips T, Piacentino G, Pianori E, Pilot J, Pitts K, Plager C, Pondrom L, Poprocki S, Potamianos K, Pranko A, Prokoshin F, Ptohos F, Punzi G, Redondo Fernández I, Renton P, Rescigno M, Rimondi F, Ristori L, Robson A, Rodriguez T, Rolli S, Ronzani M, Roser R, Rosner J, Ruffini F, Ruiz A, Russ J, Rusu V, Sakumoto W, Sakurai Y, Santi L, Sato K, Saveliev V, Savoy-Navarro A, Schlabach P, Schmidt E, Schwarz T, Scodellaro L, Scuri F, Seidel S, Seiya Y, Semenov A, Sforza F, Shalhout S, Shears T, Shepard P, Shimojima M, Shochet M, Shreyber-Tecker I, Simonenko A, Sliwa K, Smith J, Snider F, Song H, Sorin V, St. Denis R, Stancari M, Stentz D, Strologas J, Sudo Y, Sukhanov A, Suslov I, Takemasa K, Takeuchi Y, Tang J, Tecchio M, Teng P, Thom J, Thomson E, Thukral V, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Totaro P, Trovato M, Ukegawa F, Uozumi S, Vázquez F, Velev G, Vellidis C, Vernieri C, Vidal M, Vilar R, Vizán J, Vogel M, Volpi G, Wagner P, Wallny R, Wang S, Waters D, Wester W, Whiteson D, Wicklund A, Wilbur S, Williams H, Wilson J, Wilson P, Winer B, Wittich P, Wolbers S, Wolfe H, Wright T, Wu X, Wu Z, Yamamoto K, Yamato D, Yang T, Yang U, Yang Y, Yao WM, Yeh G, Yi K, Yoh J, Yorita K, Yoshida T, Yu G, Yu I, Zanetti A, Zeng Y, Zhou C, Zucchelli S. Study of the energy dependence of the underlying event in proton-antiproton collisions. Int J Clin Exp Med 2015. [DOI: 10.1103/physrevd.92.092009] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
50
|
Aaltonen T, Abazov VM, Abbott B, Acharya BS, Adams M, Adams T, Agnew JP, Alexeev GD, Alkhazov G, Alton A, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Appel JA, Arisawa T, Artikov A, Asaadi J, Ashmanskas W, Askew A, Atkins S, Auerbach B, Augsten K, Aurisano A, Avila C, Azfar F, Badaud F, Badgett W, Bae T, Bagby L, Baldin B, Bandurin DV, Banerjee S, Barbaro-Galtieri A, Barberis E, Baringer P, Barnes VE, Barnett BA, Barria P, Bartlett JF, Bartos P, Bassler U, Bauce M, Bazterra V, Bean A, Bedeschi F, Begalli M, Behari S, Bellantoni L, Bellettini G, Bellinger J, Benjamin D, Beretvas A, Beri SB, Bernardi G, Bernhard R, Bertram I, Besançon M, Beuselinck R, Bhat PC, Bhatia S, Bhatnagar V, Bhatti A, Bland KR, Blazey G, Blessing S, Bloom K, Blumenfeld B, Bocci A, Bodek A, Boehnlein A, Boline D, Boos EE, Borissov G, Bortoletto D, Borysova M, Boudreau J, Boveia A, Brandt A, Brandt O, Brigliadori L, Brock R, Bromberg C, Bross A, Brown D, Brucken E, Bu XB, Budagov J, Budd HS, Buehler M, Buescher V, Bunichev V, Burdin S, Burkett K, Busetto G, Bussey P, Buszello CP, Butti P, Buzatu A, Calamba A, Camacho-Pérez E, Camarda S, Campanelli M, Canelli F, Carls B, Carlsmith D, Carosi R, Carrillo S, Casal B, Casarsa M, Casey BCK, Castilla-Valdez H, Castro A, Catastini P, Caughron S, Cauz D, Cavaliere V, Cerri A, Cerrito L, Chakrabarti S, Chan KM, Chandra A, Chapon E, Chen G, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Cho K, Cho SW, Choi S, Chokheli D, Choudhary B, Cihangir S, Claes D, Clark A, Clarke C, Clutter J, Convery ME, Conway J, Cooke M, Cooper WE, Corbo M, Corcoran M, Cordelli M, Couderc F, Cousinou MC, Cox CA, Cox DJ, Cremonesi M, Cruz D, Cuevas J, Culbertson R, Cutts D, Das A, d'Ascenzo N, Datta M, Davies G, de Barbaro P, de Jong SJ, De La Cruz-Burelo E, Déliot F, Demina R, Demortier L, Deninno M, Denisov D, Denisov SP, D'Errico M, Desai S, Deterre C, DeVaughan K, Devoto F, Di Canto A, Di Ruzza B, Diehl HT, Diesburg M, Ding PF, Dittmann JR, Dominguez A, Donati S, D'Onofrio M, Dorigo M, Driutti A, Dubey A, Dudko LV, Duperrin A, Dutt S, Eads M, Ebina K, Edgar R, Edmunds D, Elagin A, Ellison J, Elvira VD, Enari Y, Erbacher R, Errede S, Esham B, Evans H, Evdokimov A, Evdokimov VN, Farrington S, Fauré A, Feng L, Ferbel T, Fernández Ramos JP, Fiedler F, Field R, Filthaut F, Fisher W, Fisk HE, Flanagan G, Forrest R, Fortner M, Fox H, Franklin M, Freeman JC, Frisch H, Fuess S, Funakoshi Y, Galloni C, Garbincius PH, Garcia-Bellido A, García-González JA, Garfinkel AF, Garosi P, Gavrilov V, Geng W, Gerber CE, Gerberich H, Gerchtein E, Gershtein Y, Giagu S, Giakoumopoulou V, Gibson K, Ginsburg CM, Ginther G, Giokaris N, Giromini P, Glagolev V, Glenzinski D, Gogota O, Gold M, Goldin D, Golossanov A, Golovanov G, Gomez G, Gomez-Ceballos G, Goncharov M, González López O, Gorelov I, Goshaw AT, Goulianos K, Gramellini E, Grannis PD, Greder S, Greenlee H, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grosso-Pilcher C, Group RC, Grünendahl S, Grünewald MW, Guillemin T, Guimaraes da Costa J, Gutierrez G, Gutierrez P, Hahn SR, Haley J, Han JY, Han L, Happacher F, Hara K, Harder K, Hare M, Harel A, Harr RF, Harrington-Taber T, Hatakeyama K, Hauptman JM, Hays C, Hays J, Head T, Hebbeker T, Hedin D, Hegab H, Heinrich J, Heinson AP, Heintz U, Hensel C, Heredia-De La Cruz I, Herndon M, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hoang T, Hobbs JD, Hocker A, Hoeneisen B, Hogan J, Hohlfeld M, Holzbauer JL, Hong Z, Hopkins W, Hou S, Howley I, Hubacek Z, Hughes RE, Husemann U, Hussein M, Huston J, Hynek V, Iashvili I, Ilchenko Y, Illingworth R, Introzzi G, Iori M, Ito AS, Ivanov A, Jabeen S, Jaffré M, James E, Jang D, Jayasinghe A, Jayatilaka B, Jeon EJ, Jeong MS, Jesik R, Jiang P, Jindariani S, Johns K, Johnson E, Johnson M, Jonckheere A, Jones M, Jonsson P, Joo KK, Joshi J, Jun SY, Jung AW, Junk TR, Juste A, Kajfasz E, Kambeitz M, Kamon T, Karchin PE, Karmanov D, Kasmi A, Kato Y, Katsanos I, Kaur M, Kehoe R, Kermiche S, Ketchum W, Keung J, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YN, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SH, Kim SB, Kim YJ, Kim YK, Kimura N, Kirby M, Kiselevich I, Knoepfel K, Kohli JM, Kondo K, Kong DJ, Konigsberg J, Kotwal AV, Kozelov AV, Kraus J, Kreps M, Kroll J, Kruse M, Kuhr T, Kumar A, Kupco A, Kurata M, Kurča T, Kuzmin VA, Laasanen AT, Lammel S, Lammers S, Lancaster M, Lannon K, Latino G, Lebrun P, Lee HS, Lee HS, Lee JS, Lee SW, Lee WM, Lei X, Lellouch J, Leo S, Leone S, Lewis JD, Li D, Li H, Li L, Li QZ, Lim JK, Limosani A, Lincoln D, Linnemann J, Lipaev VV, Lipeles E, Lipton R, Lister A, Liu H, Liu H, Liu Q, Liu T, Liu Y, Lobodenko A, Lockwitz S, Loginov A, Lokajicek M, Lopes de Sa R, Lucchesi D, Lucà A, Lueck J, Lujan P, Lukens P, Luna-Garcia R, Lungu G, Lyon AL, Lys J, Lysak R, Maciel AKA, Madar R, Madrak R, Maestro P, Magaña-Villalba R, Malik S, Malik S, Malyshev VL, Manca G, Manousakis-Katsikakis A, Mansour J, Marchese L, Margaroli F, Marino P, Martínez-Ortega J, Matera K, Mattson ME, Mazzacane A, Mazzanti P, McCarthy R, McGivern CL, McNulty R, Mehta A, Mehtala P, Meijer MM, Melnitchouk A, Menezes D, Mercadante PG, Merkin M, Mesropian C, Meyer A, Meyer J, Miao T, Miconi F, Mietlicki D, Mitra A, Miyake H, Moed S, Moggi N, Mondal NK, Moon CS, Moore R, Morello MJ, Mukherjee A, Mulhearn M, Muller T, Murat P, Mussini M, Nachtman J, Nagai Y, Naganoma J, Nagy E, Nakano I, Napier A, Narain M, Nayyar R, Neal HA, Negret JP, Nett J, Neu C, Neustroev P, Nguyen HT, Nigmanov T, Nodulman L, Noh SY, Norniella O, Nunnemann T, Oakes L, Oh SH, Oh YD, Oksuzian I, Okusawa T, Orava R, Orduna J, Ortolan L, Osman N, Osta J, Pagliarone C, Pal A, Palencia E, Palni P, Papadimitriou V, Parashar N, Parihar V, Park SK, Parker W, Partridge R, Parua N, Patwa A, Pauletta G, Paulini M, Paus C, Penning B, Perfilov M, Peters Y, Petridis K, Petrillo G, Pétroff P, Phillips TJ, Piacentino G, Pianori E, Pilot J, Pitts K, Plager C, Pleier MA, Podstavkov VM, Pondrom L, Popov AV, Poprocki S, Potamianos K, Pranko A, Prewitt M, Price D, Prokopenko N, Prokoshin F, Ptohos F, Punzi G, Qian J, Quadt A, Quinn B, Ratoff PN, Razumov I, Redondo Fernández I, Renton P, Rescigno M, Rimondi F, Ripp-Baudot I, Ristori L, Rizatdinova F, Robson A, Rodriguez T, Rolli S, Rominsky M, Ronzani M, Roser R, Rosner JL, Ross A, Royon C, Rubinov P, Ruchti R, Ruffini F, Ruiz A, Russ J, Rusu V, Sajot G, Sakumoto WK, Sakurai Y, Sánchez-Hernández A, Sanders MP, Santi L, Santos AS, Sato K, Savage G, Saveliev V, Savitskyi M, Savoy-Navarro A, Sawyer L, Scanlon T, Schamberger RD, Scheglov Y, Schellman H, Schlabach P, Schmidt EE, Schwanenberger C, Schwarz T, Schwienhorst R, Scodellaro L, Scuri F, Seidel S, Seiya Y, Sekaric J, Semenov A, Severini H, Sforza F, Shabalina E, Shalhout SZ, Shary V, Shaw S, Shchukin AA, Shears T, Shepard PF, Shimojima M, Shochet M, Shreyber-Tecker I, Simak V, Simonenko A, Skubic P, Slattery P, Sliwa K, Smirnov D, Smith JR, Snider FD, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Song H, Sonnenschein L, Sorin V, Soustruznik K, St Denis R, Stancari M, Stark J, Stentz D, Stoyanova DA, Strauss M, Strologas J, Sudo Y, Sukhanov A, Suslov I, Suter L, Svoisky P, Takemasa K, Takeuchi Y, Tang J, Tecchio M, Teng PK, Thom J, Thomson E, Thukral V, Titov M, Toback D, Tokar S, Tokmenin VV, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Totaro P, Trovato M, Tsai YT, Tsybychev D, Tuchming B, Tully C, Ukegawa F, Uozumi S, Uvarov L, Uvarov S, Uzunyan S, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vasilyev IA, Vázquez F, Velev G, Vellidis C, Verkheev AY, Vernieri C, Vertogradov LS, Verzocchi M, Vesterinen M, Vidal M, Vilanova D, Vilar R, Vizán J, Vogel M, Vokac P, Volpi G, Wagner P, Wahl HD, Wallny R, Wang MHLS, Wang SM, Warchol J, Waters D, Watts G, Wayne M, Weichert J, Welty-Rieger L, Wester WC, Whiteson D, Wicklund AB, Wilbur S, Williams HH, Williams MRJ, Wilson GW, Wilson JS, Wilson P, Winer BL, Wittich P, Wobisch M, Wolbers S, Wolfe H, Wood DR, Wright T, Wu X, Wu Z, Wyatt TR, Xie Y, Yamada R, Yamamoto K, Yamato D, Yang S, Yang T, Yang UK, Yang YC, Yao WM, Yasuda T, Yatsunenko YA, Ye W, Ye Z, Yeh GP, Yi K, Yin H, Yip K, Yoh J, Yorita K, Yoshida T, Youn SW, Yu GB, Yu I, Yu JM, Zanetti AM, Zeng Y, Zennamo J, Zhao TG, Zhou B, Zhou C, Zhu J, Zielinski M, Zieminska D, Zivkovic L, Zucchelli S. Tevatron Combination of Single-Top-Quark Cross Sections and Determination of the Magnitude of the Cabibbo-Kobayashi-Maskawa Matrix Element V_{tb}. Phys Rev Lett 2015; 115:152003. [PMID: 26550718 DOI: 10.1103/physrevlett.115.152003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/19/2015] [Indexed: 06/05/2023]
Abstract
We present the final combination of CDF and D0 measurements of cross sections for single-top-quark production in proton-antiproton collisions at a center-of-mass energy of 1.96 TeV. The data correspond to total integrated luminosities of up to 9.7 fb^{-1} per experiment. The t-channel cross section is measured to be σ_{t}=2.25_{-0.31}^{+0.29} pb. We also present the combinations of the two-dimensional measurements of the s- vs t-channel cross section. In addition, we give the combination of the s+t channel cross section measurement resulting in σ_{s+t}=3.30_{-0.40}^{+0.52} pb, without assuming the standard model value for the ratio σ_{s}/σ_{t}. The resulting value of the magnitude of the top-to-bottom quark coupling is |V_{tb}|=1.02_{-0.05}^{+0.06}, corresponding to |V_{tb}|>0.92 at the 95% C.L.
Collapse
Affiliation(s)
- T Aaltonen
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014 Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - V M Abazov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - B Abbott
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - B S Acharya
- Tata Institute of Fundamental Research, Mumbai, India
| | - M Adams
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - T Adams
- Florida State University, Tallahassee, Florida 32306, USA
| | - J P Agnew
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - G D Alexeev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - G Alkhazov
- Petersburg Nuclear Physics Institute, St. Petersburg, Russia
| | - A Alton
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - S Amerio
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - D Amidei
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Anastassov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Annovi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Antos
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - G Apollinari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J A Appel
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - A Artikov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - J Asaadi
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - W Ashmanskas
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Askew
- Florida State University, Tallahassee, Florida 32306, USA
| | - S Atkins
- Louisiana Tech University, Ruston, Louisiana 71272, USA
| | - B Auerbach
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - K Augsten
- Czech Technical University in Prague, Prague, Czech Republic
| | - A Aurisano
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - C Avila
- Universidad de los Andes, Bogotá, Colombia
| | - F Azfar
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - F Badaud
- LPC, Université Blaise Pascal, CNRS/IN2P3, Clermont, France
| | - W Badgett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - T Bae
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - L Bagby
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B Baldin
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D V Bandurin
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - S Banerjee
- Tata Institute of Fundamental Research, Mumbai, India
| | - A Barbaro-Galtieri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - E Barberis
- Northeastern University, Boston, Massachusetts 02115, USA
| | - P Baringer
- University of Kansas, Lawrence, Kansas 66045, USA
| | - V E Barnes
- Purdue University, West Lafayette, Indiana 47907, USA
| | - B A Barnett
- The Johns Hopkins University, Baltimore, Maryland 21218, USA
| | - P Barria
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - J F Bartlett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Bartos
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | | | - M Bauce
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - V Bazterra
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - A Bean
- University of Kansas, Lawrence, Kansas 66045, USA
| | - F Bedeschi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - M Begalli
- Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil
| | - S Behari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - L Bellantoni
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Bellettini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - J Bellinger
- University of Wisconsin, Madison, Wisconsin 53706, USA
| | - D Benjamin
- Duke University, Durham, North Carolina 27708, USA
| | - A Beretvas
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S B Beri
- Panjab University, Chandigarh, India
| | - G Bernardi
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, Paris, France
| | - R Bernhard
- Physikalisches Institut, Universität Freiburg, Freiburg, Germany
| | - I Bertram
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | | | - R Beuselinck
- Imperial College London, London SW7 2AZ, United Kingdom
| | - P C Bhat
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Bhatia
- University of Mississippi, University, Mississippi 38677, USA
| | | | - A Bhatti
- The Rockefeller University, New York, New York 10065, USA
| | - K R Bland
- Baylor University, Waco, Texas 76798, USA
| | - G Blazey
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - S Blessing
- Florida State University, Tallahassee, Florida 32306, USA
| | - K Bloom
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - B Blumenfeld
- The Johns Hopkins University, Baltimore, Maryland 21218, USA
| | - A Bocci
- Duke University, Durham, North Carolina 27708, USA
| | - A Bodek
- University of Rochester, Rochester, New York 14627, USA
| | - A Boehnlein
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Boline
- State University of New York, Stony Brook, New York 11794, USA
| | - E E Boos
- Moscow State University, Moscow, Russia
| | - G Borissov
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - D Bortoletto
- Purdue University, West Lafayette, Indiana 47907, USA
| | - M Borysova
- Taras Shevchenko National University of Kyiv, Kiev, Ukraine
| | - J Boudreau
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - A Boveia
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - A Brandt
- University of Texas, Arlington, Texas 76019, USA
| | - O Brandt
- II. Physikalisches Institut, Georg-August-Universität Göttingen, Göttingen, Germany
| | - L Brigliadori
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - R Brock
- Michigan State University, East Lansing, Michigan 48824, USA
| | - C Bromberg
- Michigan State University, East Lansing, Michigan 48824, USA
| | - A Bross
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Brown
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, Paris, France
| | - E Brucken
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014 Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - X B Bu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Budagov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - H S Budd
- University of Rochester, Rochester, New York 14627, USA
| | - M Buehler
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - V Buescher
- Institut für Physik, Universität Mainz, Mainz, Germany
| | | | - S Burdin
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - K Burkett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Busetto
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - P Bussey
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | | | - P Butti
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - A Buzatu
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - A Calamba
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | | | - S Camarda
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193 Bellaterra (Barcelona), Spain
| | - M Campanelli
- University College London, London WC1E 6BT, United Kingdom
| | - F Canelli
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - B Carls
- University of Illinois, Urbana, Illinois 61801, USA
| | - D Carlsmith
- University of Wisconsin, Madison, Wisconsin 53706, USA
| | - R Carosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Carrillo
- University of Florida, Gainesville, Florida 32611, USA
| | - B Casal
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Casarsa
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - B C K Casey
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - A Castro
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - P Catastini
- Harvard University, Cambridge, Massachusetts 02138, USA
| | - S Caughron
- Michigan State University, East Lansing, Michigan 48824, USA
| | - D Cauz
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - V Cavaliere
- University of Illinois, Urbana, Illinois 61801, USA
| | - A Cerri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - L Cerrito
- University College London, London WC1E 6BT, United Kingdom
| | - S Chakrabarti
- State University of New York, Stony Brook, New York 11794, USA
| | - K M Chan
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - A Chandra
- Rice University, Houston, Texas 77005, USA
| | | | - G Chen
- University of Kansas, Lawrence, Kansas 66045, USA
| | - Y C Chen
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - M Chertok
- University of California, Davis, Davis, California 95616, USA
| | - G Chiarelli
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - G Chlachidze
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Cho
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - S W Cho
- Korea Detector Laboratory, Korea University, Seoul, Korea
| | - S Choi
- Korea Detector Laboratory, Korea University, Seoul, Korea
| | - D Chokheli
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | | | - S Cihangir
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Claes
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - A Clark
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - C Clarke
- Wayne State University, Detroit, Michigan 48201, USA
| | - J Clutter
- University of Kansas, Lawrence, Kansas 66045, USA
| | - M E Convery
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Conway
- University of California, Davis, Davis, California 95616, USA
| | - M Cooke
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - W E Cooper
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Corbo
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Corcoran
- Rice University, Houston, Texas 77005, USA
| | - M Cordelli
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | | | - M-C Cousinou
- CPPM, Aix-Marseille Université, CNRS/IN2P3, Marseille, France
| | - C A Cox
- University of California, Davis, Davis, California 95616, USA
| | - D J Cox
- University of California, Davis, Davis, California 95616, USA
| | - M Cremonesi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - D Cruz
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - J Cuevas
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - R Culbertson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Cutts
- Brown University, Providence, Rhode Island 02912, USA
| | - A Das
- Southern Methodist University, Dallas, Texas 75275, USA
| | - N d'Ascenzo
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Datta
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Davies
- Imperial College London, London SW7 2AZ, United Kingdom
| | - P de Barbaro
- University of Rochester, Rochester, New York 14627, USA
| | - S J de Jong
- Nikhef, Science Park, Amsterdam, Netherlands
- Radboud University Nijmegen, Nijmegen, Netherlands
| | | | | | - R Demina
- University of Rochester, Rochester, New York 14627, USA
| | - L Demortier
- The Rockefeller University, New York, New York 10065, USA
| | - M Deninno
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - D Denisov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S P Denisov
- Institute for High Energy Physics, Protvino, Russia
| | - M D'Errico
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - S Desai
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Deterre
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - K DeVaughan
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - F Devoto
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014 Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - A Di Canto
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - B Di Ruzza
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H T Diehl
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Diesburg
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P F Ding
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | | | - A Dominguez
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - S Donati
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - M D'Onofrio
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - M Dorigo
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- University of Trieste, I-34127 Trieste, Italy
| | - A Driutti
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - A Dubey
- Delhi University, Delhi, India
| | - L V Dudko
- Moscow State University, Moscow, Russia
| | - A Duperrin
- CPPM, Aix-Marseille Université, CNRS/IN2P3, Marseille, France
| | - S Dutt
- Panjab University, Chandigarh, India
| | - M Eads
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - K Ebina
- Waseda University, Tokyo 169, Japan
| | - R Edgar
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - D Edmunds
- Michigan State University, East Lansing, Michigan 48824, USA
| | - A Elagin
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - J Ellison
- University of California Riverside, Riverside, California 92521, USA
| | - V D Elvira
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Enari
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, Paris, France
| | - R Erbacher
- University of California, Davis, Davis, California 95616, USA
| | - S Errede
- University of Illinois, Urbana, Illinois 61801, USA
| | - B Esham
- University of Illinois, Urbana, Illinois 61801, USA
| | - H Evans
- Indiana University, Bloomington, Indiana 47405, USA
| | - A Evdokimov
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | | | - S Farrington
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - A Fauré
- CEA, Irfu, SPP, Saclay, France
| | - L Feng
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - T Ferbel
- University of Rochester, Rochester, New York 14627, USA
| | - J P Fernández Ramos
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - F Fiedler
- Institut für Physik, Universität Mainz, Mainz, Germany
| | - R Field
- University of Florida, Gainesville, Florida 32611, USA
| | - F Filthaut
- Nikhef, Science Park, Amsterdam, Netherlands
- Radboud University Nijmegen, Nijmegen, Netherlands
| | - W Fisher
- Michigan State University, East Lansing, Michigan 48824, USA
| | - H E Fisk
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Flanagan
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Forrest
- University of California, Davis, Davis, California 95616, USA
| | - M Fortner
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - H Fox
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - M Franklin
- Harvard University, Cambridge, Massachusetts 02138, USA
| | - J C Freeman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Frisch
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - S Fuess
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - C Galloni
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - P H Garbincius
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | | | - A F Garfinkel
- Purdue University, West Lafayette, Indiana 47907, USA
| | - P Garosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - V Gavrilov
- Institution for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - W Geng
- Michigan State University, East Lansing, Michigan 48824, USA
- CPPM, Aix-Marseille Université, CNRS/IN2P3, Marseille, France
| | - C E Gerber
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - H Gerberich
- University of Illinois, Urbana, Illinois 61801, USA
| | - E Gerchtein
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Gershtein
- Rutgers University, Piscataway, New Jersey 08855, USA
| | - S Giagu
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | | | - K Gibson
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - C M Ginsburg
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Ginther
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- University of Rochester, Rochester, New York 14627, USA
| | - N Giokaris
- University of Athens, 157 71 Athens, Greece
| | - P Giromini
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - V Glagolev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - D Glenzinski
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - O Gogota
- Taras Shevchenko National University of Kyiv, Kiev, Ukraine
| | - M Gold
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - D Goldin
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - A Golossanov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Golovanov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - G Gomez
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - G Gomez-Ceballos
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - M Goncharov
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - O González López
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - I Gorelov
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - A T Goshaw
- Duke University, Durham, North Carolina 27708, USA
| | - K Goulianos
- The Rockefeller University, New York, New York 10065, USA
| | - E Gramellini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - P D Grannis
- State University of New York, Stony Brook, New York 11794, USA
| | - S Greder
- IPHC, Université de Strasbourg, CNRS/IN2P3, Strasbourg, France
| | - H Greenlee
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Grenier
- IPNL, Université Lyon 1, CNRS/IN2P3, Villeurbanne, France and Université de Lyon, Lyon, France
| | - Ph Gris
- LPC, Université Blaise Pascal, CNRS/IN2P3, Clermont, France
| | - J-F Grivaz
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | | | - C Grosso-Pilcher
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - R C Group
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- University of Virginia, Charlottesville, Virginia 22906, USA
| | - S Grünendahl
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - T Guillemin
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | | | - G Gutierrez
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Gutierrez
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - S R Hahn
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Haley
- Oklahoma State University, Stillwater, Oklahoma 74078, USA
| | - J Y Han
- University of Rochester, Rochester, New York 14627, USA
| | - L Han
- University of Science and Technology of China, Hefei, People's Republic of China
| | - F Happacher
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - K Hara
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - K Harder
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - M Hare
- Tufts University, Medford, Massachusetts 02155, USA
| | - A Harel
- University of Rochester, Rochester, New York 14627, USA
| | - R F Harr
- Wayne State University, Detroit, Michigan 48201, USA
| | | | | | | | - C Hays
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - J Hays
- Imperial College London, London SW7 2AZ, United Kingdom
| | - T Head
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - T Hebbeker
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | - D Hedin
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - H Hegab
- Oklahoma State University, Stillwater, Oklahoma 74078, USA
| | - J Heinrich
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - A P Heinson
- University of California Riverside, Riverside, California 92521, USA
| | - U Heintz
- Brown University, Providence, Rhode Island 02912, USA
| | - C Hensel
- LAFEX, Centro Brasileiro de Pesquisas Físicas, Rio de Janeiro, Brazil
| | | | - M Herndon
- University of Wisconsin, Madison, Wisconsin 53706, USA
| | - K Herner
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Hesketh
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - M D Hildreth
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - R Hirosky
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - T Hoang
- Florida State University, Tallahassee, Florida 32306, USA
| | - J D Hobbs
- State University of New York, Stony Brook, New York 11794, USA
| | - A Hocker
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B Hoeneisen
- Universidad San Francisco de Quito, Quito, Ecuador
| | - J Hogan
- Rice University, Houston, Texas 77005, USA
| | - M Hohlfeld
- Institut für Physik, Universität Mainz, Mainz, Germany
| | - J L Holzbauer
- University of Mississippi, University, Mississippi 38677, USA
| | - Z Hong
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - W Hopkins
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Hou
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - I Howley
- University of Texas, Arlington, Texas 76019, USA
| | - Z Hubacek
- Czech Technical University in Prague, Prague, Czech Republic
- CEA, Irfu, SPP, Saclay, France
| | - R E Hughes
- The Ohio State University, Columbus, Ohio 43210, USA
| | - U Husemann
- Yale University, New Haven, Connecticut 06520, USA
| | - M Hussein
- Michigan State University, East Lansing, Michigan 48824, USA
| | - J Huston
- Michigan State University, East Lansing, Michigan 48824, USA
| | - V Hynek
- Czech Technical University in Prague, Prague, Czech Republic
| | - I Iashvili
- State University of New York, Buffalo, New York 14260, USA
| | - Y Ilchenko
- Southern Methodist University, Dallas, Texas 75275, USA
| | - R Illingworth
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Introzzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- INFN Pavia, I-27100 Pavia, Italy
- University of Pavia, I-27100 Pavia, Italy
| | - M Iori
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
- Sapienza Università di Roma, I-00185 Roma, Italy
| | - A S Ito
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Ivanov
- University of California, Davis, Davis, California 95616, USA
| | - S Jabeen
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Jaffré
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - E James
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Jang
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - A Jayasinghe
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - B Jayatilaka
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E J Jeon
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - M S Jeong
- Korea Detector Laboratory, Korea University, Seoul, Korea
| | - R Jesik
- Imperial College London, London SW7 2AZ, United Kingdom
| | - P Jiang
- University of Science and Technology of China, Hefei, People's Republic of China
| | - S Jindariani
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Johns
- University of Arizona, Tucson, Arizona 85721, USA
| | - E Johnson
- Michigan State University, East Lansing, Michigan 48824, USA
| | - M Johnson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Jonckheere
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Jones
- Purdue University, West Lafayette, Indiana 47907, USA
| | - P Jonsson
- Imperial College London, London SW7 2AZ, United Kingdom
| | - K K Joo
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - J Joshi
- University of California Riverside, Riverside, California 92521, USA
| | - S Y Jun
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - A W Jung
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - T R Junk
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Juste
- Institució Catalana de Recerca i Estudis Avançats (ICREA) and Institut de Física d'Altes Energies (IFAE), Barcelona, Spain
| | - E Kajfasz
- CPPM, Aix-Marseille Université, CNRS/IN2P3, Marseille, France
| | - M Kambeitz
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - T Kamon
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - P E Karchin
- Wayne State University, Detroit, Michigan 48201, USA
| | | | - A Kasmi
- Baylor University, Waco, Texas 76798, USA
| | - Y Kato
- Osaka City University, Osaka 558-8585, Japan
| | - I Katsanos
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - M Kaur
- Panjab University, Chandigarh, India
| | - R Kehoe
- Southern Methodist University, Dallas, Texas 75275, USA
| | - S Kermiche
- CPPM, Aix-Marseille Université, CNRS/IN2P3, Marseille, France
| | - W Ketchum
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - J Keung
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - N Khalatyan
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Khanov
- Oklahoma State University, Stillwater, Oklahoma 74078, USA
| | - A Kharchilava
- State University of New York, Buffalo, New York 14260, USA
| | - Y N Kharzheev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - B Kilminster
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D H Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - H S Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - J E Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - M J Kim
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - S H Kim
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S B Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - Y J Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - Y K Kim
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - N Kimura
- Waseda University, Tokyo 169, Japan
| | - M Kirby
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - I Kiselevich
- Institution for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - K Knoepfel
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J M Kohli
- Panjab University, Chandigarh, India
| | - K Kondo
- Waseda University, Tokyo 169, Japan
| | - D J Kong
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - J Konigsberg
- University of Florida, Gainesville, Florida 32611, USA
| | - A V Kotwal
- Duke University, Durham, North Carolina 27708, USA
| | - A V Kozelov
- Institute for High Energy Physics, Protvino, Russia
| | - J Kraus
- University of Mississippi, University, Mississippi 38677, USA
| | - M Kreps
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - J Kroll
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - M Kruse
- Duke University, Durham, North Carolina 27708, USA
| | - T Kuhr
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - A Kumar
- State University of New York, Buffalo, New York 14260, USA
| | - A Kupco
- Institute of Physics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - M Kurata
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - T Kurča
- IPNL, Université Lyon 1, CNRS/IN2P3, Villeurbanne, France and Université de Lyon, Lyon, France
| | | | - A T Laasanen
- Purdue University, West Lafayette, Indiana 47907, USA
| | - S Lammel
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Lammers
- Indiana University, Bloomington, Indiana 47405, USA
| | - M Lancaster
- University College London, London WC1E 6BT, United Kingdom
| | - K Lannon
- The Ohio State University, Columbus, Ohio 43210, USA
| | - G Latino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - P Lebrun
- IPNL, Université Lyon 1, CNRS/IN2P3, Villeurbanne, France and Université de Lyon, Lyon, France
| | - H S Lee
- Korea Detector Laboratory, Korea University, Seoul, Korea
| | - H S Lee
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - J S Lee
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - S W Lee
- Iowa State University, Ames, Iowa 50011, USA
| | - W M Lee
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - X Lei
- University of Arizona, Tucson, Arizona 85721, USA
| | - J Lellouch
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, Paris, France
| | - S Leo
- University of Illinois, Urbana, Illinois 61801, USA
| | - S Leone
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - J D Lewis
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Li
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, Paris, France
| | - H Li
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - L Li
- University of California Riverside, Riverside, California 92521, USA
| | - Q Z Li
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J K Lim
- Korea Detector Laboratory, Korea University, Seoul, Korea
| | - A Limosani
- Duke University, Durham, North Carolina 27708, USA
| | - D Lincoln
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Linnemann
- Michigan State University, East Lansing, Michigan 48824, USA
| | - V V Lipaev
- Institute for High Energy Physics, Protvino, Russia
| | - E Lipeles
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - R Lipton
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Lister
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - H Liu
- University of Virginia, Charlottesville, Virginia 22906, USA
| | - H Liu
- Southern Methodist University, Dallas, Texas 75275, USA
| | - Q Liu
- Purdue University, West Lafayette, Indiana 47907, USA
| | - T Liu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Liu
- University of Science and Technology of China, Hefei, People's Republic of China
| | - A Lobodenko
- Petersburg Nuclear Physics Institute, St. Petersburg, Russia
| | - S Lockwitz
- Yale University, New Haven, Connecticut 06520, USA
| | - A Loginov
- Yale University, New Haven, Connecticut 06520, USA
| | - M Lokajicek
- Institute of Physics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - R Lopes de Sa
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Lucchesi
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - A Lucà
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Lueck
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Lujan
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - P Lukens
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - G Lungu
- The Rockefeller University, New York, New York 10065, USA
| | - A L Lyon
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Lys
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R Lysak
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - A K A Maciel
- LAFEX, Centro Brasileiro de Pesquisas Físicas, Rio de Janeiro, Brazil
| | - R Madar
- Physikalisches Institut, Universität Freiburg, Freiburg, Germany
| | - R Madrak
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Maestro
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | | | - S Malik
- The Rockefeller University, New York, New York 10065, USA
| | - S Malik
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - V L Malyshev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - G Manca
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | | | - J Mansour
- II. Physikalisches Institut, Georg-August-Universität Göttingen, Göttingen, Germany
| | - L Marchese
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - F Margaroli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - P Marino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | | | - K Matera
- University of Illinois, Urbana, Illinois 61801, USA
| | - M E Mattson
- Wayne State University, Detroit, Michigan 48201, USA
| | - A Mazzacane
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Mazzanti
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - R McCarthy
- State University of New York, Stony Brook, New York 11794, USA
| | - C L McGivern
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - R McNulty
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - A Mehta
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - P Mehtala
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014 Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - M M Meijer
- Nikhef, Science Park, Amsterdam, Netherlands
- Radboud University Nijmegen, Nijmegen, Netherlands
| | - A Melnitchouk
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Menezes
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | | | - M Merkin
- Moscow State University, Moscow, Russia
| | - C Mesropian
- The Rockefeller University, New York, New York 10065, USA
| | - A Meyer
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | - J Meyer
- II. Physikalisches Institut, Georg-August-Universität Göttingen, Göttingen, Germany
| | - T Miao
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - F Miconi
- IPHC, Université de Strasbourg, CNRS/IN2P3, Strasbourg, France
| | - D Mietlicki
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Mitra
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - H Miyake
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Moed
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Moggi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - N K Mondal
- Tata Institute of Fundamental Research, Mumbai, India
| | - C S Moon
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Moore
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M J Morello
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - A Mukherjee
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Mulhearn
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - Th Muller
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Murat
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Mussini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - J Nachtman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Nagai
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | | | - E Nagy
- CPPM, Aix-Marseille Université, CNRS/IN2P3, Marseille, France
| | - I Nakano
- Okayama University, Okayama 700-8530, Japan
| | - A Napier
- Tufts University, Medford, Massachusetts 02155, USA
| | - M Narain
- Brown University, Providence, Rhode Island 02912, USA
| | - R Nayyar
- University of Arizona, Tucson, Arizona 85721, USA
| | - H A Neal
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - J P Negret
- Universidad de los Andes, Bogotá, Colombia
| | - J Nett
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - C Neu
- University of Virginia, Charlottesville, Virginia 22906, USA
| | - P Neustroev
- Petersburg Nuclear Physics Institute, St. Petersburg, Russia
| | - H T Nguyen
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - T Nigmanov
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - L Nodulman
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Y Noh
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - O Norniella
- University of Illinois, Urbana, Illinois 61801, USA
| | - T Nunnemann
- Ludwig-Maximilians-Universität München, München, Germany
| | - L Oakes
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - S H Oh
- Duke University, Durham, North Carolina 27708, USA
| | - Y D Oh
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - I Oksuzian
- University of Virginia, Charlottesville, Virginia 22906, USA
| | - T Okusawa
- Osaka City University, Osaka 558-8585, Japan
| | - R Orava
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014 Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - J Orduna
- Rice University, Houston, Texas 77005, USA
| | - L Ortolan
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193 Bellaterra (Barcelona), Spain
| | - N Osman
- CPPM, Aix-Marseille Université, CNRS/IN2P3, Marseille, France
| | - J Osta
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - C Pagliarone
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - A Pal
- University of Texas, Arlington, Texas 76019, USA
| | - E Palencia
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - P Palni
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - V Papadimitriou
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Parashar
- Purdue University Calumet, Hammond, Indiana 46323, USA
| | - V Parihar
- Brown University, Providence, Rhode Island 02912, USA
| | - S K Park
- Korea Detector Laboratory, Korea University, Seoul, Korea
| | - W Parker
- University of Wisconsin, Madison, Wisconsin 53706, USA
| | - R Partridge
- Brown University, Providence, Rhode Island 02912, USA
| | - N Parua
- Indiana University, Bloomington, Indiana 47405, USA
| | - A Patwa
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - G Pauletta
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - M Paulini
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - C Paus
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - B Penning
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - Y Peters
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - K Petridis
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - G Petrillo
- University of Rochester, Rochester, New York 14627, USA
| | - P Pétroff
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - T J Phillips
- Duke University, Durham, North Carolina 27708, USA
| | - G Piacentino
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E Pianori
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - J Pilot
- University of California, Davis, Davis, California 95616, USA
| | - K Pitts
- University of Illinois, Urbana, Illinois 61801, USA
| | - C Plager
- University of California, Los Angeles, Los Angeles, California 90024, USA
| | - M-A Pleier
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - V M Podstavkov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - L Pondrom
- University of Wisconsin, Madison, Wisconsin 53706, USA
| | - A V Popov
- Institute for High Energy Physics, Protvino, Russia
| | - S Poprocki
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Potamianos
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Pranko
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Prewitt
- Rice University, Houston, Texas 77005, USA
| | - D Price
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - N Prokopenko
- Institute for High Energy Physics, Protvino, Russia
| | - F Prokoshin
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - F Ptohos
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - G Punzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - J Qian
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Quadt
- II. Physikalisches Institut, Georg-August-Universität Göttingen, Göttingen, Germany
| | - B Quinn
- University of Mississippi, University, Mississippi 38677, USA
| | - P N Ratoff
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - I Razumov
- Institute for High Energy Physics, Protvino, Russia
| | - I Redondo Fernández
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - P Renton
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - M Rescigno
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - F Rimondi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - I Ripp-Baudot
- IPHC, Université de Strasbourg, CNRS/IN2P3, Strasbourg, France
| | - L Ristori
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - F Rizatdinova
- Oklahoma State University, Stillwater, Oklahoma 74078, USA
| | - A Robson
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - T Rodriguez
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - S Rolli
- Tufts University, Medford, Massachusetts 02155, USA
| | - M Rominsky
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Ronzani
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - R Roser
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J L Rosner
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - A Ross
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - C Royon
- CEA, Irfu, SPP, Saclay, France
| | - P Rubinov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Ruchti
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - F Ruffini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - A Ruiz
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Russ
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - V Rusu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Sajot
- LPSC, Université Joseph Fourier Grenoble 1, CNRS/IN2P3, Institut National Polytechnique de Grenoble, Grenoble, France
| | - W K Sakumoto
- University of Rochester, Rochester, New York 14627, USA
| | | | | | - M P Sanders
- Ludwig-Maximilians-Universität München, München, Germany
| | - L Santi
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - A S Santos
- LAFEX, Centro Brasileiro de Pesquisas Físicas, Rio de Janeiro, Brazil
| | - K Sato
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - G Savage
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - V Saveliev
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Savitskyi
- Taras Shevchenko National University of Kyiv, Kiev, Ukraine
| | - A Savoy-Navarro
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - L Sawyer
- Louisiana Tech University, Ruston, Louisiana 71272, USA
| | - T Scanlon
- Imperial College London, London SW7 2AZ, United Kingdom
| | - R D Schamberger
- State University of New York, Stony Brook, New York 11794, USA
| | - Y Scheglov
- Petersburg Nuclear Physics Institute, St. Petersburg, Russia
| | - H Schellman
- Northwestern University, Evanston, Illinois 60208, USA
| | - P Schlabach
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E E Schmidt
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Schwanenberger
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - T Schwarz
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - R Schwienhorst
- Michigan State University, East Lansing, Michigan 48824, USA
| | - L Scodellaro
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - F Scuri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Seidel
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Y Seiya
- Osaka City University, Osaka 558-8585, Japan
| | - J Sekaric
- University of Kansas, Lawrence, Kansas 66045, USA
| | - A Semenov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - H Severini
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - F Sforza
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - E Shabalina
- II. Physikalisches Institut, Georg-August-Universität Göttingen, Göttingen, Germany
| | - S Z Shalhout
- University of California, Davis, Davis, California 95616, USA
| | - V Shary
- CEA, Irfu, SPP, Saclay, France
| | - S Shaw
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - A A Shchukin
- Institute for High Energy Physics, Protvino, Russia
| | - T Shears
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - P F Shepard
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - M Shimojima
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - M Shochet
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - I Shreyber-Tecker
- Institution for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - V Simak
- Czech Technical University in Prague, Prague, Czech Republic
| | - A Simonenko
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - P Skubic
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - P Slattery
- University of Rochester, Rochester, New York 14627, USA
| | - K Sliwa
- Tufts University, Medford, Massachusetts 02155, USA
| | - D Smirnov
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - J R Smith
- University of California, Davis, Davis, California 95616, USA
| | - F D Snider
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G R Snow
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - J Snow
- Langston University, Langston, Oklahoma 73050, USA
| | - S Snyder
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | | | - H Song
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - L Sonnenschein
- III. Physikalisches Institut A, RWTH Aachen University, Aachen, Germany
| | - V Sorin
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193 Bellaterra (Barcelona), Spain
| | - K Soustruznik
- Charles University, Faculty of Mathematics and Physics, Center for Particle Physics, Prague, Czech Republic
| | - R St Denis
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - M Stancari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Stark
- LPSC, Université Joseph Fourier Grenoble 1, CNRS/IN2P3, Institut National Polytechnique de Grenoble, Grenoble, France
| | - D Stentz
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - M Strauss
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - J Strologas
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Y Sudo
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A Sukhanov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - I Suslov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - L Suter
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - P Svoisky
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - K Takemasa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - Y Takeuchi
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - J Tang
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - M Tecchio
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - P K Teng
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - J Thom
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E Thomson
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - V Thukral
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - M Titov
- CEA, Irfu, SPP, Saclay, France
| | - D Toback
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - S Tokar
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - V V Tokmenin
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - K Tollefson
- Michigan State University, East Lansing, Michigan 48824, USA
| | - T Tomura
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - D Tonelli
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Torre
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - D Torretta
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Totaro
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
| | - M Trovato
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - Y-T Tsai
- University of Rochester, Rochester, New York 14627, USA
| | - D Tsybychev
- State University of New York, Stony Brook, New York 11794, USA
| | | | - C Tully
- Princeton University, Princeton, New Jersey 08544, USA
| | - F Ukegawa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Uozumi
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - L Uvarov
- Petersburg Nuclear Physics Institute, St. Petersburg, Russia
| | - S Uvarov
- Petersburg Nuclear Physics Institute, St. Petersburg, Russia
| | - S Uzunyan
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - R Van Kooten
- Indiana University, Bloomington, Indiana 47405, USA
| | | | - N Varelas
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - E W Varnes
- University of Arizona, Tucson, Arizona 85721, USA
| | - I A Vasilyev
- Institute for High Energy Physics, Protvino, Russia
| | - F Vázquez
- University of Florida, Gainesville, Florida 32611, USA
| | - G Velev
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Vellidis
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Y Verkheev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - C Vernieri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - L S Vertogradov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - M Verzocchi
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Vesterinen
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - M Vidal
- Purdue University, West Lafayette, Indiana 47907, USA
| | | | - R Vilar
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Vizán
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Vogel
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - P Vokac
- Czech Technical University in Prague, Prague, Czech Republic
| | - G Volpi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - P Wagner
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - H D Wahl
- Florida State University, Tallahassee, Florida 32306, USA
| | - R Wallny
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M H L S Wang
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S M Wang
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - J Warchol
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - D Waters
- University College London, London WC1E 6BT, United Kingdom
| | - G Watts
- University of Washington, Seattle, Washington 98195, USA
| | - M Wayne
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - J Weichert
- Institut für Physik, Universität Mainz, Mainz, Germany
| | | | - W C Wester
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Whiteson
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - A B Wicklund
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Wilbur
- University of California, Davis, Davis, California 95616, USA
| | - H H Williams
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | | | - G W Wilson
- University of Kansas, Lawrence, Kansas 66045, USA
| | - J S Wilson
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - P Wilson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B L Winer
- The Ohio State University, Columbus, Ohio 43210, USA
| | - P Wittich
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Wobisch
- Louisiana Tech University, Ruston, Louisiana 71272, USA
| | - S Wolbers
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Wolfe
- The Ohio State University, Columbus, Ohio 43210, USA
| | - D R Wood
- Northeastern University, Boston, Massachusetts 02115, USA
| | - T Wright
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - X Wu
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - Z Wu
- Baylor University, Waco, Texas 76798, USA
| | - T R Wyatt
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - Y Xie
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Yamada
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yamamoto
- Osaka City University, Osaka 558-8585, Japan
| | - D Yamato
- Osaka City University, Osaka 558-8585, Japan
| | - S Yang
- University of Science and Technology of China, Hefei, People's Republic of China
| | - T Yang
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - U K Yang
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - Y C Yang
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - W-M Yao
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - T Yasuda
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y A Yatsunenko
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - W Ye
- State University of New York, Stony Brook, New York 11794, USA
| | - Z Ye
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G P Yeh
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yi
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Yin
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yip
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J Yoh
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yorita
- Waseda University, Tokyo 169, Japan
| | - T Yoshida
- Osaka City University, Osaka 558-8585, Japan
| | - S W Youn
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G B Yu
- Duke University, Durham, North Carolina 27708, USA
| | - I Yu
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - J M Yu
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A M Zanetti
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - Y Zeng
- Duke University, Durham, North Carolina 27708, USA
| | - J Zennamo
- State University of New York, Buffalo, New York 14260, USA
| | - T G Zhao
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - B Zhou
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - C Zhou
- Duke University, Durham, North Carolina 27708, USA
| | - J Zhu
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - M Zielinski
- University of Rochester, Rochester, New York 14627, USA
| | - D Zieminska
- Indiana University, Bloomington, Indiana 47405, USA
| | - L Zivkovic
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, Paris, France
| | - S Zucchelli
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| |
Collapse
|